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Abstract 
Accurate progress through the cell cycle necessitates robust order and timing of events, 
the molecular basis for which is incompletely understood. During exit from mitosis, it 
is vital for cells to execute events in a precise sequence. Completion of chromosome 
segregation must precede chromatin decondensation, or indeed, cytokinesis. 
 
In budding yeast, the ordering of mitotic exit events is imposed by the changing balance 
between Cdk kinase activity, which begins to decline upon anaphase entry, and 
increasing activity of the major Cdk-counteracting phosphatase, Cdc14. In early 
anaphase, Cdk activity is still high and little Cdc14 is active. Nonetheless, certain 
substrates, such as the spindle stabilizer Fin1, are dephosphorylated to facilitate early 
anaphase events, e.g. spindle elongation. It has been shown that Cdc14 has a high 
catalytic efficiency towards its early substrates, when compared to later substrates. 
 
In this study, we seek a molecular understanding of mitotic exit by probing the 
biochemical characteristics of early Cdc14 substrate recognition. Through 
complementary in vitro and in vivo approaches, we find that Cdc14 is a dimer and the 
non-conserved C-terminal domain is not important for dimerization or substrate 
dephosphorylation. Cdc14 prefers phosphoserines over phosphothreonines, as well as a 
basic residue in the +3 position, even when presented in the context of Fin1, a highly 
efficient substrate. Further, it engages with this substrate via its non-catalytic N-
terminal domain. 
 
We also find that Fin1 possesses a higher affinity towards Cdc14 compared to other 
substrates, which is independent of its phosphorylation sites. Truncation analysis 
revealed that Fin1’s C-terminus is important for this binding, and has a small impact 
on catalysis. Further, we have also established that early S-phase cyclin degradation is 
partly responsible for ensuring early dephosphorylation of this protein. In summary, 
multiple mechanisms collaborate to ensure efficient early substrate dephosphorylation.  
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Chapter 1. Introduction 
 ‘Omnis cellula e cellula’ – where a cell arises, a cell must have previously existed. These 
are the now famous words of Karl Virchow, published in 1858, and form the basic 
tenets of what we understand as Schleiden and Schwann’s Cell Theory (Virchow, 1858). 
 
Some 160 years since this pronouncement, our knowledge of the symphonic rhythms of 
cell division has expanded considerably. It is clear that each cell, whether a starfish egg, 
a human embryo, or anything in between and beyond, must adhere to the same basic 
rules. 
 
Cell division entails a task of enormous complexity and has been entrusted to many 
‘master regulators’. We are only beginning to understand the molecular features of 
their intricate input, by which they appear to imbue the cell with intelligence. 
1.1 The eukaryotic cell cycle 
The division of a cell into two daughters is arguably one of the common denominators 
of all forms of life. In order to accomplish this gargantuan task, every eukaryotic cell 
undergoes an archetypical series of events, called the cell division cycle. 
 
The fundamental aim of this process is to ensure error-free duplication of the genomic 
content and other organelles, followed by accurate segregation of these to give rise to 
two ‘daughter’ cells.  
 
Whilst the details may vary, the overall logic of the cell cycle and many of its molecular 
aspects are remarkably conserved through billions of years of evolution. 
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1.2 The budding yeast cell cycle 
Saccharomyces cerevisiae, or budding yeast is a small, single-celled fungal eukaryote 
that proliferates as a haploid. Owing to its genetic tractability, ease of growth and 
shared use of cell cycle circuitry with its counterparts higher up in the scale of 
complexity, it has emerged as an immensely useful tool in cell cycle research. Indeed, 
studies in budding yeast have been instrumental in illustrating its governing principles 
(Hartwell, Culotti, Pringle and Reid, 1974). Moreover, the master regulatory proteins 
have also been found to be structurally and functionally conserved in all rungs of the 
evolutionary ladder (Morgan, 2007). 
 
In order to divide, budding yeast first takes stock of its surrounding cues and, if they 
are found satisfactory, it ‘decides’ to undergo cell division (Fig. 1.1). It enters a period 
of growth called the gap phase or G1. Next, it duplicates its DNA during the ‘synthesis’ 
or S-phase. The beginning of DNA replication is phenotypically concomitant with the 
emergence of a bud. In fact, progression through the cell cycle witnesses a 
commensurate growth of the bud. Following a very short second gap phase called G2, 
the cell then enters the mitotic M-phase. Here, the duplicated and condensed genetic 
material lines up along the equatorial plane of the mother and daughter cells 
(metaphase), which is then segregated into two equal halves to the two cells in one fell 
swoop (anaphase). Budding yeast undergoes a ‘closed’ mitosis, that is, it does not break 
down the nuclear membrane, keeping the nucleoplasm and the cytoplasm separate. The 
following step is telophase during which the now virtually equal cells decondense their 
DNA. Finally, the cells physically separate their cytoplasm and cell walls to create two 
new cells - a process called cytokinesis. 
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Figure 1.1 – The budding yeast cell cycle. 
The cells enter the cell cycle in the G1-phase, following which they duplicate 
their DNA during S-phase. After another short G2-phase, they enter the M-
phase, where they properly align and segregate this duplicated DNA by dividing 
it equally between the mother and daughter cells.  
 
Whilst there are many differences between budding yeast and higher eukaryotes, such 
as the emergence of ‘open’ mitosis in the latter, in which the nuclear envelope is 
dissembled before mitosis and reassembled after chromosome segregation, the order of 
these phases is well conserved. 
 
1.3 The cell cycle is a highly regulated process 
As is to be expected, a process of such vast complexity has warranted equally exquisite 
molecular controls that ensure its fidelity, as the cost of not doing so can be 
catastrophic to the perpetuation of life. Indeed, failure to properly segregate 
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chromosomes can lead to aneuploidy, a hallmark of cancer cells. A striking feature of 
this process is how it appears to follow a predetermined schedule: S-phase follows M-
phase and the two do not normally coincide, for instance. What decides the order and 
course of events? This question has fascinated researchers for decades.  
1.3.1 Cyclin-dependent kinases are the master regulators of the cell 
cycle 
Despite it being known since 1971 that a Maturation Promoting Factor (MPF) controls 
entry into M-phase in oocytes and metazoan eggs (Masui and Markert, 1971), its 
identity remained elusive for nearly 20 years. The discovery that it is comprised of a 
heterodimeric enzyme hailed the dawn of a new era in cell cycle research. This enzyme 
is composed of a cyclin-dependent kinase (Cdk) subunit in complex with a partnering 
cyclin. Cdk alone exists in an auto-inhibited state, which is relieved by cyclin binding 
(Gautier et al., 1988; Draetta et al., 1989). Through the cell cycle, whilst the kinase 
subunit remains largely constant, the identity and abundance of the cyclin changes, 
with each exhibiting periodic waves of synthesis and destruction. Thus, MPF represents 
only one of the many cyclin-Cdk flavours. This behaviour forms the basis of a robust 
timer that ‘switches’ events on in the right order and the right time during the cell cycle 
(Murray and Kirschner, 1989; Minshull, Blow and Hunt, 1989). 
 
What constitutes these biochemical ‘switches’? Phosphorylation of hydroxyl-containing 
residues - serines and threonines - on protein substrates by cyclin-Cdk complexes was 
found to be the engine propelling the cell cycle forwards. Although the chemistry of the 
reaction had been discovered by Fisher and Krebs in the 1950s (Krebs and Fischer, 
1956; Fischer and Krebs, 1955), it only gradually became clear that phosphorylation 
constitutes one of the most important aspects of cell cycle regulation, and indeed 
cellular physiology.  
 
Cyclin-Cdk complexes phosphorylate (S/T)-P-x-(K/R)-containing consensus sites on 
proteins, with the +3 basic residue being preferred but not essential for catalysis (Nigg, 
1991; Songyang et al., 1994; Holt et al., 2009). These phosphorylation events change the 
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behaviour of the protein and hence promote a particular phase of the cell cycle. For 
instance, they can enhance protein-protein interactions or alter the biochemical activity 
of the modified protein. Whilst the road from phosphorylation to a cytological event 
has not always been straightforward, it is well understood in some instances. The 
molecular details of licensing and firing of replication origins during S-phase by 
phosphorylation are well understood (Fragkos, Ganier, Coulombe and Méchali, 2015). 
1.3.2 Cdk activity is temporally regulated by phosphorylation  
Although the Cdk-cyclin complex represents an active form of the enzyme, its activity 
can be further post-translationally modified by phosphorylation of the kinase subunit. 
An evolutionarily conserved tyrosine residue on Cdk (Y19 in budding yeast) gets 
phosphorylated by the conserved tyrosine kinase Wee1 (Swe1 in budding yeast), which 
severely inhibits associated kinase activity of many cyclin-Cdk complexes. This 
inhibition is relieved by dephosphorylation by the conserved phosphatase, Cdc25. Both 
Wee1 and Cdc25 are themselves subjected to regulatory input. Tyrosine 
phosphorylation of Cdk constitutes an important control mechanism and regulates G2-
M transition in many organisms by enabling timely, switch-like activation of the kinase 
at this stage. 
 
Another residue within Cdk, T169 in budding yeast, gets phosphorylated by Cdk-
activating kinases. For many cyclin-Cdk complexes, this phosphorylation is associated 
with an increase in kinase activity. 
1.3.3 Cdks associate with a number of cyclins throughout the cell cycle 
and control various cellular events 
Budding yeast contains only one major Cdk, called Cdc28, which sequentially 
associates with nine different cyclins through the cell cycle. In fact, each cell cycle stage 
is characterized by the presence of particular Cdc28-cyclin combinations, which in turn 
initiate the transcription of the cyclins necessary for the following stage (Fig. 1.2A). 
Three G1 cyclins, Cln1-3, fulfil the G1 function of bud site selection, licensing of 
spindle pole body (the yeast centrosome equivalent) duplication, phosphorylation of 
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the B-type cyclin inhibitor Sic1 and transcription of the two B-type S-phase cyclins, 
Clb5 and Clb6. Towards the end of G1, Cln1 and Cln2 are degraded by the proteasome 
following ubiquitylation by the E3 ubiquitin ligase SCFGrr1 (Barral, Jentsch and Mann, 
1995). Clb5 and Clb6 then promote S-phase by phosphorylation of different proteins, 
which leads to efficient initiation of DNA replication. At this stage, the two duplicated 
sister chromatids are held together by the topological embrace of a protein ‘glue’ - a 
cohesion ring (Uhlmann, 2016). Next, Clb1-4 are transcribed, promoting entry into M-
phase. This phase is characterized by formation of the spindle, which captures 
duplicated and condensed chromosomes in metaphase (Morgan, 2007; Bloom and 
Cross, 2007a). Following amphitelic attachment of each sister chromatid to the 
opposite spindle pole, the spindle assembly checkpoint (SAC) is satisfied. If this step is 
not completed, the checkpoint keeps the cells arrested in metaphase with high kinase 
activity (Musacchio, 2015). SAC satisfaction leads to activation of another E3 ubiquitin 
ligase, the Anaphase Promoting Complex/Cyclosome (APC/C). This complex causes 
destruction of securin, the binding partner and inhibitor of the protease separase. 
Unrestrained, separase then cleaves the cohesion ring, leading to segregation of sister 
chromatids to the opposite poles (Uhlmann, Lottspeich and Nasmyth, 1999). The 
APC/C also destroys all B-type cyclins, with the exception of Clb6, which is degraded 
earlier (Jackson, Reed and Haase, 2006). This decline in kinase activity at anaphase 
heralds the onset of exit from mitosis. 
 
Higher eukaryotes have evolved considerably more complex cyclin-Cdk control 
systems (Fig. 1.2B). Although they contains more than 10 different Cdks, in most 
contexts, only Cdk1 and Cdk2 appear to be important for mitosis, with the others 
providing ancillary support. These sequentially associate with cyclins D (in the absence 
of Cdk4 and 6) and E during G1/S phases, cyclin A during S-phase, followed by cyclin B 
over the course of M-phase. Each flavour of cyclin also contains multiple members 
within its family (Morgan, 2007; Hochegger, Takeda and Hunt, 2008). Despite this 
complexity, the overall sequence of events and principles of control remain the same 
between these organisms. 
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Figure 1.2 - Various cyclin-Cdk complexes are found throughout the cell 
cycle. 
A. In budding yeast, the kinase Cdc28 associates with Cln1-3, followed by Clb5, 
6, Clb3, 4 and Clb1, 2. B. In higher vertebrates, Cdk1 and Cdk2 control the cell 
cycle. These sequentially associate with cyclins E, A and B. Adapted from 
Bloom and Cross (2007) and Hochegger, Takeda and Hunt (2008) respectively. 
 
A 
B 
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1.4 Controlling ordered phosphorylation – a matter of quality 
or quantity? 
Does the presence of distinct forms of cyclins during different stages of the cell cycle 
imply their functional specialization? Or, can they stand in for each other?  
1.4.1 Qualitative model for ordered substrate phosphorylation 
The former hypothesis, described as the ‘qualitative model’, holds that different cyclins, 
when complexed with the kinase, imbue the latter with altered substrate specificities. 
Further, the model posits that their sequential rise and fall is the primary determinant 
of the timing and order of different cell cycle phases. 
 
Lending confidence to this theory are the following observations. Working in 
mammalian systems, a number of studies found that cyclin A, the S-phase cyclin, 
bound to and efficiently phosphorylated some of its substrates by employing a specific 
docking motif – the RxL or Cy motif (Krek et al., 1994; Adams et al., 1996). Structural 
analysis of cyclin A-Cdk2 bound to p107 found that it engaged with this motif via a 
complementary ‘hydrophobic patch’, centred about the conserved MRAIL sequence on 
the cyclin (Johnson, Brown, Noble and Endicott, 1999). By systematic analysis of Cdk 
substrates, a similar trend was discovered in the budding yeast S-phase cyclin Clb5 
(Loog and Morgan, 2005). It was shown to be highly efficient in phosphorylating about 
15 proteins compared to Clb2, an effect contingent upon their RxL motifs. These 
include replication factors such as Orc6 (Wilmes et al., 2004), and the APC/C 
specificity factor, Cdh1. 
 
Similarly, whilst examining the G1 cyclin Cln2 and its substrates, recent studies have 
also identified an LLPP motif, which greatly enhances Cln2-mediated phosphorylation 
of Ste5 and Ste20 (Bhaduri and Pryciak, 2011), components of the yeast Mitogen-
Activated Protein (MAP) Kinase pathway, via a specific docking site on the cyclin 
surface (Bhaduri et al., 2015). 
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In order to gain insights into whether specificity is a feature of other cyclin-substrate 
interactions in budding yeast, another study immunoprecipitated individually-tagged 
cyclin subunits, and subjected the interacting proteins to mass spectrometry 
(Archambault et al., 2004). This led to the identification of a handful of substrates that 
only associated with a particular cyclin. A similar approach was taken by another study, 
which assayed stage-specific interactors of tagged human cyclins E1, A2 and B1. Whilst 
they too found a number of specific interacting proteins, they also observed a 
significant degree of overlap between cyclin A2 and B1 interactors (Pagliuca et al., 
2011).  
 
However, these observations alone do not prove the qualitative model entirely. For 
instance, although it is true that both of the above mentioned studies identify some 
specific cyclin targets, one cannot ignore the issue of protein abundance. Cyclins (and 
some substrates too) are only present at specific stages of the cell cycle, in the absence of 
others. Thus, interactions might be partly explained by availability. Further 
strengthening this interpretation is another survey of the ability of different cyclin-Cdk 
complexes to phosphorylate proteins from a Xenopus cDNA library. Here, the authors 
found that a vast majority of substrates could be phosphorylated by several cyclin-Cdks 
(Errico et al., 2010). 
 
Indeed, genetic analyses have also revealed redundancies in cyclin functions. For 
instance, G1 cyclins within budding yeast were initially thought to perform an 
indispensible function, with a triple cln1∆ cln2∆ cln3∆ strain proving inviable 
(Richardson, Wittenberg, Cross and Reed, 1989). Deletion of the B-type cyclin 
inhibitor Sic1 (Tyers, 1996) or overexpression of Clb5 (Epstein and Cross, 1992) were 
both later found to rescue this inviability, suggesting that, given the right context, 
cyclins can indeed be interchangeable. 
 
A parallel principle was found to apply to the severe S-phase delay shown by clb5∆ 
clb6∆ cells, which could not be rescued by the advanced expression of mitotic Clb2 
from the Clb5 promoter (Schwob and Nasmyth, 1993). Concomitant deletion of Swe1, 
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that preferentially inhibits Clb2 over other cyclins by the inactivating Y19 
phosphorylation of the kinase, restored the S-phase timing (Hu and Aparicio, 2005).  
 
In many mammalian cells, deletion of all Cdks other than Cdk1 can drive the cell cycle 
through normal S-phase and mitosis (Santamaría et al., 2007; Hochegger et al., 2007). 
Similarly, barring cyclin B and, in some cases, cyclin A, all others appear to be 
redundant (Santamaría et al., 2007; Kalaszczynska et al., 2009; Kozar et al., 2004; Geng 
et al., 2003; Hochegger et al., 2007). 
1.4.2 A quantitative model for cell cycle regulation 
The observations outlined herein along with insights from a seminal piece of work by 
Fisher and Nurse (1996) has led to the proposition of a ‘quantitative model’, which 
posits that increasing kinase activity thresholds are required for entry into successive 
cell cycle phases – an idea which is not mutually exclusive with the qualitative model. 
Using fission yeast, they demonstrated that the mitotic cyclin, Cdc13, in complex with 
the sole Cdk, Cdc2, could impart directionality to the cell cycle and promote orderly 
progression into S- and M-phases in the absence of all other cyclins (Fisher and Nurse, 
1996). Furthermore, ablation of the complex in G2 caused rereplication as the kinase 
activity was presumably never allowed to build up to high level required for M-phase. 
Hence, a lower activity threshold needs to be traversed to trigger S-phase, whereas 
higher level leads to entry into mitosis (Stern and Nurse, 1996). 
 
Further work has lent credence to this model. The authors generated a translational 
fusion of Cdc13-Cdc2 under the control of the Cdc13 promoter and other regulatory 
elements, which garnered periodicity to the presence of the fusion protein by ensuring 
its destruction during mitotic exit. This module was sufficient to drive a normal cell 
cycle (at least under the parameters tested) in the absence of all endogenous cyclins and 
the Cdk. The ability of this strain to promote timely and orderly cell cycle progression 
was further explained by mathematical modelling of kinase activity throughout the cell 
cycle and showed that different activity thresholds promote different stages (Tyson and 
Novak, 2011). Moreover, use of a kinase allele whose activity can be modulated by the 
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ATP analogue 1-NM-PP1 demonstrated the existence of S- and M-phase specific kinase 
activity thresholds. More convincingly, release of G2-arrested cells into media 
containing various concentrations of the ATP analogue (and hence differing amounts 
of kinase activities) caused inappropriate entry into stages proportional to the new 
activity levels, or even overlap of stages (Coudreuse and Nurse, 2010). These cell cycle 
acrobatics demonstrate the lack of an inherent order inbuilt in the machinery.  
 
In accordance with these observations, manipulation of Clb2-associated kinase 
activities to supra-physiological levels causes an acceleration of mitosis in budding 
yeast, indicating that overall kinase activity levels promote cell cycle progression 
(Oikonomou and Cross, 2011).  
 
Is a quantitative rise in kinase activity responsible for ordering the cell cycle in 
unperturbed conditions? In budding yeast, it has been observed that whilst the sum of 
cyclin concentrations is roughly constant throughout the cell cycle, their abilities to 
activate Cdks are not, with the mitotic cyclin Clb2 being the best kinase activator, 
followed by the S-phase cyclin Clb5. Clns were found to be the poorest Cdk activators 
(Kõivomägi et al., 2011). Thus, one can indeed view progression from G1 to M-phase as 
a period of increasing kinase activity. Similarly, in metazoans, S-phase promoting 
cyclin E-Cdk2 has lower activity than mitotic cyclin B-Cdk1 (Hochegger, Takeda and 
Hunt, 2008). 
 
How does one reconcile the ‘qualitative’ and ‘quantitative’ models of cycle regulation? 
In the light of low overall kinase activity, the docking motifs perhaps exit as a failsafe, 
having evolved to make phosphorylation of some key targets highly likely. However, 
one can conservatively argue their existence does not constitute proof to the contrary, 
that other cyclins cannot take over the task of phosphorylating these in a timely fashion. 
Genetic experiments do suggest that greater overall catalytic efficiency perhaps makes 
up for the advantage that binding motifs provide. 
 
Chapter 1. Introduction 
 
27 
 
1.5 A role for phosphatases in cell cycle regulation 
That kinase activity promotes cell cycle progression is incontrovertible. However, thus 
far, tacit has been the assumption that phosphorylation of substrates would require a 
‘reset’ button, reversing the effects of phosphorylation and enabling the cell to carry out 
another round of division. In theory, this can be brought about by degradation of 
phosphoproteins. Given that hundreds, if not thousands of proteins are phosphorylated 
during the cell cycle (Ubersax et al., 2003; Holt et al., 2009; Dephoure et al., 2008) this 
would constitute an ineffective strategy, requiring an added layer of control of mass 
transcription, translation and degradation. Phosphatases provide an effective solution 
to this problem. 
 
The existence of proteins with phosphatase activity has long been known. Initially 
identified as a protein with “prosthetic group” (phosphoryl group) removing activity 
and referred to as PR enzyme (Cori and Cori, 1945), was the phosphatase we 
contemporaneously refer to as protein phosphatase 1 (PP1). Whilst research into 
kinases prospered, our knowledge of phosphatases languished as it was assumed that 
cell cycle regulation primarily occurs by oscillating kinase activity in a backdrop of 
constant and non-specific phosphatase activity. This kinase evangelism was perhaps 
fuelled by the inability to define kinase-style consensus motifs that phosphatases act on 
(Kennelly and Krebs, 1991). 
 
We now understand the importance of the cell cycle regulation that phosphatases 
provide. Recent work has highlighted their exquisite regulation, along with consensus 
motif preferences. In particular, their role during mitotic exit is crucial. As described in 
1.3.3, at this stage, satisfaction of the spindle assembly checkpoint leads to activation of 
the APC/C, in complex with Cdc20 as the co-activating protein, which causes 
destruction of cyclins at the metaphase-anaphase transition. In all organisms tested, 
Cdk downregulation is insufficient to remove phosphates on proteins – phosphatase 
activity is also required for exit from mitosis.  
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Broadly, this activity leads to a number of events associated with mitotic exit, such as 
proper segregation of sisters to the opposite poles, disassembly of the mitotic spindle, 
decondensation of chromosomes, reformation of the nuclear membrane (in 
vertebrates), eventually culminating in cytokinesis, the physical separation of the cells.  
1.5.1 Major phosphatases in eukaryotes 
Phosphatases comprise a broad group of enzymes, with the potential to regulate a 
myriad of cellular processes. They can be divided into two categories based on sequence 
homology and mode of catalysis: serine/threonine specific and tyrosine specific. 
 
As the name suggests, protein serine/threonine phosphatases (PSPs) target phosphoryl 
groups on the polar residues serines and threonines. They can be subdivided into three 
different families: phosphoprotein phosphatases (PPP), metal-dependent phosphatases 
(PPM) and aspartate-based phosphatases (Fig.1.3). Members of the PPP and aspartate-
based phosphatases have well defined roles in cell cycle regulation. 
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Figure 1.3 - The PSP superfamily. 
PSPs can be broadly divided into three classes each of which has its own 
members, catalytic mechanism, requirement of divalent cations, etc. From 
(Wlodarchak and Xing, 2016). 
 
Protein phosphatase 2A (PP2A) is one of the best known members of this family. It is 
highly conserved from yeast to man. Overall, an active enzyme consists of three 
different subunits: a scaffold subunit (A), a catalytic (C), and a regulatory subunit (B). 
The B subunit family can often control the subcellular location of the holoenzyme, and 
even provide substrate specificity. This family consists of many heterogeneous 
members (each with its own isoforms), not all of which are found in every organism. Of 
these, B55 (Cdc55 in budding yeast) and B56 have roles in cell cycle control. 
 
The PPP family also contains PP1 (called Glc7 in budding yeast), a protein that has 
been implicated in a wide variety of cellular processes, such as regulation of the spindle 
assembly checkpoint (Musacchio, 2015). It consists of a catalytic subunit that can 
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associate with hundreds of regulatory subunits, which guide its location, activity and 
enzymatic preferences. 
 
Finally, the aspartate-based family consists of the protein Fcp1, which 
dephosphorylates the C-terminal tail of RNA polymerase II (Kimura, Suzuki and 
Ishihama, 2002). Recently, its role in mitotic exit has also been discovered (discussed in 
section 1.7.2). 
 
The protein-tyrosine phosphatase (PTP) superfamily also consists of a wide array of 
phosphatases, which can act on substrates ranging from transmembrane proteins to 
fatty acids – a repertoire too diverse for detailed discussion presently. It has also been 
divided into two families on the basis of catalytic mechanism: cysteine-based and 
aspartate-based. The former family consists of the well-known phosphatase Cdc25 that 
responsible for dephosphorylating a conserved tyrosine (Y19 in budding yeast) on Cdk, 
which leads to activation of the enzyme and propels cells into mitosis (Strausfeld et al., 
1991). 
 
The other famous member of the cysteine-based PTP family is Cdc14, which belongs to 
a category called dual-specificity phosphatases, so named owing to their ability to 
dephosphorylate phosphoserines and phosphothreonines, and at least in vitro, 
phosphotyrosines. Nowhere is this enzyme better studied than in mitotic exit of 
budding yeast, where it has an essential role. 
 
1.6 Cdc14 and budding yeast mitotic exit 
1.6.1 Discovery of Cdc14 as a phosphatase 
Cdc14 was first discovered in a genetic screen by Hartwell and colleagues for 
temperature sensitive mutations that cause a cell cycle arrest. The cdc14-3 ts cells, when 
shifted to a high temperature, arrested with long mitotic spindles and a 2C DNA 
content – the late stages of mitosis (Culotti and Hartwell, 1971). This proffered some 
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clues as to the stage at which its function is required, though it was initially thought to 
be important for DNA replication only (Hogan and Koshland, 1992; Kroll, Hyland, 
Hieter and Li, 1996). 
 
The subsequent cloning of the gene and sequence analysis yielded similarities to other 
protein tyrosine phosphatases (Wan, Xu and Grunstein, 1992), which we now know to 
be the case because of their shared family. It was not until the 1990s that Cdc14 was 
definitively confirmed to possess phosphatase activity (Taylor, Liu, Baskerville and 
Charbonneau, 1997), placing it in the dual-specificity phosphatases sub-class of PTPs. 
 
The next discovery, that Cdc14 is required to directly downregulate Cdk activity, thus 
ushering on exit from mitosis (Visintin et al., 1998), brought home its importance as a 
major regulator of the cell cycle. It also explained why cdc14ts cells arrested in mitosis 
with high kinase activity.  
1.6.2 Cdc14 is a key regulator of exit from mitosis 
How does Cdc14 promote exit from mitosis? The answer is multi-pronged. Firstly, it 
leads to downregulation of Cdk activity. A peculiarity of budding yeast is that, the 
metaphase-to-anaphase transition does not lead to total abrogation of Cdk activity. 
Whilst all cyclins are completely degraded in other eukaryotes at this stage, budding 
yeast only witnesses complete destruction of the S-phase cyclin Clb5 by APCCdc20 
(Shirayama, Tóth, Gálová and Nasmyth, 1999; Lu et al., 2014). This initial activator of 
the APC, however, only leads to a partial decline of the mitotic cyclin Clb2 levels, to 
about 50% of their G2/M values (Yeong, Lim, Padmashree and Surana, 2000). 
Degradation of the persisting Clb2 pool is mediated by Cdh1 in telophase when the 
latter becomes active (Schwab, Lutum and Seufert, 1997; Yeong et al., 2000). It is Cdc14 
that dephosphorylates key residues within Cdh1, thereby activating it and seeing cyclin 
destruction through (Jaspersen, Charles and Morgan, 1999).  
 
Next, Cdc14 promotes the transcription of the yeast p27Kip1 homolog and B-type cyclin 
inhibitor Sic1, by promoting the nuclear localization of its zinc finger transcription 
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factor Swi5. It does so by dephosphorylating and thereby restoring its nuclear 
localization sequence (NLS). Cdc14 also directly dephosphorylates Sic1 (Visintin et al., 
1998), which, along with other mechanisms, renders mitotic exit irreversible (López-
Avilés, Kapuy, Novak and Uhlmann, 2009).  
1.6.3 Cdc14 is required for a number of mitotic exit events 
Abolishing Cdk activity is far from the only role of Cdc14. As phosphorylation 
mediates certain events during interphase, the same is true for Cdc14-mediated 
dephosphorylation, a subset of whose functions we have come to understand over the 
past few years.  
 
Anaphase onset is not only characterized by the dramatic splitting of the sister 
chromatids to the opposite poles of the cell, but also by a period of low dynamic 
instability associated with the elongating spindle. This enhanced spindle stability aids 
the process of doling out of the DNA to the mother and daughter cells. Cdc14, by 
directly dephosphorylating the DASH protein Ask1 and the spindle stabilizer (and PP1 
regulator (Akiyoshi, Nelson, Ranish and Biggins, 2009)) Fin1 early during anaphase 
aids this process (Higuchi and Uhlmann, 2005; Woodbury and Morgan, 2006). 
 
Next, now that anaphase onset has begun and the sister chromatids are moving to the 
opposite poles, kinetochores face a tension-less state, which could trigger inappropriate 
spindle assembly checkpoint signaling. This outcome is prevented by Cdc14-mediated 
dephosphorylation of the Chromosome Passenger Complex component INCENP 
(Sli15 in budding yeast), causing relocation of the complex on to the elongating 
microtubules, away from the kinetochores. This action provides a mechanism for 
silencing the SAC for good (Mirchenko and Uhlmann, 2010; Pereira, 2003).  
 
Elaborate mechanisms also exist within the cell that ensure replication of the genetic 
material strictly once per cell cycle. Late into anaphase, replication proteins such as 
Cdc6, Orc2 and Orc6 are dephosphorylated by Cdc14 (Bloom and Cross, 2007b; Zhai, 
Yung, Huo and Liang, 2010). Removal of phosphates stabilizes Cdc6 (Walter et al., 
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2016), whilst making the other proteins competent for origin activation and pre-
replicative complex assembly. This function of Cdc14 explains why a number of genetic 
interactions had been noted between the protein and the process of DNA replication, as 
mentioned previously. A vital aspect of Cdc14-facilitated origin relicensing is that it 
must occur late in anaphase, when Cdk activity has dropped sufficiently so as to 
prevent replication during mitotic exit.  
 
Cytokinesis, the physical pinching off of the cells into two, is the last step of cell 
division. Here too, following the execution of earlier mitotic exit events, a cytoplasmic 
pool of Cdc14 dephosphorylates key targets. Inn1 dephosphorylation, for instance, 
causes its relocalization to the bud-neck where it promotes formation of the primary 
septum (Palani et al., 2012). Similarly, dephosphorylation of Iqg1 also recruits it to the 
site of cell division for regulation of the acto-myosin ring (Miller et al., 2015). 
 
By no means an exhaustive list, these are but a small sampling of Cdc14 substrates. 
Recent proteomic studies, employing Cdc14 overexpression in metaphase-arrested cells 
(Kuilman et al., 2015) or comparison with cdc14-1ts cells (Kao et al., 2014), have 
revealed a plethora of new Cdc14 substrates. What can easily be appreciated though is 
the need for Cdc14 to act temporally to promote a multitude of processes in the right 
order, thus resetting the cell to a biochemically G1 state. 
1.6.4 Regulation of Cdc14 activity 
Unsurprisingly, given the importance of Cdc14 and the diverse roles it performs within 
the cell, its activity is tightly regulated throughout the cell cycle even though its levels 
remain constant. 
1.6.4.1 Cdc14 is sequestered by Net1 from G1 to M-phase 
A two-hybrid screen for Cdc14 interactors identified the nucleolar protein Net1 as a 
key inhibitor of Cdc14 (Visintin, Hwang and Amon, 1999). Subsequent biochemical 
analyses revealed that this large 1,189 amino acid-long, 128 kDa protein is a potent and 
specific competitive inhibitor of Cdc14. The constant of inhibition, Ki was found to be 3 
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nM (using tyrosine-phosphorylated Myelin Basic Protein as a Cdc14 substrate) at least 
in a sub-physiological ionic strength buffer (100 mM KCl). Increasing the KCl 
concentration to the slightly more physiological value of 120 mM led to a Ki of 74 nM 
(Traverso et al., 2001a), indicating the salt sensitivity of this interaction. 
 
Net1 binds to and tethers Cdc14 in the nucleolus, thus inhibiting its activity from G1 
through to anaphase onset. At this stage, phosphorylation of Net1 and probably Cdc14, 
mediated by Cdc5 (the yeast Polo-like kinase) and Clb2-Cdc28 reduce the affinity of the 
proteins for each other (Yoshida and Toh-e, 2002; Shou et al., 2002; Visintin, Stegmeier 
and Amon, 2003). Unfettered, Cdc14 begins to be released, bringing about 
dephosphorylation of substrates and exit from mitosis.  
 
The temporal window encompassing Cdc14 release is thus restricted to precisely when 
its activity is required – avoiding futile cycles of phosphorylation and 
dephosphorylation outside this period.  
 
What promotes Cdc14 release from Net1? A series of two distinct signaling cascades, 
named FEAR (Fourteen Early Anaphase Release) and MEN (Mitotic Exit Network) 
pathways, promote two sequential waves of release of Cdc14 upon anaphase onset.  
 
1.6.4.2 FEAR pathway causes Cdc14 release in early anaphase 
Early into anaphase, securin cleavage leads to the activation of separase. Separase, along 
with concerted action of the proteins Slk19 and Spo12, leads to Zds1/Zds2-mediated 
downregulation of PP2ACdc55 activity, which, up until now, had been keeping Net1 
dephosphorylated (Rossio and Yoshida, 2011; Queralt and Uhlmann, 2008; Stegmeier, 
Visintin and Amon, 2002; Sullivan and Uhlmann, 2003). Thus Clb2-Cdc28 and Cdc5 
gain the upper hand and are now able to phosphorylate Net1 on key sites, causing its 
dissociation from Cdc14 (Azzam, 2004). How these components come together 
biochemically to promote Cdc14 release is poorly understood. 
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FEAR-mediated Cdc14 release is thought to be only “partial” and is cytologically 
restricted to the nucleus; for “fully” released Cdc14, particularly into the cytoplasm, the 
second, Ras-like MEN signaling pathway is required. 
1.6.4.3 MEN pathway causes sustained release of Cdc14 from mid- to late-
anaphase 
Mutations that abrogate MEN signaling lead to a late anaphase arrest, highlighting its 
importance in Cdc14 release. At the top of this cascade is the GTPase protein Tem1, 
which is stimulated by declining Cdk activity and rising Cdc14 activity (Jensen et al., 
2002). It activates the protein kinases Cdc15 and Dbf2-Mob1, which sustain the 
phosphorylation of Net1, thereby keeping Cdc14 released (Asakawa, Yoshida, Otake 
and Toh-e, 2001; Bardin, Boselli and Amon, 2003; Lee et al., 2001; Mah, Jang and 
Deshaies, 2001). Cdc14 also dephosphorylates and activates Cdc15, thereby sanctioning 
its own freedom (Jaspersen and Morgan, 2000). Tem1 is negatively regulated by the 
GTPase activating protein complex Bub2-Bfa1, which is further phosphorylated and 
inactivated by Cdc5 (Hu et al., 2001). 
 
At this stage, Cdc14 is also granted admittance to the cytoplasm by Dbf2-Mob1-
mediated phosphorylation and abrogation of its nuclear localization signal (Mohl et al., 
2009), thus probably allowing its nuclear export signal (NES) to predominate 
(Bembenek et al., 2014). 
 
Later in anaphase, following the Cdh1-mediated degradation of Cdc5 (Visintin et al., 
2008) - which removes the Net1 phosphorylation signal - and dephosphorylation and 
activation of Bfa1 (Pereira, Manson, Grindlay and Schiebel, 2002; Baro et al., 2013)  (a 
negative regulator of MEN), Cdc14 is resequestered into the nucleolus. 
 
Curiously, there has been one report of a substrate, Dsn1 – a part of the MIND complex 
at kinetochores – being dephosphorylated by Cdc14 in metaphase, when the latter’s 
activity is thought to be inhibited (Akiyoshi and Biggins, 2010). 
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Why has Cdc14 release evolved to be rather complicated? One explanation proffered is 
that every protein requirement ensures that a separate, earlier biological event has been 
completed. For instance, the requirement for separase for FEAR activation ensures 
satisfaction of the spindle assembly checkpoint, concomitant cohesin cleavage, and 
hence commitment to exit from mitosis. Similarly, the MEN GTPase Tem1, found on 
the spindle pole body, can only meet its activating GEF (Guanine Exchange Factor) 
Lte1, present in the daughter bud, when the dividing nucleus partitions correctly along 
the mother-bud axis, enters the daughter and brings the two proteins together (Bardin, 
Visintin and Amon, 2000). Thus, it only leads to the release of Cdc14 under strict 
conditions of accurate partitioning of the spindle, which have been called the ‘spindle 
positioning checkpoint’. 
 
Differences between levels and localization notwithstanding, FEAR or MEN-released 
Cdc14 are not biochemically distinct. In fact, globally, one can envision the following 
picture of mitotic exit: one of Cdk activity levels falling concomitant with steadily 
increasing Cdc14 activity released through these pathways (Fig. 1.4). 
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Figure 1.4 - Cdk/Cdc14 activity levels throughout the cell cycle. 
Cdk1 activity (blue) experiences a dynamic change throughout the cell cycle, 
reaching a maxima at anaphase and falling to its G1 levels after anaphase. 
Cdc14 activity (red) remains constrained through most of the cell cycle, rising 
gradually from anaphase onset. 
 
1.7 Cdc14 and phosphatases in other organisms 
Cdc14 orthologs are found in a wide variety of species, with considerable conservation 
of the overall structure (discussed in section 1.8.2). Given the importance of the 
phosphatase in budding yeast cell cycle, does it perform the same functions within 
other organisms too? Overall, it appears that the mitotic exit function of the Cdc14 has 
not been conserved through evolution. Instead, different organisms have varying 
reliance on the phosphatase to promote a number of other cellular functions (Fig. 1.5). 
Mitotic exit promotion has been taken up by other phosphatases, the identity and 
substrates of which, barring a few, remain at large in many organisms.  
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Figure 1.5 - Diverse roles of Cdc14 in different organisms. 
Functions of S. cerevisiae (ScCdc14) S. pombe (Clp1), C. elegans (CeCdc14), 
X. Leavis (XCdc14A), G. gallus (cCdc14A/B) and human (hCdc14A/B) are 
depicted, with Cdc14 localization in red. Adapted from Mocciaro and Schiebel 
(2010).  
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Nonetheless, the principle that exit from mitosis requires Cdk-opposing phosphatase 
activity(ies) is a defining feature of eukaryotic life. 
1.7.1 Schizosacchromyces pombe (fission yeast) 
The fission yeast homolog of Cdc14, Clp1/Flp1 was found to be inessential for 
executing exit form mitosis (Cueille et al., 2001). Similar to its budding yeast 
counterpart, Clp1 is nucleolar during most of interphase. However, it is released at the 
G2/M transition in a Cdk1 phosphorylated, inactive form, spreading to the nucleus and 
the cytoplasm at the same time. Following a decline in Cdk activity in anaphase, it 
autocatalytically removes these phosphorylations and self-activates (Wolfe, McDonald, 
Yates and Gould, 2006).  
 
Clp1 was shown to dephosphorylate and inactivate the Cdk-activating phosphatase 
Cdc25 both in vivo and in vitro (Wolfe and Gould, 2004), thereby contributing to Cdk 
downregulation. Similarly, it has also been implicated in dephosphorylation of Ase1, a 
microtubule-bundling spindle midzone protein, thus contributing to anaphase spindle 
dynamics (Fu et al., 2009). Later in mitosis, a signalling cascade analogous to MEN, 
called the Septation Initiation Network (SIN) enables localization of Clp1 to the acto-
myosin ring, where it regulates septum formation. Accordingly, although clp1∆ cells are 
viable, they display frequent defects in cytokinesis (Celton-Morizur et al., 2004). In 
these regards, Clp1 and ScCdc14 display some overlap in their cellular functions. 
 
Which phosphatases promote mitotic exit in fission yeast? A recent study found the 
existence of a ‘relay’ driving mitotic exit, wherein upon anaphase onset, active PP1 
sequentially activates PP2A-B55, which then initiates PP2A-B56 activation. Disruption 
of this regulatory cascade leads to errors in chromosome segregation (Grallert et al., 
2014). As these events correlate with mitotic exit, it is tempting to speculate that these 
are bona fide mitotic exit phosphatases. However, the knowledge of which substrates 
they dephosphorylate and how these relate to cytological events still eludes us. 
Proteomic studies have identified many PP2A-B55 substrates (Bernal et al., 2014), but 
they tend to cluster in processes controlling cellular metabolism.  
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1.7.2 Mammalian cells 
1.7.2.1  Mitotic exit function of Cdc14 is not conserved in mammals 
In mammalian cells, Cdc14 is found in three, structurally similar isoforms: Cdc14A, 
Cdc14B and Cdc14C. Overall, the three isoforms appear to have distinct expression 
profiles in tissues and even subcellular locations. For instance, Cdc14A is found to be 
primarily centrosomal (Mailand et al., 2002) whilst Cdc14B appears nucleolar during 
interphase (Li et al., 1997). During mitosis, they appear delocalized from these locations, 
similarly to their budding yeast counterpart. Mechanisms controlling this 
delocalization or indeed their locations are not well understood. 
 
Substrates and processes regulated by Cdc14A and B have mostly been discovered on a 
case-by-case basis, with findings as to the functions of these phosphatases often being 
inconsistent. For instance, one study found that overexpression of Cdc14A in U2OS 
cells led to unscheduled centrosome amplification and supernumerary spindles, along 
with chromosome missegregation and cell death (Mailand et al., 2002). Overexpression 
of Cdc14B had no effect in these cells. However, Cdc14B knockdown using siRNA in 
HeLa cells caused extensive centrosome duplication, with overexpression causing a 
prolonged S-phase (Wu et al., 2008). 
 
Similar studies taking overexpression/knockdown approaches have implicated the 
proteins in a myriad of other cellular processes such as regulation of Cdk activity by 
dephosphorylating Wee1 and altering its stability (Ovejero, Ayala, Bueno and Sacristan, 
2012) or Cdc25 dephosphorylation which inhibits its activity (Vazquez-Novelle et al., 
2010), dephosphorylation of ERK3 leading to its stabilization (Tanguay, Rodier and 
Meloche, 2010), promotion of mitotic exit by dephosphorylation and degradation of 
the histone deacetylase Sirt2 (Dryden et al., 2003), etc. 
 
In contrast, other studies taking a homozygous knockout approach have failed to 
replicate these cell cycle phenotypes. Instead, these studies have implicated Cdc14 
phosphatases in DNA repair processes. For instance, Cdc14A or Cdc14B single 
Chapter 1. Introduction 
 
41 
 
knockout cells showed no cell cycle delay and were competent in mounting a DNA 
damage response, but showed elevated levels of background DNA damage and reduced 
DNA damage repair (Mocciaro et al., 2010), associating the phosphatases with this 
process.  
 
Accordingly, Mouse Embryonic Fibroblasts (MEFs) homozygous null for Cdc14B 
displayed DNA repair defects which were found to be redundantly controlled by 
Cdc14A (Lin et al., 2015). Otherwise, these cells were found to have normal cell cycle 
profiles, contradicting previous studies that linked Cdc14B with mitotic processes. In a 
similar vein, contrary to previous reports, Cdc14B homozygous knockout RPE-TERT 
cells exhibited no discernible mitotic phenotype when scored for events such as 
chromosome segregation, mitotic exit, and cytokinesis (Berdougo, Nachury, Jackson 
and Jallepalli, 2014). 
 
Taken together, an overall theme in Cdc14 studies has emerged: misexpression or 
knockdown studies tend to have a cell cycle phenotype whilst knockout studies do not. 
How to reconcile these observations? It is worth mentioning that Cdc14A and B double 
knockout cells still await analysis, thus redundancy between the proteins cannot be 
ruled out, as is known to be the case for proteins such as the mammalian Cdc25 
paralogs (Ferguson, White, Donovan and Piwnica-Worms, 2005). It is also possible that 
knockout cell lines do not recapitulate previous observations as the procedure leads to 
selection of cells that have adapted to the loss of the proteins via different mechanisms. 
Extrapolating from observations in Caenorhabditis elegans, a study found that RNAi of 
Cdc-14 caused many cytokinetic defects in embryos, which causes embryonic lethality 
in the long run (Gruneberg, Glotzer, Gartner and Nigg, 2002). However, another study 
was successful in generating Cdc-14 null worms, perhaps alluding to the existence of 
compensatory mechanisms (Saito et al., 2004). In contrast, comparison of acute and 
well as long-term Cdc14 knockout performed in human cells by Berdougo and 
colleagues (2014) found no differences in phenotypes. 
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In summary, the involvement and precise functions of Cdc14 proteins are far from 
clear in mammals, but they do not appear to be major players in mitotic exit.  
1.7.2.2  PP2A is a mammalian mitotic exit phosphatase  
Nonetheless, regulation by phosphatases has been shown to be a central requirement of 
mitotic exit in mammals. 
 
Potapova et. al., (2006) found that chemical inhibitor-mediated downregulation of Cdk 
activity at metaphase in HeLa cells led to mitotic exit and cytokinesis. This was 
accompanied by loss of phosphorylation of Cdh1, indicating activation of 
phosphatase(s). Other studies found that treatment of cells with okadaic acid (OA) (an 
inhibitor of PP1 and PP2A depending on the concentration used, with the IC50 of PP2A 
being 100-fold lower) lessened bulk substrate dephosphorylation (Skoufias et al., 2007; 
McCloy et al., 2015). Similarly, OA treatment or siRNA of B55α or B55δ, too led to 
preservation of mitotic phosphorylations (Manchado et al., 2010; Schmitz et al., 2010). 
 
These observations have led to the conclusion that certain isoforms of PP2A-B55 
contribute to mitotic exit in higher animals. But, how is its activity regulated to 
coincide with mitotic exit? Findings in various model organisms have led to the 
following picture: PP2A-B55 activity is firstly downregulated at mitotic entry, which 
enables efficient Cdk activation via dampening of Wee1 activity. Cdk1 phosphorylates 
and activates the conserved kinase Greatwall (also known as MASTL in humans), 
which then goes on to phosphorylate two highly unstructured, small protein inhibitors 
called Ensa and Arpp19 (Mochida, Maslen, Skehel and Hunt, 2010; Ma et al., 2016; 
Vigneron et al., 2009; Burgess et al., 2010; Gharbi-Ayachi et al., 2010). These act as 
‘unfair substrates’ for PP2A, as the enzyme exhibits very high Km and low kcat towards 
them, in effect being inhibited by the proteins (Williams et al., 2014).  
 
Following anaphase, cyclin proteolysis leads to the downregulation of Cdk activity and 
causes dephosphorylation and inactivation of Greatwall by PP1, Fcp1 and PP2A-B55 
itself (Heim, Konietzny and Mayer, 2015; Ma et al., 2016; Monica et al., 2015). With the 
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kinase input ablated, Ensa/ARPP19 can now be dephosphorylated by PP2A or by Fcp1 
(Williams et al., 2014; Hégarat et al., 2014), thereby relieving PP2A-B55 inhibition. 
Unconstrained, the phosphatase can now dephosphorylate its substrates.  
 
By combining mass spectrometry- and modelling-based approaches, a recent study has 
been able to delineate hundreds of PP2A-B55α substrates during an induced mitotic 
exit in vivo (Cundell et al., 2016), controlling processes such as spindle dynamics and 
nuclear envelope reassembly.  Accordingly, a previous study also identified the spindle 
midzone protein Prc1 (human Ase1 homolog) as a PP2A-B55α substrate during mitotic 
exit (Cundell et al., 2013). However, this study and others did not detect complete 
substrate dephosphorylation by PP2A-B55 alone, as adjudged by western blotting with 
a pan-Cdk antibody. This observation points to the complicity of other phosphatases in 
bringing about mitotic exit.  
 
Accordingly, PP1 has also been proposed as a major mitotic exit phosphatase. In an 
analogous regulatory circuit to PP2A, PP1 also gets activated during mitotic exit due to 
Cdk downregulation. Autodephosphorylation of an inactivating residue, followed by 
dephosphorylation and dissociation of a small protein inhibitor, Inhibitor-1 generates 
active PP1 (Wu et al., 2009). Indeed, substrate dephosphorylation following PP1 
activation has been observed in some studies (such as Manchado et. al., 2010). Whether 
this is primarily due to PP1-mediated activation of PP2A-B55, or due to its more direct 
role in opposing Cdk phosphorylations remains an open question. 
 
Overall, one can say that no one phosphatase has been identified whose inhibition leads 
to a complete block of mitotic exit. It is possible that this is due to siRNA-related 
technical reasons. The other possibility is that many phosphatases collaborate to bring 
about mitotic exit in mammalian cells and that redundancy is built into the system. 
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1.7.3 Other organisms 
The contribution of Cdc14 in bringing about mitotic exit is not much clearer in other 
organisms. Xenopus laevis contains two Cdc14 homologs, XCdc14A and XCdc14B, 
which share considerable sequence identities with the human hCdc14A and hCdc14B 
respectively (Mocciaro and Schiebel, 2010; Krasinska et al., 2007). Of these, only 
XCdc14A has been studied in some detail. The ectopically expressed protein localizes to 
the centrosome during interphase, but is found at the midbody in mitosis where it has 
been implicated in cytokinesis (Krasinska et al., 2007), but has not been found to have a 
more general role in mitotic exit.  
 
Recent studies have started to unravel this knot: one reported the existence of an 
oscillating phosphatase activity that was required for the second meiotic exit in 
PP2B/Calcineurin-released Xenopus egg extracts (Mochida and Hunt, 2007), the 
identity of which was later revealed to be PP2A-B55δ (Mochida, Ikeo, Gannon and 
Hunt, 2009). This is in accordance with an earlier report that biochemically assayed for 
phospho-H1 directed phosphatase activity from fractionated extracts (Ferrigno, Langan 
and Cohen, 1993), indicating that PP2A-B55δ activity indeed controls mitotic exit. 
 
However, based on further experiments, one is forced to conclude that PP2A-B55δ is 
only a part of the mitotic exit story: whilst immunodepletion of this B isoform in 
interphase led to a complete block of mitotic exit (when induced by Cdk inhibition), 
doing so in mitotic extracts had a very small affect (Mochida et al., 2009), arguing that 
other phosphatases might be doing the bulk of the heavy lifting. 
 
A similar theme has emerged in Drosophila. Although PP2A-B55 has been suggested to 
be important (Mayer-Jaekel et al., 1993), an RNAi screen directed against multiple 
phosphatases found that many, in fact collaborate to bring about mitotic exit (Chen et 
al., 2007). The details of requirement of each will have to be teased out further. In both 
Drosophila and Xenopus, the Greatwall-Ensa/Arpp19 regulation operates, showing that 
this level of phosphatase control is highly conserved. 
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More generally, that mitotic exit requires phosphatases is unequivocal, even though 
their identities and regulation vary between organisms.  
 
1.8 Biochemical properties of Cdc14 
1.8.1 Mechanism of catalysis 
As mentioned previously, Cdc14 phosphatases belong to a family of dual-specificity 
phosphatases that can dephosphorylate both phosphoserine (pSer)/phosphothreonine 
(pThr) and phosphotyrosine (pTyr) residues. Although the overall dephosphorylation 
mechanism is conserved with other PTPs, their unique active site, defined by the 
consensus HC-(x)5-R, allows accommodation of both types of residues (Tonks, 2006).  
 
The active site contains the catalytic cysteine, Cys283 in budding yeast, which mounts a 
nucleophilic attack on the phosphorous atom of the incoming phosphorylated substrate 
(Fig. 1.6A). This leads to the formation of a thiol-phosphate intermediate, a step 
stabilized by the general acid Asp253 which donates a proton to the dephosphorylated 
protein. At this stage, the newly dephosphorylated substrate dissociates. Next, a water 
molecule leads to hydrolysis of the thiophosphate enzyme intermediate, again mediated 
by the general base Asp253, that accepts a proton from the water molecule (Fig. 1.6B) 
(Wang et al., 2004). Following this step, the phosphate moiety dissociates from the 
enzyme (Fig. 1.6C). 
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Figure 1.6 - Cdc14 catalysis mechanism.  
A. Phosphate of the substrate experiences a nucleophilic attack by the thiol-
containing Cys283, leading to B. an enzyme-phosphate intermediate and 
dissociation of the substrate. C. The general acid Asp253 and a water molecule 
lead to regeneration of the enzyme. Adapted from (Hobiger and Friedrich, 
2015).  
 
Structures of human Cdc14B indicate that although the Cdc14 catalytic pocket can 
easily accommodate pSer residues, it lacks the depth required for pTyr residue 
dephosphorylation (Gray, Good, Tonks and Barford, 2003). Accordingly, even though 
it is competent in pTyr-targeted activity in vitro (Taylor et al., 1997), in vivo, Cdc14 is 
thought to target pSer/pThr residues. 
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1.8.2 Structural properties 
S. cerevisiae Cdc14 is a 551 amino acid long, 62 kDa protein. Curiously, it was found to 
be oligomeric in vitro via a number of biophysical and biochemical techniques (Taylor 
et al., 1997). The significance of this property is unknown.  
 
As alluded to previously, all of our structural knowledge of the enzyme stems from a 
crystal structure of a portion of the human Cdc14 isoform, Cdc14B (Gray et al., 2003). 
A spontaneously truncated form of this protein was found to readily crystallize. 
Determination of its structure divulged the reason: this part contained a well-ordered, 
bipartite structure composed of two equivalently sized, globular domains arranged in 
tandem: the N-terminal domain A and the domain B, but lacked the C-terminal 
domain. Domains A and B compose the catalytic core of the enzyme. Sequence 
alignment with Cdc14 orthologs from diverse species has revealed that whilst these 
domains are evolutionarily well conserved and exhibit considerable sequence homology, 
the C-terminal domain is variable in both length and residue composition (Mocciaro 
and Schiebel, 2010).  
 
Domain B adopts a classical dual-specificity phosphatase fold and contains the 
phosphatase consensus site along with all the residues required for catalysis. It forms 
the lion’s share of the active site of the enzyme, with some contribution from domain A. 
The two domains are connected by a linker alpha helix which lies at the base of the 
active site (Fig. 1.7).  
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Figure 1.7 - Structure of ScCdc14. 
A homology model of ScCdc14 was constructed using SWISS-MODEL 
(Schwede, Kopp, Guex and Peitsch, 2003), with hCdc14B structure as a 
template. Domain A is shown in red, and domain B in blue. The linker alpha 
helix is depicted in green. The catalytic Cys283 is shown in a stick 
representation in yellow. 
 
Even though the two domains possess little in the way of sequence identity between 
each other (11%), domain A, too, was found to adopt a DSP-like fold (Gray et al., 2003). 
Crucially however, it lacks a phosphate-binding cradle and all the residues necessary for 
catalysis (Gray et al., 2003). Nonetheless, it contributes two residues, Phe47 and Tyr132 
in budding yeast, that select for a Pro at the +1 position. Finally, the linker helix was 
found to possess a number of acidic residues facing inwards into the active site (Gray et 
al., 2003), and these could contribute to incoming phosphopeptide selection. 
 
Comparison of the apo- and phosphopeptide-bound Cdc14B structures further 
revealed that there was no significant structural change or movement induced by 
binding of the substrate. Thus, unlike many other phosphatases, Cdc14 does not 
undergo conformational changes in response to phosphopeptide binding. 
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At present, domain C remains the only part of Cdc14 about which we have no 
structural information. Analysis using the secondary structure prediction software 
PSIPRED (McGuffin, Bryson and Jones, 2000), revealed that domain C contains no 
elements that are reliably predicted as structured, perhaps explaining its recalcitrance to 
crystallization. Deletion of this domain in vitro leads to slightly compromised 
phosphatase activity of the enzyme (Taylor et al., 1997). It is nonetheless thought to 
perform a regulatory role: it possesses a NES (spanning residues 359-367) (Bembenek et 
al., 2014) and a NLS at the very C-terminus of the protein. As mentioned previously, 
phosphorylation of the NLS late in anaphase by MEN kinases is thought to be the 
mechanism enabling Cdc14 release into the cytoplasm (Mohl et al., 2009). 
 
Can domain B function by itself as a phosphatase? Aside from some contribution to +1 
Pro specificity, does domain A exert any influence on substrate specificity? How does 
domain C contribute to these processes in vivo and in vitro? These questions remain to 
be answered. 
1.8.3 Phosphosite specificity of Cdc14 
The structure of Cdc14 has shed light on its preference for Cdk substrates i.e. pSP/pTP. 
Are there any other subtleties of enzyme-phosphosite interactions that further delineate 
substrate specificity? 
 
The first question that comes to mind is: does Cdc14, like Cdk (Suzuki et al., 2015), 
prefer phosphoserines? A recent study examining this question found that ScCdc14, 
and indeed those from fission yeast and humans, have a very strong preference for 
serines over threonines (Bremmer et al., 2012). Substitution of pSer for pThr of a Cdc6-
derived peptide, for instance, led to a drop in the catalytic efficiency of the enzyme 
towards it by three orders of magnitude, caused by a decrease in both kcat and Km. Steric 
hindrance, caused by a clash between the methyl side-chain of threonine and Ala316 of 
the Cdc14 active site (Fig 1.8), was cited as the reason behind this pSer selectivity. 
Although mutagenesis of Ala316 to Gly relieved some of this specificity in vitro 
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(Bremmer et al., 2012), it came at the cost of a massive reduction in overall catalytic 
ability of the enzyme, making detailed analysis difficult. 
 
 
Figure 1.8 – Structural basis for pSer specificity of Cdc14.  
An in silico model showing Cdc14 active site (in grey) containing the conserved 
Ala316 (in mesh), that might serve as a steric hindrance to the binding and 
subsequent catalysis of the methyl group (in purple) containing threonine side 
chain (in stick representation). Adapted from Bremmer et. al., (2012). 
 
It is still unknown how, if at all, this selectivity translates in vivo. Given that 22% of Cdk 
phosphorylated substrates are threonines (based on (Holt et al., 2009)), and indeed a 
considerable proportion of dephosphorylation events dependent on Cdc14 are also on 
pTPs (Kao et al., 2014; Kuilman et al., 2015), makes this question pertinent. 
 
Further, during the course of this project, a new publication posited that the ‘full’ Cdk 
consensus site, (S/T)-P-x-(K/R), containing a +3 lysine or arginine, is preferred by 
Cdc14 (Eissler et al., 2014). Surprisingly, molecular dynamic studies of this peptide and 
the Cdc14 active site showed that the positively charged lysine at the +3 position, 
instead of forming salt bridges with the acidic residues of the Cdc14 linker alpha helix 
as predicted, interacted with Phe47 and Tyr44 within the active site, engaging in cation-
π interactions, i.e. electrostatic interactions between the delocalized electron cloud of 
these aromatic residues and the positively charged nitrogen ion of the lysine (Eissler et 
al., 2014). Basic residues downstream of the +3 position were predicted to interact with 
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the linker helix. These ideas, however, remains to be experimentally verified. These 
preferences were found to extend to enzymes from other species as well. However, in 
the crystal structure of hCdc14B bound to a peptide, ApSPR, the +3 Arg was not found 
to be structured, possibly because it engaged in a number of different interactions, 
leading to some doubt as to the precise nature of +3 residue interactions. As before, the 
importance of this position in vivo, within the context of an endogenous substrate 
(rather than a peptide) needs to be determined. 
 
Finally, the -1 position of the Cdc14-bound peptide was found to be solvent directed in 
the crystal structure, making no significant contacts with the enzyme, perhaps 
indicating a lack of selectivity at this position by the phosphatase (Gray et al., 2003). 
 
Another study found that Cdc14 disfavored catalysis of sites phosphorylated by the 
meiosis-specific serine/threonine kinase, Ime2. These sites are defined by the consensus 
RP-x-(S/T) - a subset of Cdk sites. This aversion of Cdc14 was proposed to protect 
phosphorylation of certain proteins, such as Cdh1 and the Mcm2-7 complex, thereby 
preventing complete exit from the meiotic program and DNA rereplication between 
the first and second meiotic divisions upon Cdc14 release (Holt, Hutti, Cantley and 
Morgan, 2007). The mechanistic details driving this specificity are unknown. 
 
Outside the catalytic center, whether Cdc14 possesses other substrate specificities is still 
an open question. 
 
1.9 The quantitative model of exit from mitosis  
Observations from the previous two sections bring to light two important features of 
Cdc14: the fact that it is biochemically geared to target Cdk substrates, yet it does so at 
different times during mitotic exit. In other words, there is a measure of temporality to 
the dephosphorylation of substrates, which correlates with the order in which their 
function is required.  
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What brings about this order? Whilst a number of explanations were put forward, a 
study has examined this question in depth and proposed the ‘quantitative model of exit 
from mitosis’ (Bouchoux and Uhlmann, 2011). Representative substrates that were 
dephosphorylated in vivo with ‘early’ (Fin1), ‘intermediate’ (Sli15) and ‘late’ (Orc6) 
timings were chosen. The ability of both Clb2-Cdc28 and Cdc14 to act on them was 
examined in vitro. The kinase, in part, showed similar catalytic efficiencies towards the 
substrates. Cdc14 exhibited markedly varied catalytic efficiencies towards them. 
However, the only parameter that correlated with the timing of dephosphorylation in 
vivo was the activity ratio of the phosphatase to kinase. It was found to be very high for 
Fin1, lower for Sli15, and lesser still for Orc6. This shows that both decreasing kinase 
activity, and concomitantly increasing phosphatase activity are in a constant tussle 
within the cell. At different stages during mitotic exit, depending on the unique 
sensitivity of each substrate to this ratio, will the phosphatase gain the upper hand and 
lead to complete substrate dephosphorylation. By extension, this will lead to the 
promotion of a particular cellular function in a specific order (Fig 1.9). 
 
 
 
 
 
 
Chapter 1. Introduction 
 
53 
 
 
Figure 1.9 - A quantitative model for Cdk substrate dephosphorylation 
during mitotic exit.  
Cdk substrates are dephosphorylated in an ordered manner depending on the 
ratio of Cdk to Cdc14 phosphatase activity during mitotic exit. At this stage, Cdk 
activity is declining due to the actions of the APC, and Cdc14 activity is rising 
due to the successive actions of the FEAR and MEN pathways. From Bouchoux 
and Uhlmann (2011).  
 
Intuitively, it makes sense as neither reaction exists in isolation within the cell. Further, 
studies examining this relationship found that increasing Clb2-associated kinase 
activity led to a dose-dependent delay in mitotic exit events (Drapkin et al., 2009), with 
analogous findings in human cells (Wolf, Wandke, Isenberg and Geley, 2006). 
 
However, there are other factors that can influence the dephosphorylation timing. In 
budding yeast that undergoes closed mitosis, localization of a substrate might become 
important. Cdc14 is not permitted access to the cytoplasm until later in mitosis, where 
a number of substrates (such as the cytokinetic machinery) lie. Accordingly, forced 
localization of Cdc14 to the nucleus by its fusion with a strong ectopic NLS promoted 
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mitotic exit but not cytokinesis (Kuilman et al., 2015). The representative substrates 
tested in the Bouchoux & Uhlmann (2011) study were all nuclear, showing that within 
this compartment, the quantitative model holds. One can thus assume that when Cdc14 
is released into the cytoplasm, the same rules would be applicable, albeit later into the 
cell cycle.  
 
Substrate competition can also play a part, especially in early anaphase, when small 
quantities of active enzyme face a vast molar excess of phosphorylated substrates. In 
vitro, competition with earlier, more efficient substrates was found to delay the 
dephosphorylation of the late substrate Orc6 (Bouchoux and Uhlmann, 2011). 
 
Finally, whilst many substrates within the cell are soluble and can exhibit free diffusion, 
a number of them are found as components of fixed complexes wherein free diffusion is 
not possible. Thus, it is possible that the catalysis reaction would deviate from the 
generally assumptions of Michaelis-Menten kinetics. 
 
1.10  Early substrate dephosphorylation 
Shifting our focus back to early anaphase, the following situation emerges: newly 
released Cdc14 faces a large stoichiometric excess in its choice of substrates.  
 
This stage also witnesses a number of critical events, such as securin degradation that 
promotes cohesion cleavage and sister chromatid separation. A study found that Cdk 
phosphorylation of residues close to securin’s degron motifs inhibited APC action on 
the protein, which was relieved by Cdc14 dephosphorylation (Holt, Krutchinsky and 
Morgan, 2008). 
 
Similarly, a role for Cdc14 in enabling complete compaction and segregation of the 
rDNA locus has been proposed (Sullivan, Higuchi, Katis and Uhlmann, 2004; 
D'Amours, Stegmeier and Amon, 2004), by enabling anaphase-specific recruitment of 
the condensing complex (D'Amours, Stegmeier and Amon, 2004).   
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As such, despite high kinase activity at this stage, Cdc14 needs to dephosphorylate 
some key targets, for which the reaction equilibrium must lie decidedly towards 
dephosphorylation (Fig. 1.10) for some substrates. What are the factors controlling 
efficient early substrate dephosphorylation? Possible explanations will be dealt with 
herewith.  
 
 
Figure 1.10 - Balance of powers in early anaphase. 
Early anaphase witnesses a large excess of Cdk activity over Cdc14 activity, 
which still leads to the dephosphorylation of some early substrates. 
 
1.10.1 Clb5 degradation in early anaphase 
As mentioned previously, budding yeast exhibits a biphasic pattern of Cdk inactivation, 
beginning with complete degradation of the S-phase cyclin Clb5 and only partial 
degradation of the mitotic cyclin Clb2. Furthermore, Clb5 also efficiently 
phosphorylates a subset of Cdk substrates – those containing the RxL motif. 
 
These observations have led to the hypothesis that the early degradation of Clb5 is a 
major factor responsible for early dephosphorylation of its RxL-containing substrates 
(Sullivan, Holt and Morgan, 2008; Jin et al., 2008) (Fig. 1.11) - an idea that harks back 
to the ‘unregulated phosphatases’ roots of the field.  
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Yet, it is has been appreciated that the dephosphorylation of RxL-containing Cdh1, 
Orc6 and Sic1 occurs late into mitosis, well after Clb5 has been degraded. The 
remaining mitotic cyclin, Clb2 is a stronger activator of Cdc28 than Clb5 (Kõivomägi et 
al., 2011) and its role in maintaining phosphorylation in early anaphase cannot be 
ignored. Indeed, qualitative aspects aside, the main factor pertinent to a substrate is the 
quantitative input it receives from a kinase. 
 
Nonetheless, a systematic study examining this question remains to be performed. 
Additionally, the dependence of early Cdc14 substrates, some of which are RxL-bearing, 
on early Clb5 degradation is as yet unknown.  
 
 
 
 
Figure 1.11 – A kinase-centric hypothesis for early substrate 
dephosphorylation. 
One hypothesis of early substrate dephosphorylation is that early degradation of 
Clb5 enables the kinase’s preferred substrates to be dephosphorylated by 
Cdc14. 
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1.10.2 Early substrate dephosphorylation – a role for docking sites? 
1.10.2.1  Use of docking sites is ubiquitous amongst cell cycle 
regulators 
Another possibility is that a subset of early substrates is able to overcome the fierce 
competition for phosphatase attention in early anaphase by ‘finding’ the phosphatase 
using remote docking sites. 
 
Docking site-mediated interactions are a ubiquitous feature of the cell cycle and indeed, 
cellular regulation. They facilitate processes such as efficient Cln2- or Clb5-driven 
phosphorylation (Bhaduri and Pryciak, 2011; Loog and Morgan, 2005), multisite 
substrate phosphorylation by Cks1 (Kõivomägi et al., 2013; McGrath et al., 2013), 
substrate degradation by Cdc20/Cdh1 (Glotzer, Murray and Kirschner, 1991; Pfleger 
and Kirschner, 1992) and association with regulatory proteins of PP1 (Egloff et al., 
1997). These regulator-substrate interactions are often mediated by short, linear 
interaction motifs, ten or fewer residues in length, typically found in intrinsically 
unstructured protein regions (Davey, Cyert and Moses, 2015). They tend to possess 
weak, low micromolar-range affinity for the substrate (Van Roey et al., 2014) allowing 
for dynamic interactions. 
 
For instance, even though Cln2 is a poor activator of Cdc28, possessing 2.4% of the 
catalytic efficiency of Clb2-Cdc28 (calculated from (Kõivomägi et al., 2011)), it can 
nonetheless promote efficient and timely phosphorylation of LLPP motif-containing 
proteins (Bhaduri and Pryciak, 2011). In this way, it promotes progression of cells 
through Start and commitment to the cell cycle. 
 
Modular combination of docking sites within the same substrate can also allow for 
coordination of different events. Efficient phosphorylation is promoted by the RxL 
motif, and efficient degradation by the cyclosome via D-box and ABBA motifs – all 
contained within Clb5 (Lu et al., 2014). Figure 1.12 summarizes a few examples of 
docking sites employed by some important cell cycle regulators. 
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Figure 1.12 – Regulator-substrate interactions are often facilitated by 
short linear binding motifs.  
 
  
Given these examples, it seems reasonable to suggest that early Cdc14 substrates may 
possess docking sites for the phosphatase that promote timely and efficient 
dephosphorylation of a critical subset of targets. 
1.10.2.2  Fin1 – a candidate Cdc14 docking-site possessor?  
Bouchoux & Uhlmann (2011) found that Fin1 is not only one of the earliest substrates 
of Cdc14 but that the phosphatase also possesses a high catalytic efficiency towards it. 
When compared to some of the later substrates, it is an order of magnitude higher. This 
high catalytic efficiency also correlates with efficient interaction of Fin1 with the 
phosphatase, especially when compared to intermediate and later substrates. The fact 
that this interaction stays largely intact even when the Fin1 is not phosphorylated, 
points to phosphosite-independent interactions – a docking motif, perhaps.  
 
Although the function of Fin1 is not well understood, the importance of its timely 
phosphoregulation is clear, with overexpression of non-phosphorylatable mutant being 
lethal. 
 
Fin1 is a 31 kDa highly basic protein (with a pI of 10), which is predicted to be mostly 
unstructured, barring two coiled-coils at its C-terminus that enable self-association. 
They also enhance microtubule binding (van Hemert et al., 2003; Woodbury and 
Morgan, 2007). Absent in G1 due to APCCdh1 activity, Fin1’s abundance rises during S-
phase. It is phosphorylated by Clb5-Cdc28, which is known to enhance its association 
to the localization anchor 14-3-3 proteins Bmh1 and Bmh2 in vitro and in vivo 
(Mayordomo and Sanz, 2002).  
 
During interphase, a small pool of Fin1 is also bound to the budding yeast PP1, Glc7 at 
kinetochores, where it enhances PP1 activity towards unknown targets and regulates 
the mitotic checkpoint (Akiyoshi et al., 2009). At anaphase onset, Cdc14-mediated 
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dephosphorylation of Fin1 on Cdk residues drives its localization to the spindle pole 
body and the elongating spindle. Here, it is thought to stabilize the spindle through the 
microtubule-binding activity of its N-terminal region (Woodbury and Morgan, 2006; 
2007), prevent checkpoint signaling by upregulating PP1 levels at the spindle (Akiyoshi 
et al., 2009) and enable clearance of the checkpoint protein Bub1 at kinetochores 
(Bokros et al., 2016). During late anaphase, APCCdh1 begins degradation of Fin1. 
 
Whilst fin1∆ cells do not have a phenotype, expression of the non-phosphorylatable 
Fin1 is lethal, and causes rampant chromosome mis-segregation (Woodbury and 
Morgan, 2006), which is partly contingent upon its binding to Glc7 via RVxF-type 
motifs (Bokros et al., 2016). 
 
Thus, efficient dephosphorylation of Fin1 by Cdc14 could be regulating both spindle 
integrity and the spatial dynamics of the mitotic checkpoint in anaphase.  
 
1.11  Project aims 
1.11.1 Biochemical features of Cdc14 that enable substrate recognition 
As mentioned in section 1.8.2, Cdc14 is thought to be multimeric in vitro. To further 
understand the importance of this property and its relevance to substrate recognition 
and dephosphorylation, the precise stoichiometry of Cdc14 needs to be determined. 
Also, an understanding of which domain(s) of Cdc14 enable this oligomerization 
would provide a direct way of comparing monomeric and dimeric proteins, and testing 
their properties with regards to substrate recognition and subsequent catalysis. 
 
Further, Cdc14 contains three tandemly arranged domains, two of which are 
evolutionarily conserved. However, the importance of each domain in substrate and 
inhibitor recognition presents a gap in our knowledge. 
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In chapter 3, I have outlined my results concerning Cdc14 stoichiometry, and the 
importance of the three domains for substrate recognition and catalysis in vitro and in 
vivo. 
1.11.2 What factors influence efficient early substrate dephosphorylation? 
Having studied properties of the phosphatase, I wanted to focus my attention on 
features within substrates that enable efficient catalysis. One readily appreciated fact 
about Cdc14 is that there is a huge spread in its catalytic efficiencies towards substrates. 
What features is Cdc14 ‘reading’ and subsequently ‘integrating’ within substrates that 
change its behaviour towards them? I have used Fin1 as a model substrate to answer 
these questions because of our prior knowledge of catalytic efficiencies of both the 
kinase and the phosphatase towards it. Most importantly, not only was Fin1 found to 
be a highly efficient Cdc14 substrate, it also exhibits strong interactions with the 
phosphatase compared to other, less efficient substrates. These observations make it 
likely that Fin1 possesses unique features that enable its early and proficient 
dephosphorylation by Cdc14.  
 
Further, I have divided the question of substrate recognition and catalysis into two 
parts. First, the place of Cdc14 action is the site(s) of phosphorylation within a protein. 
Thus, it is possible that differences within these could define windows of 
dephosphorylation timings for substrates. Chapter 4 describes my systematic analysis 
of the importance of various motifs within phosphosites and their impact on 
dephosphorylation, both in vivo and in vitro. Using Fin1, I have attempted to provide a 
full description of kinase and phosphatase reactions, and found that they together 
determine equilibrium phosphorylation/dephosphorylation.  
 
Second, I have considered the possibility that phosphosites are only part of this 
equation; ‘remote’ features within substrates could also enable efficient 
dephosphorylation. In this regard, I attempted to define a Cdc14 docking site within 
Fin1 that enables its efficient dephosphorylation. Multiple biochemical and biophysical 
techniques were employed, but I was unable define a short linear motif within the 
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protein of the kind described for other binary enzyme-substrate interactions. 
Nonetheless, I was able to discover a number of features of Cdc14-Fin1 binding. 
Further, I have also examined a kinase-centric model of early dephosphorylation of 
Fin1. These results are presented in chapter 5. 
 
Finally, in chapter 6, I have discussed the relevance and implications of these findings, 
and how they relate to our current view of the cell cycle and beyond.  
 
(Bhaduri et al., 2015; Bhaduri and Pryciak, 2011; Elia, Cantley and Yaffe, 2003; 
Bardwell et al., 2001; Boustany and Cyert, 2002; Egloff et al., 1997; Pfleger and 
Kirschner, 1992; Glotzer, Murray and Kirschner, 1991; Wang et al., 2016; 
McGrath et al., 2013; Johnson et al., 1999) (Godfrey et al., n.d.) (Potapova et 
al., 2006) 
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Chapter 2. Materials and Methods 
2.1 Yeast techniques 
2.1.1 Yeast strains and growth conditions 
All budding yeast strains used in this study were of W303 background. The strains were 
grown in YP (Yeast Extract Peptone) media, which was supplemented with 2% (w/v) 
glucose (YPD – YP Dextrose) or, 2% (w/v) raffinose/galactose with 0.05% (w/v) glucose 
(YP-Raff/Gal). 
 
For selection of transformants, YNB (Yeast Nitrogen Agar) plates, supplemented with 
60 µg/ml of the following amino acids (except for the one used for selection) were used: 
adenine, isoleucine, leucine, lysine, histidine, phenylalanine, tyrosine, tryptophan, and 
50 µg/ml threonine.  
 
Cells were sporulated on sporulation media (table 2.1). 
Medium name/ 
Abbreviation 
Composition 
YP 
Yeast Extract Peptone –  1.1% w/v yeast extract, 2.2% w/v bacto-
peptone and 0.0055% w/v adenine-HC 
YNB Yeast Nitrogen Base –  0.8% w/v yeast nitrogen base 
YP agar 
1.1% w/v yeast extract, 2.2% w/v bacto-peptone and 0.0055% w/v 
adenine-HC, 2% w/v agar 
YNB agar 0.8% w/v yeast nitrogen base, 2% w/v agar 
Sporulation 
media 
100 mM CH3COONa, 20 mM NaCl, 25 mM KCl, 1.5mM MgSO4 
and 1.5% w/v agar 
 
Table 2.1 – Media composition 
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2.1.2 Strain list 
Strain 
name Genotype 
Mating 
Type 
MK14 Fin1∆ 263 - 3PK::TRP, Ask1-9myc::URA a	
MK16 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3 HA::URA Mut A a	
MK17 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA KNL a	
MK18 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA Mut B a	
MK19 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA Mut C a	
MK20 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA Mut D a	
MK21 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA Mut E a	
MK22 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA Mut F a	
MK23 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA Mut G a	
MK24 Dsn -3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA Mut H a	
MK25 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA Mut I a	
MK26 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA Mut J a	
MK27 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA Mut K a	
MK28 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA Mut L a	
MK29 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA Mut M a	
MK30 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA Mut N a	
MK31 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA Mut O a	
MK32 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA Mut P a	
MK33 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA Mut Q a	
MK34 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA Mut R a 
MK35 Dsn1- 3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA Mut S a 
MK36 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA Mut T a 
MK37 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA Mut U a 
MK38 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA +3A a 
MK39 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA a 
MK40 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA 6TP a 
MK41 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1-3HA::URA 6TPxA a 
MK42 Yen1-3PK::TRP, Fin1-3HA::URA, Ask1-9myc::LEU a 
MK46 Ask1-9myc::LEU, Fin1-3HA::URA, Cdc14-6Pk ::TRP a 
MK47 Ask1-9myc::LEU, Fin1-3HA::URA, Cdc14 (1-374)-6Pk ::TRP a 
MK67 Dsn1-3Pk::HIS, Ask1-9myc::LEU, Fin1 ∆C250::URA a 
MK72 Clb5 ∆db::His, FIn1-3HA::URA, Ask1-9myc::TRP a 
MK79 GAL-Cdc20::LEU, Fin1-3HA::URA a 
 
Table 2.2 – List of strains used in this thesis. 
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2.1.3 Cell synchronisation 
For arresting cells in the G1 phase of the cell cycle, yeast cells of the ‘a’ mating type were 
grown to early log phase (OD600 = 0.15), and then treated with synthetically derived 
mating pheromone α-factor (manufactured by the Peptide Chemistry Laboratory, The 
Francis Crick Institute Lincoln’s Inn Fields Laboratory) at a final concentration of 2.5 
µg/ml. Cultures were treated with α-factor once an hour, for a total time of 2.5 hours. 
Following synchronisation, the cells were released into the appropriate medium 
(devoid of α-factor), by collecting the cells on a membrane filter using a filtration 
device, and extensively washing (>10 times the culture volume) the cells with YP media. 
For re-arrest in the G1 phase of the following cell cycle, 7.5 µg/ml of α-factor was added 
to the cells 70 minutes post-release. 
 
For arresting cells in metaphase, yeast strains that had the endogenous Cdc20 promoter 
replaced by a galactose inducible promoter were constructed. The strains were grown in 
YP containing raffinose and galactose, each at a final concentration of 2% (w/v). For 
achieving the metaphase arrest by Cdc20 depletion, the cultures were extensively 
washed and resuspended in media lacking galactose (containing raffinose as the only 
energy source) for 2.5 hours at OD600 of 0.2. Next, the cells were released to progress 
through the cell cycle by adding galactose at a final concentration of 2% (w/v) and 
arrested in G1 by α-factor addition at a concentration of 2.5 µg/ml at the time of release. 
2.1.4 Yeast transformation 
Yeast transformation was performed using PCR reactions for tagging genes with an 
epitope, gene mutagenesis, or with enzyme-linearized plasmid DNA for exchanging 
promoters of genes. 
 
Briefly, 50-100 ml of mid-log phase cells (OD600 = 0.1 - 0.5) were pelleted and washed 
with 1 ml distilled water, followed by 1 ml TEL (10 mM Tris/HCl pH 7.5, 100 mM 
EDTA, 100 mM LiOAc). The cells were finally resuspended in 50 µl TEL. This cell 
suspension was added to a mixture of 1 µg linearized plasmid DNA or 8 µl PCR 
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product mixed with 2 µl of 10 mg/ml single stranded salmon sperm carrier DNA. Three 
hundred µl of TEL-P (TEL containing 40% PEG 4000) was added to the mixture, and 
vortexed briefly. The cells were incubated at 25°C for 2 - 4 hours, following which they 
were heat-shocked for 15 minutes at 42°C. After pelleting, the cells are resuspended in 1 
ml 1 M sorbitol and plated on selective media.  
 
Positive clones were checked for the appropriate integration by PCR, western blot 
analysis, diagnostic PCRs and/or Sanger sequencing. 
2.1.5 Yeast mating and tetrad dissection 
Mating was induced by incubation of the opposite mating type yeast strains on YPD 
plates at 25°C for 8 hours. Diploids were selected on appropriate selective media and 
grown again on YPD for 24 hours. For sporulation, they were plated on a sporulation 
plate for 2 - 3 days. Spores were then resuspended in 1 M sorbitol and treated with 
Lyticase (Sigma-Aldrich) at 30°C for 10 minutes to digest the asci. The four released 
spores from each ascus were dissected using Singer-MSM micromanipulator and 
incubated at 25°C until colony formation. 
 
2.2 General biochemistry 
2.2.1 Preparation of yeast extracts by protein precipitation 
Protein extracts were prepared by precipitation with tricholoroacetic acid (TCA), 
washed with 1 M Tris-base and resuspended in 100 μl 2 x SDS buffer (100 mM Tris-
HCl pH 6.8, 200 mM DTT, 4% SDS, 0.1% bromophenol blue, 20% glycerol). 200 μl of 
0.5 mm glass beads (Biospec Products) were added and cells were lysed using a 
FastPrep at 5.5 m/s for 1 minute. Extracts were then spun down to separate them from 
the glass beads. Collected supernatant was boiled at 95°C for 2 minutes and cleared by 
briefly centrifuging at 13,000 rpm. 
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2.2.2 SDS-polyacrylamide gel electrophoresis (PAGE) and Western 
blotting 
Protein samples were resolved on acrylamide/bis-acrylamide gels (37.5:1, 30% solution), 
with 375 mM Tris-HCl pH 8.8 and 0.1% SDS. Proteins were migrated at 50 mA using 
SDS-PAGE running buffer (25 mM Tris, 250 mM glycine and 0.1% SDS) in 
electrophoresis tanks from CBS scientific, CA. A broad range pre-stained protein 
marker (New England Biolabs) was added to determine protein migration. 
  
Separated proteins were transferred onto pre-equilibrated nitrocellulose membranes 
using a wet-transfer tank (Bio-Rad). Transfer buffer contained 3.03 g/l Tris base, 14.1 
g/l glycine, 0.05% SDS and 20% v/v methanol, and was carried out either at 250 mA for 
12 hours or 400 mA for 2 hours in a cold room. 
 
The membrane was blocked with a 5% skimmed milk solution (Marvel) in PBST for 30 
minutes - 1 hour at room temperature. Membranes were then incubated with the 
primary antibodies diluted in PBST containing 5% milk for 1-2 hours at room 
temperature or at 4°C overnight. The antibodies concentrations were as indicated in 
table 2.3. Membranes were washed for 3 x 10 minutes with PBST before being 
incubated with α-mouse, α-rabbit or α-rat horseradish peroxidase (HRP) coupled 
secondary antibodies in PBST containing 5% milk for 30 minutes – 2 hours at room 
temperature. Membranes were washed a further three times before adding ECL 
(Amersham) according to the manufacturer’s instructions, and then were either 
exposed to an ECL film, or photographed using an ImageQuant las 4000 (GE 
Healthcare).  
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Antigen Description 
Dilution 
WB IF 
Clb2 Santa Cruz, sc9071 (0.2 mg/ml) - Rabbit 
1/500-
1/1000  
Orc6 
In house, clone SB49 (1.1 mg/ml) - 
Mouse 1/1000  
Sic1 Santa Cruz, sc50441 (0.2 mg/ml) - Rabbit 1/500  
Tub1 
Clone YOL1/34, AbD Serotec (1 mg/ml) 
- Rat 1/1000 1/200 
Tat1 Sigma-Aldrich (1.5 mg/ml) - Mouse 1/10000  
HA Clone 12CA5, Abcam (1 mg/ml) - Mouse 1/5000 
 
myc 
In house, clone 9E10 (1.2 mg/ml) - 
Mouse 1/5000 
 
Pk Clone SV5-Pk1 AbD Serotec - Mouse 1/5000 1/200 
MultiMab 
No. 9477 Cell Signalling - Rabbit 1/1000  
Mouse IgG GE Healthcare – HRP-coupled secondary 1/5000 
 
Rabbit IgG GE Healthcare – HRP-coupled secondary 1/5000 
 
Rat IgG GE Healthcare – HRP-coupled secondary 1/5000  
Rat IgG Sigma – Cy3-Coupled secondary  1/500 
Rabbit IgG Chemicon – FITC-coupled secondary  1/200 
 
Table 2.3 – List of antibodies used 
 
2.3 Other biophysical and biochemical techniques 
2.3.1 Microscale thermophoresis (MST) 
Purified Cdc14 tagged with superfolder green fluorescent protein (Pédelacq et al., 2005), 
was mixed with increasing concentrations of a binding partner (Fin1 or Ask1)  in a final 
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buffer of 50 mM Tris/HCl pH 7.5, 250 mM NaCl, 10% glycerol, 0.5 mM TCEP, 0.05% 
Tween-20, containing GFP-Cdc14 at a final concentration of 200 nM.  
 
After incubating the mixtures in the dark at room temperature for 30 minutes, each 
mixture was loaded into glass capillaries (Monolith NT.115 Standard Treated 
Capillaries) by capillary action. All measurements were performed at 60% MST power, 
9% blue LED-power on the Monolith NT.115 Blue/Red instrument. Dissociation 
constants were determined by fitting MST data using the MO Affinity Analysis 
software into an equation based on law of mass action. 
2.3.2 Crosslinking and mass spectrometry 
Purified Fin1 and Cdc14 mixed together in a final concentration of 9.82 µM and 3.42 
µM respectively, in a buffer containing 50 mM HEPES pH 7.5, 250 mM NaCl, 10% 
glycerol and 0.5 mM TCEP for 10 minutes and room temperature. Next, the proteins 
were cross-linked using the hydrophilic crosslinker BS3 (Bissulfosuccinimidyl suberate) 
at the indicated concentrations for 45 minutes at room temperature. The reactions were 
quenched using ammonium bicarbonate at the final concentration of 50 mM for 30 
minutes at room temperature. Optimum cross-linking efficiency was determined by 
varying BS3 concentration and crosslinking time, as adjudged by SDS-PAGE.  
 
Following resolution by SDS-PAGE (or precipitation by 8 M urea), the reactions were 
resuspended in 8 M urea and 50 mM TCEP to reduce disulfide bonds, for 30 min at 
37 °C. Next, they were alkylated with 100 mM iodoacetamide for 30 min at room 
temperature and protected from light. The solutions were then diluted with 50 mM 
ammonium bicarbonate to reduce the urea concentration to 1 M. The samples were 
digested with sequencing grade trypsin at a ratio of 1:50 (enzyme:protein) and left 
overnight at 37 °C. Digested peptides were next acidified to 2 % (v/v) formic acid to 
stop the enzymatic activity. Peptides were desalted using a C18 SepPak, 50 mg bed 
volume and dried under vacuum. Following this step, peptide mixtures were re-
suspended in 35 µl 0.1 % trifluoroacetic acid, with 10 µl per injection into an LTQ-
Orbitrap Velos instrument for data collection. Each run was a 3 h gradient elution with 
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collision-induced dissociation being the selected activation method. Data processing 
was performed using the xQuest/xProphet bioinformatics suite (currently v2.1.1) 
2.3.3 Peptide array analysis 
Fin1 peptide array was first activated by incubation in 50 ml of 50% methanol, 10% 
acetic acid for one hour. All steps were carried out at room temperature unless 
otherwise stated. Following activation, the peptide array was extensively washed with 
50 ml PAB (25 mM Tris/HCl pH 7.5, 50 mM NaCl, 0.1% Tween-20) three times for 10 
minutes (per wash). The array was then blocked for 2 hours in 50 ml PAB + 2.5% 
skimmed milk (Marvel). For the antibody only control, 4 µl of the anti-HA antibody 
(table 2.3) was added to 25 ml PAB + 2.5% skimmed milk, and the array incubated in it 
for 2 hours. Following three washes with PAB, the array was incubated in1.25 µl of anti-
mouse HRP-conjugated secondary antibody (table 2.3) added to 25 ml PAB +2.5% milk 
for an hour. As before, the membrane was washed three times in PAB, developed using 
ECL and exposed to an ECL film. 
 
For the protein binding experiment, activation and blocking steps were followed as 
described above. Following these, purified His-HA-Cdc14 was added to PAB + 2.5% 
skimmed milk at a final concentration of 1µg/ml, and the array was incubated in this 
solution overnight at 4 °C. The following day, the array was washed three times with 
PAB. Next, primary and secondary antibody binding steps, and membrane 
development were carried out as described above.  
2.3.4 Size exclusion chromatography coupled with multiple-angle laser 
light scattering (SEC-MALLS) 
Purified protein samples (100 µl, at a concentration of 45 µM each) were subjected to 
size-exclusion chromatography in conjunction with MALLS at 16 different light angles 
using the DAWN-HELEOS II photometer coupled to an OPTILAB-TrEX differential 
refractometer (Wyatt Technology) at room temperature in a buffer containing 50 mM 
Tris/HCl pH 7.5, 500 mM NaCl, 10% glycerol, 0.5 mM TCEP. The data were analysed 
using ASTRA software version 6.1. 
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2.3.5 Glycerol gradient sedimentation 
In order to determine the sedimentation coefficient of recombinant Cdc14, 
sedimentation analysis was performed. A glycerol gradient of 15 – 35% was prepared in 
50 mM Tris/HCl pH 7.5, 250 mM NaCl, 0.5 mM TCEP. The gradient was prepared by 
manually layering individually prepared buffers with the appropriate glycerol 
concentration, in steps of 2.5% glycerol. For instance, 500 µl of 35% glycerol buffer was 
pipetted to the bottom of the tube, followed by 500 µl of 32.5% glycerol buffer, and so 
on. Finally, 100 µl of Cdc14, at a concentration of 0.5 µg/µl in the same buffer was 
carefully overlaid on the top of the gradient. In parallel, an identical gradient was 
prepared, and a protein standard mixture containing Thyroglobulin, Bovine Serum 
Albumin and Catalase (GE Healthcare), each at a concentration of 0.5 µg/µl, was 
overlaid on top. 
 
Next, the gradients were centrifuged at 42,000 rpm (equivalent to 117,000 g) for 16 
hours at 4°C in a swinging-bucket rotor (TLS-55) in Optima MAX-XP ultracentrifuge 
(Beckman Coulter, Inc.), with a deceleration of 0 to avoid disturbing the equilibrated 
proteins. 
 
Finally, 200 µl fractions were carefully pipetted, and an aliquot analysed by SDS-PAGE 
and stained by the Coomassie stain InstantBlue (Expedeon). 
2.3.6 Pull-down assays 
2.3.6.1  Glutathione S-Transferase (GST) pull-down 
In order to assay protein-protein interactions, purified GST-tagged proteins were 
immobilized on 10 µl of Glutathione Sepharose 4B (GE Healthcare) beads equilibrated 
in the appropriate binding buffer for an hour. Next, the beads were washed four times 
with 500 µl of binding buffer to remove excess unbound protein.  
 
The prey protein(s), in the appropriate binding buffers (50 mM Tris pH 7.5, 100 mM 
NaCl, 10% glycerol, 0.5 mM TCEP, unless otherwise indicated), were added to the 
Chapter 2. Materials and Methods 
 
72 
 
immobilized GST-tagged bait protein at the final concentration of 1 µM for 5 minutes 
at 25°C. Next, the beads were washed four times in 700 µl buffer to remove unbound 
proteins. Finally, the beads were boiled in 30 µl of 2x SDS sample buffer, and the eluate 
was separated by SDS-PAGE, and Coomassie stained. Band intensities of the input and 
pulled down proteins were quantified by densitometry using ImageQuant software (GE 
Healthcare). 
2.3.6.2  Nickel pulldown 
A similar protocol was followed to assay interactions between hexahistidine-tagged bait 
proteins with their preys. Ten µl of Ni-NTA beads (Qiagen) were equilibrated in the 
appropriate binding buffer (containing 20 mM imidazole to prevent non-specific 
interactions), following which, they were chelated to His6-tagged protein for an hour. 
After three washes of 500 µl each, the prey protein(s) were added to the Ni-NTA-bound 
bait proteins for 5 minutes at 25°C in 50 mM Tris pH 7.5, 200 mM NaCl, 10% glycerol, 
0.5 mM TCEP. The beads washed four times in 700 µl buffer and boiled in 30 µl of 2x 
SDS sample buffer. The proteins were separated by SDS-PAGE and stained with 
Coomassie. Band intensities of the input and pulled down proteins were quantified by 
densitometry using ImageQuant software (GE Healthcare). 
 
2.4 Enzyme activity assays 
2.4.1 In vitro Clb2-Cdc28 kinase assay 
A buffer containing 50 mM Tris/HCl pH 7.5, 150 mM NaCl, 10 mM MgCl2, 100 µM 
ATP and 0.5 mg/ml BSA, 33 nM (or as indicated) purified Clb2-Cdc28 kinase was used 
to phosphorylate 1.66 µM purified substrate protein at 30 °C for 1 hour, or as indicated. 
The reaction was then stopped by addition of EDTA at a final concentration of 15 mM 
if used for subsequent phosphatase assays. Otherwise, the reactions were stopped by 
adding 2x sample buffer, resolved using SDS-PAGE and stained using Coomassie. 
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2.4.2 In vitro Cdc14 phosphatase assay 
Fully phosphorylated protein substrates (see above) were diluted to a protein 
concentration of 640 nM, in a buffer containing 50 mM Tris/HCl pH 7.5 and 100 mM 
NaCl, containing 6.4 nM (or as indicated) purified Cdc14. The reactions were 
incubated at 30°C for the indicated amounts of time and stopped using 2x sample 
buffer. They were resolved by SDS-PAGE and stained using Coomassie. 
 
If used in a kinetic assay, reaction aliquots were removed at 15 second intervals from 
the time of commencement and stopped by resuspension in 2x sample buffer 
maintained at 95 °C. The reactions were resolved on an SDS-PAGE gel, which was then 
transferred on to a nitrocellulose membrane. Phosphorylation was detected by western 
blotting using the MultiMab antibody (no. 9477) at a dilution of 1/1000. In order to 
ensure that the western blot signal was in the linear range of signal, the blots were 
developed using an ImageQuant LAS 4000 (GE Healthcare) imager. Band intensity was 
then quantified using the ImageQuant TL software (GE Healthcare). After conversion 
into concentration of substrate hydrolysed, the data was fitted into an integrated form 
of the Michaelis-Menten equation outlined in section 7.3 and catalytic efficiencies were 
calculated. 
2.4.3 para-Nitrophenyl phosphate phosphatase (p-NPP) assay 
Phosphatase activity was assessed using the colorimetric p-NPP assay, based on 
dephosphorylation of the non-specific substrate p-nitrophenyl phosphate.  
 
All assays were performed in 50 mM Tris/HCl pH 7.5, 100 mM NaCl, 0.5 mM TCEP, 
containing 20 mM p-nitrophenyl phosphate (Calbiochem). The reactions were started 
by mixing the Cdc14, or its variants, and a pre-prepared reagent mixture, leading to a 
final volume of 100 µl, and were incubated at 37°C for the indicated amount of time. 
Development of colour was monitored using the BioTek microplate reader at 410 nm. 
A410 was converted to µmol of substrate hydrolysed by applying Beer’s Law and using 
the molar extinction coefficient of 18,000 M-1 cm-1. 
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2.5 Protein purification 
2.5.1 Purification of His6-Cdc14, GST-Cdc14, Fin1, Ask1 and Sli15 and 
Clb2-Cdc28 
His6-Cdc14 and GST-Cdc14, along with mutants based on these proteins, Fin1 
(including all mutants), Ask1 and Sli15 were purified following overexpression in 
Escherichia coli. In case of Clb2-Cdc28, the complex was purified following 
overexpression in S. cerevisiae. Purification protocols described in Bouchoux and 
Uhlmann (2011) were followed. 
2.5.2 Purification of Cdc14 domains 
2.5.2.1 GST-Cdc14A and GST-Cdc14C 
Purifications of these constructs followed the same protocol. Cloned plasmids were 
transformed into BL21 (DE3) pLys.S  Escherichia coli cells by electroporation. An 
overnight culture of the cells was backdiluted to OD600 0.1, and grown for another few 
hours in a 37°C incubator with shaking at 250 rpm, until they reached mid-log phase 
(OD600 = 0.6). Next, the cultures were transferred to an incubator maintained at 19°C. 
The cultured were allowed to cool for an hour, following which IPTG was added at a 
final concentration of 0.05 mM. Protein production was induced overnight for 16 hours. 
The following day, cells were harvested by pelleting in a centrifuge at 4200 rpm. Cell 
pellets were flash frozen in liquid nitrogen. 
 
The cell pellets were resuspended in 20 ml of buffer A (50 mM Tris/HCl pH 7.5, 10% 
glycerol, 0.5 mM TCEP) supplemented with 500 mM NaCl, 0.2% Triton X-100, 0.2 mM 
PMSF, 1 EDTA-free protease inhibitor tablet (Roche), 1 µl Benzonase Nuclease (Sigma-
Aldrich). The cells were lysed by sonication on ice (30 s on, 1 min rest, repeated 3 
times). The extracts were clarified by centrifugation at 40,000 rpm in a MLA-80 rotor in 
an ultracentrifuge at 4 °C. 
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Clarified supernatant was bound to 1 ml Glutathione-Sepharose 4B beads (GE 
Healthcare), which had been extensively equilibrated in buffer A (+ 500 mM NaCl, 
0.2% Triton X-100). Binding was carried out at 4 °C for 2 hours by end-on-end rotation. 
The beads were then washed extensively in the above buffer, and protein was eluted by 
addition of buffer A containing 20 mM reduced glutathione (Sigma-Aldrich). Peak 
fractions containing the protein were pooled, clarified at 13,000 rpm in a table-top 
centrifuge and applied to a Superdex 200 10/300 HR column, equilibrated in buffer A 
(+ 250 mM NaCl). Peak fractions were pooled, aliquoted and flash frozen in liquid 
nitrogen. 
2.5.2.2 GST-Cdc14AB 
Cloned plasmids were transformed into BL21 (DE3) pLys.S  Escherichia coli cells by 
electroporation. An overnight culture of the cells was backdiluted to OD600 0.1, and 
grown for another few hours in a 37°C incubator with shaking at 250 rpm, until they 
reached mid-log phase. Next, the cultures were transferred to an incubator maintained 
at 19°C. The cultured were allowed to cool for an hour, following which IPTG was 
added at a final concentration of 0.5 mM. Protein production was induced overnight 
for 16 hours. The following day, cells were harvested by pelleting in a centrifuge at 4200 
rpm. Cell pellets were flash frozen in liquid nitrogen. 
 
The cell pellets were resuspended in 20 ml of buffer A (50 mM Tris/HCl pH 7.5, 10% 
glycerol, 0.5 mM TCEP) supplemented with 500 mM NaCl, 0.2% Triton X-100, 0.2 mM 
PMSF, 1 EDTA-free protease inhibitor tablet (Roche), 1 µl Benzonase Nuclease (Sigma-
Aldrich). The cells were lysed by sonication on ice (30 s on, 1 min rest, repeated 3 
times). The extracts were clarified by centrifugation at 40,000 rpm in a MLA-80 rotor in 
an ultracentrifuge at 4 °C. 
 
Clarified supernatant was bound to 1 ml Glutathione-Sepharose 4B beads (GE 
Healthcare), which had been extensively equilibrated in buffer A (+ 500 mM NaCl, 
0.2% Triton X-100). Binding was carried out at 4 °C for 2 hours by end-on-end rotation. 
The beads were then washed extensively in the above buffer, and protein was eluted by 
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addition of buffer A containing 20 mM reduced glutathione (Sigma-Aldrich). Peak 
fractions containing the protein were pooled, clarified at 13,000 rpm in a table-top 
centrifuge and applied to a Superdex 200 10/300 HR column, equilibrated in buffer A 
(+ 500 mM NaCl). Peak fractions were pooled, aliquoted and flash frozen in liquid 
nitrogen. 
2.5.3 Purification of Net11-600 
For purification of His6-Net11-600 E. coli transformation, protein induction and lysis 
protocols described in section 2.5.1 were followed, with the only difference being that 
buffer A was additionally supplemented with 20 mM imidazole. Next, clarified protein 
supernatant was applied to 1 ml Ni-NTA beads (Qiagen) which had been pre-
equilibrated in buffer A (+ 500 mM NaCl, 0.2% Triton X-100, 20 mM imidazole). 
Binding was carried out at 4 °C for an hour by end-on-end rotation. The beads were 
then washed extensively in the above buffer, and protein was eluted by addition of 
buffer containing 300 mM imidazole. 
 
An aliquot of each fraction was assayed using SDS-PAGE for presence of Net11-600; peak 
fractions containing the protein were pooled, clarified at 13,000 rpm in a table-top 
centrifuge and applied to a Superdex 200 10/300 HR column, equilibrated in buffer A 
(+ 500 mM NaCl). Peak fractions were pooled, aliquoted and flash frozen in liquid 
nitrogen. 
 
2.6 Molecular biology and DNA manipulation 
2.6.1 Genomic DNA preparation 
Yeast genomic DNA for PCR genotyping was prepared from freshly streaked patches of 
the strain of interest. Cells was resuspended in 100 µl 200 mM LiOAc, 1% SDS solution, 
and incubated at 70°C for 10 min. After incubation, 300 µl of 100% ethanol was added, 
and DNA was collected by centrifugation at 13,000 rpm for 3 min. DNA pellets were 
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dried for 3 minutes at 65˚C and dissolved in 100 µl TE. Cell debris was spun down by 
brief centrifugation at 13,000 rpm for 1 min, and 1 µl supernatant was used for the PCR.  
2.6.2 Polymerase Chain Reaction (PCR) 
PCR reactions were carried out in 25 or 50 μl reactions containing Taq (Qiagen), 
Expand High Fidelity (Roche), or ClonAmp (ClonTech) polymerases with buffers 
supplied by the manufacturers, 0.5 μM of each primer, and, if necessary 0.2 mM 
dNTPs. All PCRs were performed on a Peltier Thermal Cycler (MJ Research). PCR 
products were resolved by agarose gel electrophoresis to confirm the size of the 
fragments. 
2.6.3 Strain design 
2.6.3.1  Epitope tagging 
Epitope tagging of endogenous genes was performed by gene targeting using PCR 
products (Bähler et al., 1998; Knop et al., 1999).  
Forward and reverse primers with homology to the 3’ end of the gene of interest and 
the 3’ UTR respectively were used. These also contained an 18-mer sequence 
homologous to the vector used for tagging. These were used to amplify the vector by 
PCR, with the subsequent product containing the epitope tag, a marker, and a 50-mer 
sequence at each end homologous to the region of marker insertion.  
 
Transformants were subsequently selected on plates by using auxotrophic markers 
(derived from either Kluyveromyces lactis or Schizosaccharomyces pombe) to minimize 
the odds of integration at the marker locus.  
2.6.3.2  Gene mutagenesis 
For Fin1 gene mutagenesis, a cassette containing full-length Fin1 tagged with three 
repeats of the HA epitope, followed by the URA4 selection marker from S. pombe was 
cloned into the pCRTM 2.1 Topo vector using the TA cloning kit (Invitrogen). Next, 
appropriate mutations were introduced using the Q5 Mutagenesis Kit (New England 
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Biolabs). Finally, the entire cassette, containing the mutations, was amplified by PCR, 
and transformed into the strain(s) of interest. Integration of the mutation into the 
endogenous protein was confirmed by sequencing. 
2.6.4 Agarose gel electrophoresis 
DNA samples were loaded on a 0.8-2% agarose gel (depending on the size of the DNA 
fragment) in 6x loading buffer (0.25% w/v bromophenol blue, 0.25% w/v xylene cyanol, 
30% (v/v) glycerol). Agarose gels were prepared in 1x Tris-acetate EDTA buffer (TAE) 
(40 mM Tris base, 1 mM EDTA pH 8.0, 0.115% v/v acetic acid), to which GelRed 
(Biotium) was added to a final concentration of 0.5 μg/ml. Electrophoresis was carried 
out in TAE at 80-20 V in electrophoresis tanks (Anachem).  
2.6.5 Plasmid construction 
2.6.5.1  Transformation of chemically competent bacteria with plasmid 
DNA 
Chemically competent Escherichia coli (DH5α) cells were thawed on ice. Five µl of the 
appropriate cloning reaction was added to 50 µl of competent cells, and the mix was 
incubated on ice for 30 minutes. Following a heat shock at 42°C for 1 minute, and 2 
minute-long cool down period on ice, 950 µl of LB media was added to the cells. They 
were allowed to recover in a shaking incubator for 1 h, and then plated on LB agar 
plates containing the appropriate antibiotic and left to grow overnight at 37°C. 
2.6.5.2  Isolation of plasmid DNA from E. coli 
Plasmid DNA was purified using the Qiagen Miniprep kit according to the 
manufacturer’s instructions.  
2.6.5.3  Sanger sequencing 
Each sequencing reaction was set up using 200 ng of DNA, 3.2 pmol of sequencing 
primer, 8 µl of BigDye Terminator Cycle Sequencing Ready Reaction Mix, made up to 
20 µl with water. Following thermal cycling, unincorporated dideoxynucleotides were 
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removed by ethanol precipitation and the sequencing reactions were loaded on to 
automated sequencing machines (Applied Biosystems) at the Equipment Park at The 
Francis Crick Institute. 
 
2.7 Microscopy and cell biology 
2.7.1 In situ Immunofluorescence (IF) 
Two ml of log-phase cells were resuspended in 1 ml ice-cold 1% formaldehyde buffer 
(IF1), and fixed overnight at 4°C. The cells were then washed in the same buffer lacking 
formaldehyde. Next, the cells were resuspended in a sorbitol-based buffer, IF2. The cells 
were finally resuspended in 200 µl of spheroplasting solution (IF2 containing 2 µl 2-
mercaptoethanol and 2 µl Liticase per ml of solution). Following this, the spheroplasted 
cells were washed once, and subsequently resuspended in IF2. Five µl of cells were 
loaded on polylysine-coated wells on 15-well slides (MP Biomedicals). The slides were 
blocked with a blocking buffer (0.5% Bovine Serum Albumin, BSA, in PBS) after fixing 
cells in methanol and acetone. 
 
The following antibodies were used: α-Tub1 (clone YOL1/ 34, AbD Serotec), α-Pk 
(clone SV5-Pk1, AbD Serotec), along with FITC and Cy3-dye labeled secondary 
antibodies (Sigma and Chemicon, respectively) (see table 2.3 for antibody 
concentrations). Cells were counterstained with the DNA binding dyes 4’,6-diamidino-
2- phenylindole (DAPI), or Hoescht, present in the mounting media ProLong Gold at a 
concentration of 100 ng/ml. Fluorescent images were acquired using an Axioplan 2 
imaging microscope (Zeiss) equipped with a 100x (NA = 1.45) Plan-Neofluar objective 
and an ORCA-ER camera (Hamamatsu).  
 
2.7.2 Cell cycle analysis by Flow Cytometry (FACS) 
To determine cell cycle progression by monitoring the DNA content, 1 ml of cells was 
fixed in ethanol for 2 - 24 hours at 4˚C, RNase treated in 50 mM Tris-HCl pH 7.5 with 
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0.1 mg/ml RNase A for 2 - 24 hours at 37˚C, and resuspended in propidium iodide-
containing buffer (200 mM Tris-HCl pH 7.5, 211 mM NaCl, 78 mM MgCl2, 50μg/ml 
propidium iodide). Cells were sonicated (Sanyo, Soniprep 150) before being analyzed 
on a FACScan or a FACSCalibur (Becton Dickinson). DNA content profiles were 
prepared using FlowJo.  
 
2.8 Bioinformatic Analysis 
As described in section 4.1, lists of phosphopeptides containing early (section 7.2), late 
(Kuilman et. al., 2015) and Cdk substrates (Holt et al., 2009) were assembled. Next, to 
ensure equivalent lengths of each phosphopeptide centered about the phosphorylated 
residue, the list was expanded using MotixX (Chou and Schwartz, 2002) to a length of 
22 residues using the S. cerevisiae genome sequence as a reference. Using WebLogo3 
(Crooks, Hon, Chandonia and Brenner, 2004), a sequence logo of each was generated.
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Chapter 3. Biochemical properties of Cdc14 
As discussed in chapter 1, the question of stoichiometry of Cdc14 has not been 
adequately resolved. Analysis using orthogonal techniques has indicated that the 
protein exists either as a dimer or a higher order multimer. According to estimates 
obtained by gel filtration and glycerol gradient centrifugation of the purified protein, it 
is a 2.6-mer in solution (Taylor et al., 1997). 
 
Protein oligomerization is a recurring theme in biological systems. Amongst major 
mitotic exit phosphatases, Cdc14 is an outlier, in that it represents the sole class that is 
thought to function as a monomer. Indeed, the monomer contains all the residues 
required for full catalytic activity.  
 
In order to deepen our understanding of the mechanisms of actions of Cdc14, and to 
resolve the disparities regarding the nature of the phosphatase, I aimed to examine the 
stoichiometry of Cdc14. An important question is whether oligomerization is 
physiologically relevant. How might the stoichiometry of Cdc14 impinge on substrate 
recognition, or indeed substrate dephosphorylation? It is possible that this potential 
oligomerization enhances the kinetics of dephosphorylation by increasing the local 
concentration of the phosphatase that a substrate experiences. Alternatively, it could 
also generate novel binding interfaces for substrates (Marianayagam, Sunde and 
Matthews, 2004).  
 
In support of a role for oligomerization of Cdc14 in vivo is the fact that the active site 
phosphatase mutant, Cdc14C283S suppresses the temperature sensitivity of cdc14-1, 
(Taylor et al., 1997), indicating a degree of collaborative action between the alleles. 
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3.1 Recombinant Cdc14 is a tight dimer in solution 
3.1.1 Gradient sedimentation and gel filtration indicate that Cdc14 
behaves as either a dimer or a trimer in solution 
I performed glycerol gradient sedimentation coupled with size exclusion 
chromatography to ascertain the stoichiometry of purified Cdc14 in solution. 
 
Sedimentation of proteins through a glycerol gradient is based on the principle that a 
protein moves through the gradient based on its size, with heavier proteins sedimenting 
faster – thus oligomeric Cdc14 would move through the gradient faster than 
monomeric Cdc14 (Fig. 3.1A). This is measured in sedimentation coefficient, S20,w, i.e. 
sedimentation through water at 20 °C, where S is the Svedberg unit with a value of 10-13 
s (Erickson, 2009). 
 
Using BSA, catalase and thyroglobulin as protein standards whose properties are 
known, Cdc14 was found to have a sedimentation coefficient of 7.5 S (Fig 3.1B & 3.1C). 
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Figure 3.1 - Glycerol gradient sedimentation of Cdc14. 
A. Schematic of the principle behind glycerol gradient sedimentation. B. SDS-
PAGE gel showing the Cdc14-containing fractions relative to protein markers. 
C. Peak fractions containing the protein markers plotted against their 
sedimentation coefficients. 
 
This value provides some initial clues as to the nature of Cdc14. It can be used to 
calculate the ratio S/Smax, where Smax is the maximum possible sedimentation coefficient 
of a protein, a value derived from the molecular mass of a protein when it is assumed to 
be a smooth sphere without a hydration shell (Erickson, 2009). For Cdc14, this ratio is 
1.31. Comparison to S/Smax values of proteins with known structures allows one to 
deduce that Cdc14 is a globular, rather than an elongated protein. 
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Next, I performed gel filtration chromatography on the protein to determine its Stokes 
radius, Rs, the radius of a smooth, theoretical sphere that would elute from the column 
at the given size. As before, thyroglobulin, ferritin and catalase were used as protein 
standards (Fig. 3.2). Compared to these standards, the Stokes radius of Cdc14 was 
found to be 5.3 nm. 
 
 
 
Figure 3.2 - Size exclusion chromatography of Cdc14. 
A. UV spectrum (A280) showing the elution volume of Cdc14 relative to protein 
markers. B. Elution volume of protein markers plotted against their Stokes radii 
to determine Cdc14’s Stokes radius. 
 
Using these values, it was then possible to determine Cdc14’s molecular mass, M, by 
applying the Svedberg equation - a function of S and Rs. (see section 7.1 for a detailed 
description of the Svedberg equation). Molecular mass of Cdc14 was calculated to be 
169,300 Da, which is in close agreement with the previously calculated value of 169,000 
Da using a similar methodology (Taylor et al., 1997). Based on a calculated monomeric 
molecular weight of 64,069 Da, Cdc14 appears to exist as a 2.64-mer in solution, i.e. a 
dimer or a trimer. 
 
Given these results, it can be concluded that Cdc14 is most likely oligomeric rather than 
monomeric in solution; however, its exact stoichiometry still remains uncertain.  
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3.1.2 SEC-MALLS shows that Cdc14 is a dimer, with its C-terminal 
domain being dispensable for dimerization 
In the absence of a clear answer from the above experiments, I used Size Exclusion 
Chromatography coupled with Multiple Angle Laser Light Scattering (SEC-MALLS) as 
an orthogonal technique to assess the stoichiometry of Cdc14 in solution. In this 
technique, laser beams are passed through a protein in solution at various angles. When 
the particle encounters the light, it scatters the incident photons, which are then picked 
up by a detector. This technique can be used to detect the hydrodynamic profile of the 
particles in solution, thus providing a method for the calculation of their molecular 
weight. 
 
Cdc14 was purified to homogeneity as before, and diluted to a concentration of 2.9 
µg/µl (or 45 µM) and eluted through a hydrophilic gel filtration column coupled to a 
multiple angle light scattering instrument. The analysis was performed in a high NaCl 
buffer (500 mM) because of the proclivity of the protein to precipitate at lower ionic 
strengths at the high concentrations required for SEC-MALLS. 
 
The analysis yielded a single peak containing Cdc14. The calculated molecular weight 
was 121,000 Da (Fig. 3.3A), which is close to a dimeric value of 128 kDa. Thus, Cdc14 is 
a tight dimer in solution. The fact that this interaction is detectable in this supra-
physiological ionic strength implies the existence of either very strong ionic 
interactions, and/or hydrophobic interactions between the dimers.  
 
Now that it has been ascertained that Cdc14 is a dimer in solution, the following 
question arises: which domain of Cdc14 enables this dimerization? The Barford group 
crystallized a truncated form of one of the human Cdc14 homologues, Cdc14B (Pro44 – 
His386) (Gray et al., 2003). This protein contains the conserved N-terminal domain A 
and the catalytic domain B (with ≈ 60% homology to its yeast counterparts), whilst 
lacking the variable, non-conserved C-terminal domain. It was found to crystallize as a 
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monomer. Therefore, I wondered if the C-terminal domain of the S. cerevisiae Cdc14 
could be driving multimerization.  
 
To test this hypothesis, I constructed a plasmid encoding Cdc14AB, spanning residues 1-
374, which contained solely domains A and B of the protein but lacked domain C. I 
then purified the protein to homogeneity and analysed it using SEC-MALLS in the 
same buffer conditions. Surprisingly, it too eluted as a dimer of 78 kDa (close to its 
calculated dimeric weight of 90 kDa) (Fig. 3.3B). Thus, the C-terminal domain is 
dispensable for dimerization.  
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Figure 3.3 - Elution profiles of Cdc14 (A) and Cdc14AB (B) determined 
through SEC-MALLS. 
The horizontal black lines correspond to the SEC-MALS calculated molecular 
masses of the proteins across the entire peak. 
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This experiment indicates that the dimerization cues are contained within domains A 
or B (or both). I thus attempted to further narrow down a dimerization domain by 
truncation analysis, but met with limited success. Whilst domain A alone could be 
purified to homogeniety (discussed in the next section 3.2.1), the protein was only 
stable in the presence of an N-terminal GST tag. As GST is known to weakly dimerize 
itself (Fabrini et al., 2009), GST-tagged domain A was unsuitable for such analysis. 
 
3.2 Contribution of Cdc14 domains to substrate recognition 
and dephosphorylation 
3.2.1 The non-catalytic N-terminal domain A interacts with Cdc14 
substrates 
As Cdc14 is organized into three discrete domains, I next wanted to assess the 
contribution of each of them to substrate recognition and dephosphorylation. To this 
end, I cloned and purified GST-tagged individual domains of Cdc14. The domain 
boundaries were guided by the structure of human Cdc14B and its sequence alignment 
with the yeast homolog (Fig. 3.4A and 3.4B).  
 
Domain A included the linker alpha helix that connects it to the catalytic domain B. 
This helix is acidic in nature and might aid substrate recognition by binding to 
positively charged residues downstream of the target phosphosite. Domain B proved to 
be recalcitrant to purification, with all constructs tried being insoluble; thus, domain 
AB was constructed in its stead. 
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Figure 3.4 - Domains of Cdc14 
A. Schematic of GST-tagged domains of Cdc14. B. SDS-PAGE gel depicting 
the purified proteins. 
 
Next, I asked whether these domains are capable of interacting with Cdc14 substrates. 
The full-length protein and Cdc14AB could bind to both the early substrate Fin1, and the 
intermediate substrate Sli15 (Fig. 3.5). Surprisingly, the non-catalytic Cdc14A, too, 
bound these substrates. Although possessing little in the way of sequence identity, 
domains A and B form two structurally equivalent domains, with an r.m.s.d. of 2.6 Å. 
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Whilst domain A contains the WPD loop comprising the invariant general acid/base 
aspartic acid, it crucially lacks the signature PTP motif of domain B (Gray et al., 2003). 
Thus, it is possible that this domain is engaging in a ‘pseudo-domain B’ interaction 
with substrates. Alternatively, domain A might be important for substrate recognition. 
Cdc14C, however, did not interact with either of the substrates, indicating that it is 
inessential for substrate interaction per se. 
 
 
Figure 3.5 – Cdc14 domain interactions with the substrates Fin1 and Sli15. 
Bead immobilized Cdc14WT, Cdc14A and Cdc14AB efficiently pull down both 
added Fin1 and Sli15, whilst immobilized Cdc14C and the control protein GST 
do not. Pulled down proteins have been indicated by a dotted box. 
 
3.2.2 Cdc14AB is a hypomorphic Cdc14 allele, whilst the C-terminal 
domain is dispensable for Cdc14 function in vivo 
As Cdc14C does not contain residues required for phosphatase catalysis, dimerization 
and interaction with substrates, I wanted to understand its importance in vivo. This 
domain has been implicated in a number of regulatory functions: firstly, it houses 
numerous residues that are extensively phosphorylated in vivo in anaphase by Cdc5, 
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with contribution from Cdk1 (Holt et al., 2009). Their phosphorylation is thought to 
weaken its binding to its stoichiometric inhibitor, Net1 (Shou et al., 2002; Stegmeier 
and Amon, 2004). Secondly, the very C-terminus of the protein functions as a nuclear 
localization signal (Mohl et al., 2009). Consistent with this hypothesis, a Cdc14 C-
terminus-derived peptide was recently crystallized with the karyopherin Kap121. MEN-
activated Dbf2-Mob1 is thought to abrogate this NLS by its phosphorylation in late 
anaphase, leading to translocation of the protein into the cytoplasm (Mohl et al., 2009). 
 
Before performing an in vivo comparison, I first wanted to determine if Cdc14WT and 
the C-terminal truncated Cdc14AB possessed equivalent phosphatase activities. Using 
purified proteins, the basal phosphatase activities of each were measured by employing 
the colorimetric p-nitrophenyl phosphate (p-NPP) phosphatase assay. Cdc14AB 
exhibited a defect in velocity of substrate hydrolysis (Fig. 3.6). Thus, Cdc14’s activity is 
compromised in the absence of domain C, possibly due to small defects in protein 
folding. 
 
Figure 3.6 – Comparison of phosphatase activities of wild type and 
truncated GST-tagged Cdc14 proteins. 
The velocity of hydrolysis (right) of 20 mM p-NPP by various concentrations of 
the two purified proteins (left), GST-Cdc14 and GST- Cdc14AB, is depicted. The 
error bars indicate standard deviation from the mean. The experiment was 
independently repeated three times. 
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Next, a yeast strain was constructed which had its endogenous Cdc14 gene replaced 
with Cdc14AB, under the control of its own promoter. The strain was not only viable, 
but also exhibited growth indistinguishable from the wild type control (Fig. 3.7). 
 
 
Figure 3.7 – Cdc14AB does not exhibit a growth defect. 
Serial dilutions of strains harbouring the wild type and truncated Cdc14 alleles 
were spotted on to a YPD plate, which was grown at room temperature for 2 
days. Representative images are shown. 
 
Next, I sought to test whether the lack of domain C has any bearing on the order and 
extent of dephosphorylation of proteins during exit from mitosis, when Cdc14 function 
is essential. After synchronising Cdc14WT and Cdc14AB cells in the G1 phase using the 
pheromone α-factor, I released them to progress through a synchronous cell cycle, 
taking protein samples at the indicated time points (Fig. 3.8). The cells were re-arrested 
in the subsequent G1 by re-addition of α-factor towards the end of the experiment.  
 
I compared the dephosphorylation timings of known Cdc14 targets, namely Fin1, Ask1 
and Orc6 in the two strains. The dephosphorylation of the three proteins was delayed 
by up to 20 minutes in Cdc14AB cells (Fig. 3.8). Difference in timings of entry into 
anaphase was not a reason for these observations, as both strains entered anaphase at 
the same time. This was adjudged by counting spindles corresponding to metaphase 
(short) and anaphase lengths (medium or long), a commonly used cell cycle marker in 
budding yeast (Fig. 3.8). Even though a considerable delay in substrate 
dephosphorylation was observed, the dephosphorylation order was preserved, 
indicating that the cells must await the release of higher amounts of active Cdc14, 
perhaps due to the hypomorphic nature of this allele. 
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Nonetheless, Clb2 degradation and Sic1 accumulation occurred on the clock, 
demonstrating that the APC function was not adversely affected.  
 
Overall, the FACS profiles of the two strains were nearly identical, indicating that, 
firstly, the cells can survive with reduced phosphatase activity, and secondly, there are 
other, redundant, mechanisms that ensure timely decline of kinase activity, such as 
cyclin degradation.         
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
      
 
Figure 3.8 – Dephosphorylation of substrates is delayed in Cdc14AB. 
FACS and western blot profiles of Fin1, Ask1, Orc6, Clb2 and Sic1 at the 
indicated time points in Cdc14WT (left) and Cdc14AB (right) from a representative 
experiment are shown. Tubulin (tub) serves as the loading control. Red, blue 
and magenta shaded boxes indicate the mid-point of protein dephosphorylation, 
when 50% of the indicated protein is in a dephosphorylated state. Percentages 
of cells containing metaphase and anaphase spindles were also determined at 
each time point for the two strains. Four repeats of the experiment were 
performed. 
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Next, I examined the profiles of the two Cdc14 proteins during the cell cycle. Whilst 
Cdc14WT was phosphorylated at a time coinciding with anaphase and dephosphorylated 
as the cells underwent cytokinesis and re-arrested in the following G1, no 
phosphorylation of Cdc14AB was apparent, confirming that the C-terminal domain is 
the hub of most Cdc14 phosphorylation events (Fig. 3.9A).  
 
As the C-terminal domain also harbours the NLS (Bembenek et al., 2014), it is possible 
that Cdc14AB could have been mislocalized. To test this possibility, I also examined the 
localization of the proteins during G1 phase of the cell cycle by indirect 
immunofluorescence, when Cdc14 is supposed to be sequestered in the nucleolus by its 
inhibitor Net1, to assess whether this sequestration is perturbed. The two proteins 
appeared to be fully sequestered, showing only a nucleolar density (Fig. 3.9B), denoting 
that Cdc14AB was not mislocalized. This was surprising, as the very end of domain AB 
contains the NES, which would be expected to predominate in the absence of the NLS.  
 
   
Figure 3.9 – Cdc14AB is not mislocalized in the G1 phase.  
A. Western blot profiles of Cdc14WT (left) and Cdc14AB (right) proteins are 
shown at the indicated time points over the course of the cell cycle. B. Indirect 
immunofluorescence of the two Cdc14 proteins (green) at time point 0 minutes, 
with tubulin (red) and DNA (blue) marked for reference. The scale bar 
represents a length of 5 µm. 
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Thus, the C-terminal domain is required for full catalytic activity of Cdc14 in vitro and 
in vivo. However, cell cycle progression and, in particular, the overall timing of exit 
from mitosis and cytokinesis appear to be unaffected. Thus, it is possible that 
phosphatases other than Cdc14 are active during mitotic exit, and are able to 
compensate for the lack of its full activity, thereby ensuring timely exit from the mitotic 
program. 
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Chapter 4. Phosphosite-specific features of efficient 
Cdc14 substrates 
Thus far, little is known about substrate specificity of Cdc14 phosphatases other than 
the facts that they are Cdk1-opposing, and that they preferentially target pSP-x-(K/R)-
containing peptides (Bremmer et al., 2012; Eissler et al., 2014). Given the large range of 
dephosphorylation timings of substrates in vivo, I theorized that it is possible that there 
are differences within the phosphosite features of substrates that are dephosphorylated 
with an ‘early’ timing, and those that are dephosphorylated ‘late’ in anaphase. For 
instance, it has been suggested that a close match to a pSP-x-KKK motif would 
constitute a particularly good Cdc14 substrate (Eissler et al., 2014).  
 
4.1 Phosphosite composition of Cdc14 substrates 
dephosphorylated ‘early’ and ‘late’ into anaphase is similar 
To systematically examine whether phosphosite features distinguish early from late 
dephosphorylated Cdc14 substrates in an unbiased way, I took advantage of a mass 
spectrometry-based screen performed by T. Kuilman in the lab (Kuilman et al., 2015). 
Briefly, the cells were arrested in metaphase by depleting the APC regulator Cdc20, and 
Cdc14 was then overexpressed. Protein samples were taken at specific time points. 
These were then subjected to mass spectrometric analysis to ascertain phosphosubstrate 
abundance at different time points upon Cdc14 induction – a measure for 
dephosphorylation. Whilst this does not represent an unperturbed exit from mitosis, 
previous work has shown that a series of candidate substrates tested maintain the 
correct order of dephosphorylation following Cdc14 overexpression as compared to a 
natural mitotic exit program (Bouchoux and Uhlmann, 2011). 
 
Thus, I first selected phosphopeptides that disappeared with ‘early’ dephosphorylation 
timing, i.e. reached their minimum value no more than 20 minutes after Cdc14 
induction. The list was further reduced to remove proteins that had fewer than 30% of 
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peptides in the ‘early’ category. This step was included to ensure that the final list 
contained high confidence early phosphosubstrates, as mass spectrometry based 
assignments can contain errors. This led to 40 unique peptides (listed in section 7.2). A 
dataset containing ‘late’ dephosphorylated phosphopeptides (containing 72 unique 
peptides) was used for comparison (Kuilman et al., 2015). 
 
Next, using MotifX and WebLogo, a sequence logo for both early and late 
dephosphorylated Cdc14 substrate peptides was made (Fig. 4.1A). These logos depict 
the probability of occurrence of a particular amino acid at each position relative to the 
phosphosite of both early and late phosphopeptides. The sequence logos are centred on 
the phosphorylated Ser or Thr residue, which is followed by a proline – the minimal 
Cdk consensus. Using a list of Cdk-phosphorylated peptides (547 unique peptides in 
total) identified in another mass spectrometry-based study (Holt et al., 2009), I also 
made a sequence logo to represent all ‘Cdk phosphopeptides’ for comparison (Fig 4.1B). 
The three sequence logos were analysed for enriched residues at each position with the 
help of Probir Chakraborty from The Francis Crick Institute’s Bioinformatics and 
Biostatistics facility. 
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Figure 4.1 – Comparison of sequence logos derived from ‘early’, ‘late’ and 
‘Cdk’ phosphopeptides. 
The X-axis indicates the position relative to the phosphosite identified in the 
mass spectrometric screens, which has been denoted ‘0’. The Y-axis denotes 
probabilities. The height of each amino acid within the sequence logo is 
indicative of the probability with which it occurs within each dataset. 
 
First, it is apparent that there is an overwhelming predominance of Ser over Thr at 
position 0 in all three datasets. Cdk’s preference for phosphorylating serines has been 
previously exhibited in vitro (Suzuki et al., 2015). Also, whilst the frequency of SP and 
TP occurrence in the S. cerevisiae genome is similar (with the SP/TP ratio being 1.2, as 
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calculated by Probir Chakraborty), the ratio of SP/TP in this aforementioned Cdk 
substrate list is 3.4. Thus, at least a part of this SP enrichment might be driven by Cdk’s 
substrate preferences. 
 
Next, an overabundance of positively charged residues is also apparent particularly at 
the +3 position in both the early and late datasets, much more so than the enrichment 
within the Cdk dataset. This proteome-wide trend agrees well with previously 
published data (Eissler et al., 2014), wherein a few Cdc14 targets were examined in vitro.  
 
There also appears to be a slight enrichment of non-polar, aliphatic residues at the -3 
position, particularly in the ‘late’ list.  
 
Overall, however, there is not a strict consensus within the ‘early’ list outside of the 
pSP-x-(K/R) preference that is also shared by late dephosphorylated Cdc14 targets; 
whilst the pattern of amino acid enrichment differs between the two lists, there is no 
clear preference for residue(s) belonging to a particular physicochemical class. This 
analysis indicates that there are no obvious phosphosite-specific features that are solely 
responsible for defining an early substrate. 
 
4.2 Phosphosite mutants of Fin1 reveal Cdc14 substrate 
specificity in vivo 
Although comparison of early and late dephosphorylated phosphopeptides yielded little 
differences between the two, an overall striking feature of this proteomic analysis 
revealed that phosphoserines, followed by positively charged residues at the +3 position 
are features that are generally preferred by Cdc14. These observations are in accordance 
with previously published data (Bremmer et al., 2012; Eissler et al., 2014) as has been 
discussed in section 1.8.3. 
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 In order to further verify these Cdc14 substrate preferences, I wanted to ascertain if 
abrogation of these features has any effect on the dephosphorylation timings of 
otherwise efficient Cdc14 targets in vivo. I chose Fin1 for this analysis, as the 
phosphatase possesses high catalytic efficiency towards it and the protein is one of the 
earliest Cdc14 targets known. Further, Fin1 is also rich in SP-x-(K/R) sites, making it an 
ideal tool for such an analysis. Thus, I sought to examine Cdc14’s predicted preference 
for serines over threonines in vivo, using Fin1 as a tool. 
 
Table 4.1 outlines the phosphosite composition of wild type Fin1, along with the 
mutants tested in the next few sections. 
 
Table 4.1 – Phosphosite composition of Fin1 alleles 
The table provides a breakdown of phosphosites in the wild type protein, along 
with those of all the Fin1 mutants tested in vivo or in vitro in the following 
sections. 
 
4.2.1 Dephosphorylation of Fin16TP is markedly delayed in vivo 
Fin1 is a serine-rich substrate, with five out of the six Cdk-phosphosites being serines 
(refer to table 4.1). Each of these serine residues was replaced with threonines, creating 
a Fin16TP allele. I then substituted the endogenous allele with this construct. Next, I 
performed a time course analysis by arresting the cells in G1 and releasing them 
synchronously into the next cell cycle, and examined the dephosphorylation timings of 
the two Fin1 proteins (Fig 4.2). A high time resolution around the expected time of 
anaphase was achieved by taking protein samples at intervals of 5 minutes, to look for 
subtle differences in protein dephosphorylation, if any. 
SP-x-(K/R) SP TP-x-(K/R) TP
Fin1WT 4 1 1 0
Fin16TP 0 0 5 1
Fin16TPxA 0 0 0 6
Fin1+3A 0 5 0 1
Chapter 4. Results 
 
102 
 
Although Fin1 contains six phosphosites, the phosphoshift visualized on an SDS-PAGE 
gel arises primarily due to phosphorylation of Ser148 (data not shown). Mass 
spectrometric analysis showed that phosphosites within this protein are 
dephosphorylated with similar timings and kinetics (Kuilman et al., 2015). 
Furthermore, emergence of faster migrating species of Fin1 was found to correlate with 
reduced overall phosphorylation of the protein in vivo (Bouchoux and Uhlmann, 2011). 
Thus, in the following experiments, Fin1 phosphoshift has been used as a reporter for 
bulk protein dephosphorylation.  
 
In a wild type strain, Fin1 begins to be dephosphorylated in early anaphase, and the 
protein quickly shifts to a majority-dephosphorylated species. During mid-to-late 
anaphase, the protein also starts to be degraded by APCCdh1 action. 
 
As expected, Fin1WT was dephosphorylated early, with the mid-point of 
dephosphorylation being 90 minutes. In contrast, Fin16TP’s dephosphorylation was 
markedly delayed, with the dephosphorylated species only becoming apparent as late as 
cytokinesis and after most of the protein had been degraded – well after the function of 
Fin1 is usually thought to be required. Thus, it is possible that a substrate preference of 
Cdc14 for serines translates in vivo as well as well as in vitro, with the phosphatase only 
being able to target Fin16TP very late into the cell cycle, when the activity of the 
phosphatase is at its maximum and Cdk activity has fully declined. 
 
The abundance of Fin16TP was reduced in comparison to its wild type counterpart. This 
could be due to Cdk1 not fully phosphorylating this all-threonine allele (Suzuki et al., 
2015), which is known to be required for 14-3-3 binding to this protein (Hall et al., 
2008) during interphase. This might target the protein for inappropriate degradation. 
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Figure 4.2 - Comparison of in vivo dephosphorylation timings of Fin1WT 
and Fin16TP. 
Representative FACS and western blot profiles showing the progression from 
G1 to the subsequent G1 and phosphorylation profiles of the two Fin1 protein 
variants, respectively. Comparison of proteins from the 85th minute time point 
shows that the band observed in Fin16TP is the higher, phosphorylated form of 
the protein. Red and orange shaded boxes show dephosphorylation mid-points 
of proteins.  
 
4.2.2 Fin16TPxA is dephosphorylated very early into anaphase 
Since the early Cdc14 substrate Fin1 can be converted into an inefficient substrate by 
replacing its phosphosites with threonines, I wanted to further examine the 
phosphosite specificity of the phosphatase, by combining this allele with mutations of 
the +3 positively charged residues within Fin1. Five out of the six Fin1 phosphosites 
contain a lysine or an arginine at the +3 position. As before, I replaced all serines with 
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threonines, and all lysines/arginines with alanines. I then replaced Fin1WT with the 
Fin16TPxA mutant allele in vivo. As before, the two strains were arrested in G1 and 
released to progress synchronously through the next cell cycle. As release from α-factor 
can vary between strains, dephosphorylation of Ask1, an unrelated Cdc14 target that 
gets dephosphorylated shortly after Fin1, was used as a biochemical marker of anaphase 
and served as a tool for independent comparison of experiments. 
 
Relative to the wild type protein, the behaviour of Fin16TPxA was surprising: firstly, 
Fin1TPxA never gets fully phosphorylated during interphase. Secondly, when compared 
to dephosphorylation timings of Ask1 within the two strains, Fin16TPxA 
dephosphorylation was found to precede even the wild type protein (Fig. 4.3). Whilst 
the mid-point of Fin1WT dephosphorylation was five minutes before that of Ask1, mid-
point of Fin16TPxA occurred 10 minutes prior to Ask1 dephosphorylation. 
 
As was the case for Fin16TP, the abundance of Fin16TPxA was reduced even further, with 
there being a correlation between reduced phosphorylation and diminished stability of 
the latter protein variant. 
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Figure 4.3 – Fin1TPxA is dephosphorylated very early in anaphase. 
FACS and western blot profiles of progression of G1 to the next G1 of Fin1WT 
and Fin16TPxA strains. Ask1, another early protein, has been used as an 
independent biochemical marker of entry into anaphase. Red, orange and blue 
shaded boxes indicate mid-points of dephosphorylation of proteins. The trend 
was observed in three independent repeats of the experiment. 
 
For comparison, I also monitored the dephosphorylation timings of the wild type 
protein and a mutant variant which only had the positively charged residue at the +3 
position replaced with alanines, Fin1+3A. Figure 4.4 shows that when compared to wild 
type protein dephosphorylation, Fin1+3A does not exhibit any considerable differences. 
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Figure 4.4 – Dephosphorylation timing of Fin1+3A is unaffected. 
Representative FACS and western blot profiles of progression from G1 to 
subsequent G1 of Fin1WT and Fin1+3A strains. Ask1, another early protein, has 
been used as an independent biochemical marker of entry into anaphase. Red 
and blue shaded boxes indicate mid-points of protein dephosphorylation. 
 
What explains the results of experiments discussed herein? Whilst replacement of 
serine phosphosites to threonines delays Fin1 dephosphorylation timing, the impact of 
the additional +3 K/R mutations is less clear. It is possible that that these 
dephosphorylation timings can be explained when one accounts for both the kinase and 
the phosphatase reactions: the kinase-to-phosphatase activity ratio experienced by the 
wild type and phosphosite mutant proteins.  
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4.2.3 The ratio of kinase to phosphatase activities explains the 
dephosphorylation timings of Fin1WT, Fin16TP, and Fin16TPxA 
To get a clear understanding of the behaviour of Fin1WT, Fin16TP and Fin16TPxA in vivo, 
and I sought purify them and study their behaviour, along with the kinase and 
phosphatase reactions in vitro.  
 
Purification of Fin1WT, Fin16TP, and Fin16TPxA yielded the same molar concentrations of 
the proteins. Furthermore, they also exhibited identical gel filtration profiles, indicating 
that the mutants are well folded, and gross mis-folding cannot explain their 
phosphorylation and/or dephosphorylation differences. 
 
Next, their ability to interact with Cdc14 in vitro was examined, as previous studies 
have reported that Cdc14 loses binding to phosphosite mutants of substrates such as 
Acm1 and Yen1 (Bremmer et al., 2012; Eissler et al., 2014). In contrast to previously 
published observations for other substrates, the phosphosite mutants of Fin1 were 
pulled down as efficiently as the wild type counterpart by glutathione-immobilized 
GST-Cdc14C283S, a substrate-trap allele described previously which is thought to bind 
substrates with high affinity (Bloom et al., 2011) (Fig. 4.5). Under the same conditions, 
Ask1, an inefficient substrate and a poor interactor, was not pulled down by the 
phosphatase. This implies that firstly, in vitro, the mutants are well folded, and secondly, 
Fin1 displays phosphosite-independent interactions with Cdc14. Further, this 
observation bolsters the argument that the in vivo phosphorylation and/or 
dephosphorylation profiles of Fin16TP and Fin16TPxA are not due to overall protein 
folding, but due to catalytic defects exhibited by Cdc14 and/or Cdk towards them.  
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Figure 4.5 – Fin1 phosphosite mutants interact efficiently with the 
immobilized phosphatase. 
Either GST alone, or GST-Cdc14C283S was immobilized on glutathione beads. 
Next, the three Fin1 variants and Ask1 were added to the reaction. After binding 
and washing, the beads were boiled in sample buffer, and the proteins were 
separated by SDS-PAGE and stained with InstantBlue. The experiment was 
repeated twice. 
 
4.2.3.1 Clb2-Cdc28 exhibits a defect in phosphorylation of Fin16TPxA in 
vitro 
In order to gain a fuller understanding of in vivo dephosphorylation timings of Fin1WT, 
Fin16TP, and Fin16TPxA, I first tested the ability of the kinase to phosphorylate these 
proteins in vitro.  It is possible that Cdk is able to discriminate between them. 
 
As Clb5 is degraded very early upon APC activation (Lu et al., 2014), Clb2 as the major 
cyclin present during anaphase. Thus, I performed the following analyses with purified 
Clb2-Cdc28. The ability of the kinase to phosphorylate the three Fin1 protein variants 
was tested. 
 
Full phosphorylation of Fin1 causes the emergence of slower migrating species of the 
protein (Bouchoux and Uhlmann, 2011). The ability of increasing amounts of Clb2-
Cdc28 to phosphorylate the three proteins was examined. If EDTA, a magnesium 
chelator, was added to the reactions before incubation with the substrates, no band-
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shift was observed, indicating that Clb2-Cdc28 was the sole provider of kinase activity 
in these reactions. 
 
Fin1WT and Fin16TP both exhibited full phosphorylation and a quantitative band-shift 
within 30 minutes of 33 nM Clb2-Cdc28 addition. If there are small differences within 
the phosphorylation efficiencies of the kinase towards these two variants, I suspect that 
one would need a more quantitative way of examining them. Fin16TPxA, however, was 
found to be only partially phosphorylated, even long after incubations with high kinase 
amounts (Fig 4.6).  
 
 
Figure 4.6 – Clb2-Cdc28 differs in its abilities to phosphorylate Fin1WT, 
Fin16TP, and Fin16TPxA. 
Kinase reactions were performed using 1.66 µM of each substrate and 
indicated amounts of the purified kinase in the kinase buffer (see materials and 
methods). 10 picomoles of reaction aliquots were removed at the indicated time 
points, resolved using SDS-PAGE and stained with InstantBlue. Fin1WT and 
Fin16TP are well phosphorylated in all reactions, whilst Fin16TPxA is only partially 
phosphorylated. All reactions were independently repeated thrice. 
 
This observation corroborates the inability of the kinase to fully phosphorylate 
Fin16TPxA in vivo. As such, this handicap of Cdk1 has previously also been noted in the 
vertebrate protein in vitro (Suzuki et al., 2015). 
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4.2.3.2 Cdc14 displays a strong preference for SP-x-(K/R) in vitro 
Next, I performed similar analyses with purified Cdc14 and phosphorylated Fin1 
proteins. First, the three Fin1 protein variants were phosphorylated with 300 nM Clb2-
Cdc28, which still did not lead to complete Fin16TPxA phosphorylation. Next, increasing 
amounts of the phosphatase were added, and reaction aliquots removed at indicated 
time points (Fig. 4.7). 
 
Figure 4.7 – Cdc14 differs in its abilities to dephosphorylate Fin1WT, 
Fin16TP, and Fin16TPxA. 
Kinase reactions were performed as described previously. Varying amounts of 
Cdc14 were added to 640 nM of each substrate, and aliquots (10 picomoles) 
removed at the indicated time points. These were resolved using SDS-PAGE 
and stained with InstantBlue. Whilst Fin1WT is easily dephosphorylated at low 
Cdc14 concentrations, Fin16TP and Fin16TPxA are not. All dephosphorylation 
reactions were independently repeated thrice. 
 
As expected, Fin1WT was efficiently dephosphorylated within 20 minutes of 6.4 nM 
phosphatase addition. However, dephosphorylation of Fin16TP only became apparent 
upon addition of 640 nM, i.e equimolar amounts of Cdc14. This behaviour is 
reminiscent of Fin16TP only being dephosphorylated very late into anaphase, when 
Cdc14 is fully released from its sequestration. In fact, considering that the wild type 
protein is almost completely dephosphorylated in just over a minute upon addition of 
6.4 nM phosphatase (see section 5.6.2), the dephosphorylation defect in Fin16TP is 
striking by comparison. As Fin16TPxA is still not fully phosphorylated, its 
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dephosphorylation pattern is harder to examine. Nonetheless, qualitatively, Fin16TPxA 
dephosphorylation was not apparent. This is at odds with the expectation from the in 
vivo experimental result, wherein this mutant protein could be dephosphorylated very 
early into anaphase. It is possible that subtle dephosphorylation of the protein is not 
apparent by the relatively insensitive Coomassie staining used in the experiment and is 
complicated by the phosphorylation pattern. Further, it is also possible that a different 
phosphatase targets Fin16TPxA in vivo. 
4.2.3.3 The kinase-to-phosphatase activity ratio could explain in vivo 
dephosphorylation timings of Fin1 variants 
As the kinase and phosphatase reactions do not exist in isolation within the cells, one 
must consider the two together (Table 4.2). With the readout being substrate 
dephosphorylation, it appears that phosphosite composition has a profound impact on 
the ability of both Cdc14 and Cdc28 to act on this otherwise highly efficient substrate.  
 
 
Table 4.2 – A summary of the abilities of Clb2 and Cdc14 to target the 
three Fin1 variants. 
Integrating kinase and phosphatase activities towards the three Fin1 variants 
could provide an explanation for the dephosphorylation timing exhibited by each 
in vivo. 
 
Differing phosphosite sensitivities of the two regulators, however, lead to differences in 
dephosphorylation timings. At least in the context of Fin1, Cdc28’s activity is not 
drastically hampered towards Fin16TP, which contains TP-x-(K/R) residues, whereas 
Cdc14 is severely debilitated. However, additional removal of the +3 positively charged 
residue changes the fate of the protein entirely, with both Cdc28 and Cdc14 being now 
challenged.
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Chapter 5. Phosphosite-independent features that 
contribute to dephosphorylation of the early 
substrate, Fin1 
5.1 Early degradation of Clb5 in part enables early 
dephosphorylation of the Clb5-specific substrate, Fin1 
As outlined in Chapter 1, budding yeast exhibits a unique pattern of cyclin proteolysis 
during mitotic exit. The S-phase cyclin Clb5 is degraded early on by the APC (Lu et al., 
2014), but Clb2 exhibits a biphasic pattern of destruction, with 50% of its activity 
persisting until Cdh1-mediated destruction later in anaphase.  
 
Thus, it has been postulated that early Clb5 degradation might bring about early 
substrate dephosphorylation: perhaps Cdc14 would be able to better target these Clb5-
specific substrates, as they no longer receive any input from their favoured kinase (Jin 
et al., 2008; Jin, Richmond and Wang, 2014).  
 
Whilst a systematic analysis remains to be performed, anecdotally, however, this does 
not hold up to scrutiny as a general ordering principle. Amongst substrates with known 
dephosphorylation timings, the RxL-containing Orc6, Cdh1 and Sic1, are also late 
substrates of Cdc14, even though they would be expected to be dephosphorylated 
earlier due to Clb5 degradation. 
 
5.1.1 Mutation of the RxL motif within Fin1 does not hasten its 
dephosphorylation in vivo  
Though it is unlikely to be a general principle governing ordered substrate 
dephosphorylation, I still wanted to examine whether Clb5’s specificity for certain 
targets could contribute to dephosphorylation of a known early substrate.  
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As before, I turned to our model early substrate Fin1, which is also a Clb5-specific 
substrate. As a first step, I replaced the endogenous Fin1 gene with an allele that had its 
Clb5-binding motif (KxL, residues 194-196) (Loog and Morgan, 2005) abrogated. A 
time course analysis from G1 into the subsequent G1 did not reveal a defect in the 
protein’s phosphorylation during S-phase, even on higher exposures of the western 
blots, as had been previously reported (Loog and Morgan, 2005) (Fig. 5.1). Furthermore, 
the protein’s dephosphorylation timing was not altered, as adjudged by comparing its 
dephosphorylation timing to that of the independent biochemical marker Ask1 which 
is dephosphorylated shortly after Fin1. 
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Figure 5.1 – Comparison of in vivo dephosphorylation of Fin1WT and 
Fin1KNL-AAA. 
FACS and western blots showing the progression from G1 to the next G1 and 
phosphorylation profiles of Fin1WT and Fin1KNL-AAA, respectively, with a high and 
low exposure. Fin1KNL-AAA does not show either a phosphorylation defect, or 
earlier dephosphorylation. The red and blue shaded boxes show 
dephosphorylation mid-points of proteins. Representative images from three 
independent experiments are shown. 
 
5.1.2 Stabilization of Clb5 throughout the cell cycle leads to impaired 
Fin1 dephosphorylation 
The removal of the RxL motif within Fin1 might have led to its earlier 
dephosphorylation, but given the fact that its dephosphorylation is already very early, it 
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might have been difficult to observe a further advance in dephosphorylation kinetics of 
Fin1. As an alternative approach, I sought to stabilize Clb5. This would provide a direct 
way of testing whether Clb5 degradation in early anaphase contributes towards early 
Fin1 dephosphorylation. The endogenous Clb5 gene was replaced by one that lacks a 
Cdc20-dependent destruction box (Clb5∆db) which leads of partial stabilization of the 
protein (Wäsch and Cross, 2002). As before, cell cycle profiles of a wild type (Clb5WT) 
and the mutant strain (Clb5∆db) were compared in a G1-to-G1 experiment (Fig. 5.2). 
Stabilization of the cyclin led to a reproducibly earlier release from the α-factor arrest, 
as is apparent by the FACS profiles - an effect that perhaps can be explained by the cells 
reaching the activity threshold required for S-phase more quickly in the context of 
Clb5∆db. Further, examination of Fin1’s cell cycle profile revealed that although the 
protein started being dephosphorylated early in anaphase, it only reach a partially 
dephosphorylated state, even at later points during the cell cycle. Comparison with the 
mid-point of Ask1 dephosphorylation in the Clb5∆db strain revealed that Fin1’s 
dephosphorylation exhibited a small, but highly reproducible delay of five minutes, 
even though both Ask1 and Fin1 experience the same kinase activities at each point in 
the cell cycle.  
 
Chapter 5. Results 
 
116 
 
 
Figure 5.2 – Comparison of Fin1 dephosphorylation in Clb5WT and Clb5∆db 
strains.  
FACS and western blots showing the progression through G1 to the next G1 
and phosphorylation profiles of Fin1 and Ask1 in Clb5WT and Clb5∆db strain 
backgrounds. Red and blue shaded boxes indicate dephosphorylation mid-
points of proteins. In the Clb5∆db strain, mid-point of Fin1 dephosphorylation is 
90 minutes post-release, whilst that of Ask1 is 85 minutes. Representative 
images from four independent experiments are shown. 
 
5.1.3 Disruption of the RxL motif of Fin1 restores its dephosphorylation 
timing in the Clb5∆db background 
Since stabilization of Clb5 during mitotic exit prevents complete dephosphorylation of 
Fin1, I next tested whether this effect is contingent on Fin1’s RxL motif. I reasoned that 
preventing docking interactions between Fin1 and Clb5∆db should render the former 
protein ‘blind’ to the stabilized cyclin during mitotic exit, perhaps leading to a 
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restoration of its dephosphorylation timing. This hypothesis was tested in a G1-to-G1 
experiment, wherein the dephosphorylation timing of Fin1WT was compared to Fin1RxL-
AAA mutant in a Clb5∆db background (Fig. 5.3). Indeed, disruption of the RxL motif 
within Fin1 not only hastened its dephosphorylation, but also enabled complete 
catalysis of the protein, with its dephosphorylation profile being indistinguishable to 
that of the wild type protein.  
 
 
 
Figure 5.3 – Comparison of Fin1WT and Fin1KNL-AAA dephosphorylation in a 
Clb5∆db background.  
FACS and western blots showing the progression through G1 to the next G1 
and phosphorylation profiles of Fin1 and Ask1 in Clb5WT and Clb5∆db strain 
backgrounds. Red and blue shaded boxes indicate dephosphorylation mid-
points of proteins. In the Clb5∆db strain, mid-point of Fin1 dephosphorylation is 
90 minutes post-release, whilst that of Ask1 is 85 minutes. Representative 
images from four independent experiments are shown. 
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These experiments support the conclusion that early degradation of Clb5 at least 
partially contributes to early dephosphorylation of Fin1 in a wild type setting. 
Nonetheless, this explains only part of the equation; Cdc14 is also able to discriminate 
this protein amongst others, and contribute to its efficient catalysis. 
 
5.2 Fin1 causes a modest stimulation of Cdc14’s phosphatase 
activity 
In order to explain the high catalytic activity of Cdc14 towards Fin1, I examined the 
hypothesis discussed herein. Early in anaphase, a small amount of active Cdc14 is able 
to target Fin1 and bring about its dephosphorylation. One explanation of this 
behaviour could be that Fin1 is able to stimulate the phosphatase activity of Cdc14, in 
turn leading to its own dephosphorylation in an efficient manner. This is known to be 
the case for the dual-specificity phosphatase MAP kinase phosphatase-3 (MKP-3) and 
its substrate phospho-ERK2. Binding of phospho-ERK2 leads to an allosteric change in 
MKP-3, which causes its activation loop to close, making it catalysis-competent (Camps 
et al., 1998). 
 
To test this hypothesis, I made use of purified Cdc14 and Fin1 in a p-NPP phosphatase 
assay. As described in section 2.4.3, p-NPP activity assays were performed with 
reactions containing 100 nM Cdc14 and varying amounts of (unphosphorylated) Fin1 
added into the reaction mixture. Next, accumulation of the product due to substrate 
hydrolysis was measured after an incubation period (Fig. 5.4A). As a control, purified 
GST, which is a similarly-sized protein to Fin1, was added to separate reactions. 
Surprisingly, addition of small amounts of Fin1 led to greater phosphate hydrolysis by 
Cdc14, whereas addition of the same amounts of GST had no effect. Increasing the final 
concentration of Fin1 to high amounts did not cause further stimulation of the 
phosphatase in this end point assay. 
 
To further study this effect, I used a continuous assay to determine the velocity of 
substrate hydrolysis by Cdc14 over time. Addition of Fin1 to these reactions caused a 
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dose-dependent increase in the velocity of product accumulation. As before, no further 
phosphatase stimulation was seen upon addition of Fin1 at a final concentration higher 
than 200 nM (Fig. 5.4B). Finally, addition of 800 nM of Fin1 alone exhibited no 
detectible substrate dephosphorylation, confirming that a contaminant phosphatase 
activity was not responsible for the effect. 
 
Figure 5.4 – Fin1 causes a moderate stimulation of the phosphatase 
activity of Cdc14 in vitro.  
A. Addition of increasing amounts of Fin1 (0 – 1.5 µM) to p-NPP reactions 
containing 100 nM Cdc14. The reactions were incubated at 37 °C for 40 
minutes after which they were stopped by addition of sodium hydroxide, and 
their absorbance was measured at 410 nm. B. Continuous spectrophotometric 
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(figure 5.4 continued) reactions containing 100 nM Cdc14 and increasing 
concentrations (0 – 0.8 µM) of Fin1 were set up, and the absorbance at 410 nm 
monitored for an hour. All reactions were performed in triplicate, with the error 
bars indicating standard deviation from the mean. 
 
From the experiments outlined above, one can conclude that whilst Fin1 stimulates the 
Cdc14 phosphatase activity, the effect is modest in comparison to the 30-fold 
stimulation of MKP-3 exhibited upon ERK2 binding. The crystal structure of hCdc14B 
revealed that Cdc14 is dephosphorylation competent even when not bound to a 
phosphosubstrate, unlike other dual-specificity phosphatases. Thus, Fin1 binding likely 
causes a small allosteric change within the enzyme leading to a small degree of enzyme 
activation. 
 
5.3 Fin1 is a high affinity Cdc14 substrate 
This part of project has been based on the observation that Cdc14’s ability to pull-down 
its substrates positively correlates with its catalytic efficiency towards them, and that 
efficient pull-down of Fin1 by Cdc14 might explain the phosphatase’s high catalytic 
efficiency towards it. This could be achieved by a possible docking site-mediated 
interaction increasing the local concentration of the phosphatase with respect to the 
substrate within the cell, overcoming competition by other substrates and lowering the 
Km of the dephosphorylation reaction. 
 
Previous observations that Fin1 interacts with the non-catalytic domain A of the 
protein, and that phosphosite mutants of Fin1, too, bind the protein with wild type 
efficiency pointed to the existence of phosphosite-independent interactions. 
 
Qualitatively, interactions between Fin1 and Cdc14 are well defined. Next, we sought to 
assess them in a quantitative manner by determining the equilibrium dissociation 
constant (Kd) of the binding reaction between the two proteins.  
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Microscale thermophoresis (MST) is a technique that enables Kd measurements 
between two proteins in solution. Briefly, it tracks the changes in the hydration shell of 
a fluorescently labelled protein, and changes it incurs upon binding of a partner 
(Wienken et al., 2010). To a fixed amount of the fluorescently labelled protein, varying 
concentrations of the binding partner are added. Binding then causes changes in the 
hydration shell of the former. Next, a temperature gradient is applied, which leads to an 
increase in Brownian motion and movement of the fluorescent protein along this 
gradient. This movement varies depending on the hydration shell, and therefore, 
binding of the partnering protein, and can be measured by tracking the fluorescence.  
 
As labelling Cdc14 with a fluorescent dye compromised its folding and stability, I 
constructed a plasmid containing full-length Cdc14 tagged with superfolder GFP.  
Comparison of phosphatase activities of purified GFP-Cdc14 and His6-Cdc14 showed 
that the tag does not affect catalysis (Fig. 5.5A). 
 
Binding of this fluorescent protein to a dilution series of purified Fin1 was then 
assessed using MST, yielding a Kd of about 700 nM (Fig. 5.5B). In contrast, purified 
Ask1, a poor Cdc14 substrate, exhibited a considerably higher Kd of at least 4.3 µM. 
This value could not be accurately determined as binding could not be saturated even at 
high concentrations of Ask1. Neither Fin1 nor Ask1 exhibited detectible interactions 
with GFP alone. 
 
Thus, in line with previous observations, Fin1 exhibits strong interactions to Cdc14. 
 
Figure 5.5 - Fin1 shows increased affinity to Cdc14 compared to Ask1. 
A. Activities of hexahistidine- and GFP-tagged Cdc14 were compared in 
triplicate using varying amounts of the proteins in a p-NPP activity assay, which 
showed that the latter was equally competent at catalysis. Error bars indicate 
standard deviation from the mean. B. Interactions of Fin1 (blue) and Ask1 
(magenta) with GFP-Cdc14 were analysed in triplicate with three independent 
protein preparations, with the error bars depicting standard deviation from the 
mean. The X-axis shows the fluorescence (expressed as a percentage of the 
maximum) in response to a temperature gradient in each reaction mixture. 
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5.4 Crosslinking and mass spectrometry identify extensive 
interactions between Cdc14 and Fin1 
To further delineate the interactions between Fin1 and Cdc14, in search of a possible 
docking site, I decided to crosslink bound Fin1 and Cdc14 and identify the interaction 
sites via mass spectrometry. This methodology has been used extensively for a number 
of protein complexes (Chen et al., 2010). Further, it allows one to precisely identify 
interacting residues within natively folded proteins in solution. 
 
The experiment relies on the ability of a primary amine-reactive crosslinker to 
covalently crosslink residues containing this functional group - lysines – that are in 
close proximity to each other. Subsequent protein digestion and identification by mass 
spectrometry detects the intra- or inter-molecular sites where they have been 
crosslinked. 
 
Before performing the analysis, an optimal concentration of the hydrophilic crosslinker 
BS3 (Bissulfosuccinimidyl suberate) had to be determined. I purified Fin1 and Cdc14 in 
an appropriate buffer (using a buffering agent that lacks primary amines), and 
incubated them together with increasing amounts of the crosslinker. After quenching, 
the products were visualised on a protein gel (Fig. 5.6A). The proteins were also 
incubated separately so as to identify bands corresponding to self-crosslinks. A 
concentration of 0.25 mM BS3 was deemed appropriate for further analysis, as this led 
to appearance of visible inter-protein crosslinks, without the generation of highly 
complex, slower migrating species due to over-crosslinking. 
 
Next, products from this reaction were subjected to mass spectrometric analysis. Figure 
5.6B shows a visual representation of crosslinks detected with high confidence. 
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Figure 5.6 – Crosslinking and mass spectrometric analysis of Fin1 and 
Cdc14. 
A. Cdc14, Fin1, and the indicated amount of BS3 were mixed together for 45 
minutes in the dark at room temperature. After quenching with ammonium 
bicarbonate, the mixtures were subjected to SDS-PAGE and visualized by 
staining with InstantBlue. Fin1- and Cdc14-only reactions contained 0.5 mM 
BS3. B. A visual representation of all the inter- and intra-molecular crosslinks 
identified along the primary sequences of Fin1 and Cdc14. Cdc14 active site 
has been identified for reference. 
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Extensive crosslinking, both within each protein and with the partner is apparent; 
however, there is no enrichment of crosslinks within a particular motif in Fin1. This 
could be due to the fact that Fin1 has 32 lysines (>10% of the protein) all of which are 
equally distributed along the protein. If it interacts with Cdc14 in multiple 
conformations in a dynamic manner (a likely scenario considering Cdc14 must 
dephosphorylate six separate phosphosites distributed equally within the N-terminus of 
the protein), this would lead to a high number of crosslinks. Further, Fin1 is predicted 
to have few strongly structured parts; this flexibility in solution could also contribute to 
both self- and Cdc14 crosslinks. 
 
Within Cdc14, the active site lysine, which is a part of the Cdc14 dual-specificity 
phosphatase consensus, by far exhibited the largest number of crosslinks with Fin1, 
indicating the solvent-exposed, flexible nature of this motif, as well as confirming that 
the active site contacts Fin1. 
 
The C-terminal domain of Cdc14 also showed a number of self-crosslinks, and 
crosslinks to Fin1. However, considering that the purified Cdc14 domain C does not 
show detectable physical interactions with Fin1 in a pull-down assay, these are likely to 
be artefacts that have arisen due to the flexibility and lysine-richness of this domain. 
Domain A of Cdc14, however, did not exhibit any crosslinks to Fin1, despite its strong 
interaction with the latter protein in pull-down assays. As this domain is highly acidic, 
and contains almost no lysines, this observation is perhaps not surprising. Accordingly, 
similar crosslinking analysis performed with purified GST-tagged domain A and Fin1 
did not lead to reliable identification of any inter-protein crosslinks, indicating that 
crosslinking and mass spectrometry is undemocratic. 
 
Overall, whilst the two proteins crosslink efficiently, I was not able to gather any further 
insights into the molecular details of their interaction, especially of the strong 
biochemically observed interaction between the Cdc14 domain A and Fin1. 
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5.5 Cdc14 binds to a number of Fin1 peptides in vitro 
5.5.1 Cdc14 interacts with preferred Cdk consensus sites within Fin1 in 
addition to other sequence features in vitro 
As an alternative approach, I sought to define the interaction sites of Cdc14 within Fin1 
on a sequence level using a peptide array. Briefly, the technique can be thought of as a 
far-western blot, where a protein of interest is used to probe arrayed peptides derived 
from its binding partner. Binding is then detected using an antibody against the bound 
protein. 
 
The peptide array consisted of 20-mer peptides derived from Fin1, with a successive 
shift of one amino acid, synthesized on a membrane support. For instance, if peptide 1 
contains residues 1-20 from the N-terminus of Fin1, peptide 2 is composed of residues 
2-21 and so on. This setup enables one to “walk” through the entire protein.  
 
Purified His6-HA-tagged Cdc14 was chosen to probe the array due to high background 
obtained from a histidine-specific antibody against His6-Cdc14. The anti-HA antibody 
was specific for the HA tag (Fig. 5.7A). Further, presence of the tag did not interfere 
with the activity of the protein (Fig. 5.7B). The array was probed with either the anti-
HA antibody alone as a control (Fig. 5.7C), or His-HA-Cdc14 first followed by the 
antibody to detect the bound protein. A number of peptide hits were detected upon 
latter analysis. 
 
 
Figure 5.7 – Peptide array analysis reveals Cdc14-binding peptides within 
Fin1. 
A. Dot blots showing that the anti-HA body is highly specific, detecting only His-
HA-Cdc14. B. p-NPP assays showing that the two constructs have similar 
phosphatase activities. C. The peptide array was probed with the anti-HA 
antibody alone (top), or His-HA-Cdc14 first, followed by the antibody to detect 
the bound protein (bottom). Colour-coded sequences of Cdc14-interacting 
peptides within Fin1 are shown. Cdk consensus sites detected herein are 
shown in bold and have been underlined. 
Chapter 5. Results 
 
127 
 
 
 
 
 
Chapter 5. Results 
 
128 
 
Surprisingly, Cdc14 bound to four out of the six Cdk consensus sites within Fin1-
derived peptides. All of these contained the ‘full’ Cdk consensus, SP-x-(K/R). The 
remaining two Cdk sites that Cdc14 did not bind to contained the minimal SP or a TP-
x-R motif, which are expected to be poorer targets. Thus, in vitro, Cdc14 preferentially 
binds to its favoured motifs, even though they were not phosphorylated. This shows 
that the phosphatase shows distinct affinities for potential phosphosites. 
 
In addition to the phosphosite, Cdc14 also bound to a number of other unique features 
within Fin1. To test their importance, the experiment was repeated by probing an array 
composed of these hits (Fig. 5.7C), where each residue had been sequentially mutated 
to a residue of different physico-chemical classes. However, no clear trend in binding 
requirements could be detected (data not shown). 
5.5.2 Fin1 dephosphorylation timing in vivo is remarkably resilient to 
mutagenesis 
To test the importance of these putative Fin1 binding sites in an in vivo setting, a 
mutational screen was set up. The mutations described herein were made in the context 
of the full-length protein. Five sequential amino acids were mutated at a time, walking 
through all the regions highlighted by the peptide arrays as possible interactors. The 
rationale behind this strategy was that if any of these hits contains sequence features 
that are important for the high affinity binding of Cdc14 to Fin1, it is possible that 
disrupting this interaction would lead to a considerable delay in the in vivo 
dephosphorylation timing of the mutant protein. This is analogous to the observations 
of Loog and Morgan (2005), where disruption of Fin1’s RxL motif caused a defect in the 
overall phosphorylation of the protein during interphase, although this effect was not 
observed in my hands (Fig. 5.1). 
 
Each peptide hit was divided into groups consisting of five residues each, which were 
then mutated into the following sequence within the full-length protein: G-A-G-N-G. 
This sequence of internal substitutions was chosen so as to ensure that the mutated part 
of the protein would be flexible, lack a specific physico-chemical character, and is less 
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likely to interfere with the folding of the rest of the protein. If the peptide hit consisted 
of residues at the very N- or C-terminus of Fin1, a terminal deletion of the residues was 
made. Overall, this strategy was chosen to avoid disrupting the structure (and function) 
of Fin1 with large internal mutations or deletions. 
 
Next, following mutagenesis, each of these 22 Fin1 alleles was integrated into the 
genome, where it replaced the endogenous allele. A time course was conducted for each 
strain by arresting it in G1 using the pheromone α-factor, and releasing the cells to 
undergo the cell cycle synchronously. As before, the phosphorylation profile of Fin1 
mutants was monitored by western blotting. Further, Ask1 was again chosen as an 
independent biochemical marker for anaphase, as it exhibits no known genetic 
interactions with Fin1, and its dephosphorylation timing is expected to be unaffected 
by perturbations in Fin1 abundance or dephosphorylation (as has also been shown in 
section 4.2). Table 5.1 summarizes all of the 22 mutants tested in this in vivo 
mutagenesis screen. Figure 5.8 shows a few examples of these G1-to-G1 experiments. A 
delay in Fin1 dephosphorylation should be visible as the mutant being 
dephosphorylated with kinetics similar to or later than those that of Ask1. 
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Table 5.1 - List of all Fin1 mutants tested for changes in in vivo 
dephosphorylation timing. 
 
Number Alias Mutated residues
Residue 
position Mutation
1 Mut A ΔN27 1-27 Deletion
2 Mut B KSVKF 238-242 GAGNG
3 Mut C GGDGS 130-134 GAGNG
4 Mut D LTRIR 135-139 GAGNG
5 Mut E ARFKN 140-144 GAGNG
6 Mut F GLMSP 145-149 GAGNG
7 Mut G QQQQQ 153-158 GAGNG
8 Mut H ERIQQ 150-154 GAGNG
9 Mut I QHILP 155-159 GAGNG
10 Mut J TPRRI 168-172 GAGNG
11 Mut K QNSDH 104-108 GAGNG
12 Mut L ITNII 109-113 GAGNG
13 Mut M FPTSP 114-118 GAGNG
14 Mut N TKLTF 119-124 GAGNG
15 Mut O LTFSN 121-125 GAGNG
16 Mut P SPLRT 36-40 GAGNG
17 Mut Q TSQKE 41-45 GAGNG
18 Mut R FLKPP 46-50 GAGNG
19 Mut S MRISPN 51-55 GAGNG
20 Mut T KEFLK 44-48 GAGNG
21 Mut U SLDRP 88-92 GAGNG
22 Mut V ΔC 263-291 Deletion
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Figure 5.8 – Examples of time courses from the mutagenesis screen for 
Fin1 mutants with altered dephosphorylation timings. 
Western blot profiles tracking phosphorylation and dephosphorylation of Fin1WT 
and the indicated Fin1 mutants as the cells progress from G1 to the subsequent 
G1. Ask1 profiles have been used as independent biochemical markers for 
anaphase in each of the experiments. Red and blue shaded boxes show mid-
points of dephosphorylation of protein. 
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Overall, barring a few changes in phosphorylation efficacy (data not shown), none of 
the mutations tested caused a defect in timing and extent of dephosphorylation of the 
protein compared to those of wild type. For instance, Fin1Mut A, which contains an N-
terminal deletion encompassing the D-box of the protein, led to its stabilisation. But, 
the mid-point of dephosphorylation upon anaphase entry was still earlier than that of 
Ask1. 
 
One can conclude that firstly, Fin1 dephosphorylation is remarkably robust, and 
mutations over the entire protein do not cause a significant change in 
dephosphorylation. Secondly, it is possible that Fin1 and Cdc14 interactions are not 
coded in the primary sequence; instead, they might rely on the tertiary/quaternary 
structure of the natively folded protein which were not sufficiently disrupted by these 
mutations.   
 
5.6 Binding of Fin1 to Cdc14 exerts a small effect on its 
efficient catalysis 
The experiments so far indicate that whilst Fin1 and Cdc14 interact strongly and 
independently of the phosphosites of the former, the determinants of this interaction 
might not be encoded in the primary, peptide-level sequence of the protein. 
Alternatively, it is also possible that I was not able to identify the determinant if it exists. 
 
Thus, I next wanted to examine the possibility that a larger part of the protein is 
important for efficient Cdc14 binding, and by extension, dephosphorylation. 
5.6.1 Truncation analysis of Fin1 
To directly test this hypothesis and narrow down Cdc14 interaction determinants 
within Fin1, I decided to perform a systematic truncation analysis of Fin1 in search of 
mutants that do not bind Cdc14. As a starting point, I divided the protein into three 
equal parts, and cloned and purified a truncation mutant of Fin1, called Fin1M1, that 
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lacked the latter third of the protein, but possessed all potential phosphosites (Fig. 5.8). 
Fin1M1 failed to interact with glutathione-immobilized GST-Cdc14.  
 
To further narrow down the interaction determinants, a series of truncation mutants 
was additionally cloned, Fin1M2 - Fin1M9 (Fig. 5.9), spanning the C-terminal domain of 
the protein that contains the two predicted coiled-coils thought to be important for 
self-association (Woodbury and Morgan, 2007). I then purified these nine proteins to 
homogeneity and tested their ability to interact with GST-Cdc14 as before. As expected, 
Fin1WT interacted efficiently, though a number of mutants (including Fin1M1) lost this 
interaction (Fig. 5.10). The ability to interact with Cdc14 followed a trend: if a large 
portion of the protein had been removed, it would not interact with Cdc14. If the same 
portion, however, was removed in smaller internal deletions, the protein showed robust 
Cdc14-binding ability. Furthermore, I observed another correlation: mutants that were 
dimeric like the wild type protein efficiently bound Cdc14, whilst those that were 
monomeric did not (as adjudged by elution volumes of purified proteins from a gel 
filtration column). This observation opens the possibility that dimerization of Fin1 is 
required to generate a strong interaction surface with Cdc14.  
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Figure 5.9 – Schematic depicting truncation mutants of Fin1. 
Positions of Cdk consensus sites and coiled-coils, along with their Cdc14-
binding abilities are indicated in all Fin1 mutants (M1 – M9).  
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Figure 5.10 – Pull-down of Fin1 truncation mutants by immobilized GST-
Cdc14 
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(Fig. 5.10 continued) The two representative SDS-PAGE gels (top) show the 
abilities of either GST alone, or GST-Cdc14 to interact with the purified Fin1 
truncation mutants. The efficiency of pull-down (pull-down/input) was also 
quantified (bottom), with the error bars depicting standard deviation from the 
mean calculated from three independent experiments. The values were 
normalized to that of the wild type protein.  
 
 
Whilst there are a number of possibilities that could explain this result, I favour the 
following: firstly, it is possible that the strong Cdc14 binding determinant is present not 
in the primary sequence of the C-terminal region of Fin1, but within the 
tertiary/quaternary, folded structure of the protein, as has also been indicated by 
previous experiments. It is also possible that efficient Cdc14 binding of Fin1, at least in 
the context of the pull-down experiments performed, requires dimerization of the 
protein, as is the case for Eph receptor tyrosine kinases and ephrins (Pabbisetty et al., 
2007). The fact that Cdc14 itself is a dimer could mean that a dimeric substrate offers 
better recognition. It would be interesting to examine if other early, efficient Cdc14 
substrates are also dimeric. 
5.6.2 Cdc14 targets Fin1∆C250 with reduced efficiency  
Truncation analysis of Fin1 enabled me to answer the next question: if Fin1 loses its 
wild type binding efficiency to Cdc14, does it also experience a reduced catalytic 
efficiency? I chose the Cdc14 non-binder M3, Fin1∆C250 for further in vitro analysis.  
Purified Fin1WT or Fin1∆C250 were first fully phosphorylated with 33 nM Clb2-Cdc28. A 
quantitative band-shift was observed for the two proteins upon phosphorylation, 
indicating complete phosphorylation.  
 
The proteins were then incubated with catalytic amounts of Cdc14 (6.4 nM), with 
reaction aliquots taken every 15 seconds, to observe the dephosphorylation reaction. 
Quantifying the band intensities obtained with a phospho-specific antibody gave a 
measure of substrate dephosphorylation over time (for a full description, see section 
2.4.2). The data obtained for the two proteins were fitted to an integrated form of the 
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Michaelis-Menten equation (Bouchoux and Uhlmann, 2011), yielding the catalytic 
efficiencies of Cdc14 towards the two proteins (Fig. 5.11 ).  
 
Figure 5.11 – Comparison of catalytic efficiencies of Cdc14 towards 
Fin1WT and Fin1∆C250. 
Fully phosphorylated proteins were incubated with 6.4 nM Cdc14 and reaction 
aliquots were taken at the indicated times (top panel). These were resolved 
using SDS-PAGE. Remaining phosphorylation was quantified at each point, and 
the data fitted to an integrated form of the Michaelis-Menten equation (bottom 
panel). The experiment was performed in duplicate, with the error bars 
indicating standard deviation from the mean. 
 
Whilst Fin1 exhibited a catalytic efficiency of 5.21 (± 0.19) x106 M-1 s-1 (in close 
agreement with the previously calculated value of 5.39 (± 0.30) x106 M-1 s-1 (Bouchoux 
and Uhlmann, 2011), the value for Fin1∆C250 was 4.03 (± 0.13) x106 M-1 s-1. Thus, there 
was a small dephosphorylation defect upon Fin1’s loss of binding to Cdc14, but the 
value is not as low as that observed for other substrates such as Sli15 (1.8 ± 0.46 x106 M-
1 s-1), which is dephosphorylated slightly later than Fin1 (Bouchoux and Uhlmann, 
2011). 
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Thus, inability to bind Cdc14 causes a measurable dephosphorylation defect in Fin1. 
The magnitude of the defect however, is smaller than what would be expected if 
substrate interaction were the major determinant of catalytic efficiency. 
5.6.3 Dephosphorylation timing of Fin1∆C250 is same as that of the wild 
type protein 
Following the in vitro analyses outlined above, I next wanted to ascertain the effect of 
Fin1∆C250 mutation in vivo. As before, the endogenous allele was replaced with Fin1∆C250. 
Firstly, I wanted to establish whether Fin1∆C250 loses interaction with Cdc14 in vivo too. 
To this end, Cdc14 was immunoprecipitated from asynchronous cells (Fig. 5.12). 
Whilst Fin1WT was efficiently co-immunoprecipitated with Cdc14, Fin1∆C250 remained 
undetectable, indicating that the loss of interaction observed in vitro could be 
recapitulated in vivo as well.     
                      
Figure 5.12 – Coimmunoprecipitation of Fin1WT and Fin1∆C250 with Cdc14. 
Endogenous Cdc14-18myc was immunoprecipitated from asynchronously 
growing cells containing HA-tagged Fin1WT or Fin1∆C250.  
 
Next, I sought to ascertain the dephosphorylation timing of Fin1∆C250. As the 
dephosphorylation defect one would expect is small, I chose to synchronize the cells in 
metaphase, by using a galactose-inducible Cdc20 background strain. Growing the cells 
in raffinose as the sole carbohydrate source turns off the galactose promoter and causes 
depletion of Cdc20, leading to metaphase accumulation of cells. They are then released 
synchronously into anaphase by addition of galactose. This method leads to excellent 
synchrony of cells during anaphase, making small differences easier to visualize.  
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Release from metaphase showed that both Fin1WT and Fin1∆C250 were completely 
dephosphorylated early within anaphase, with the mid-point of dephosphorylation 
being 15 minutes after release. In this instance, Orc6 was used as an independent 
marker of anaphase (Fig. 5.13). Degradation of Fin1∆C250 appeared to be hastened 
during mitotic exit. However, a G1-to-G1 analysis did not show reduced stability of the 
protein during interphase (data not shown), perhaps indicating enhanced action of the 
APC on this protein during mitotic exit.   
 
Nonetheless, the inability of Fin1 to bind to Cdc14 does not show a measurable 
dephosphorylation defect in vivo. This result is not entirely unexpected given the small 
dephosphorylation defect shown by the mutant in vitro. As temporal resolution in this 
experiment only extends to five-minute time points, should the defect be smaller than 
this window, it would not be observable. For instance, abrogation of the Cdc20-binding 
ABBA motif within Clb5 causes the cyclin’s destruction to be delayed by 2 minutes in 
vivo (Lu et al., 2014). Overall, one can conclude that Cdc14 binding is not a major 
determinant of efficient Fin1 dephosphorylation. 
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Figure 5.13 – Comparison of in vivo dephosphorylation of Fin1WT and 
Fin1∆C250. 
FACS and western blot profiles showing the progression through metaphase to 
the subsequent G1 of the two strains. Phosphorylation profiles of Fin1WT and 
Fin1∆C250, along with Orc6 in both strains are depicted with the red and magenta 
shaded boxes showing mid-points of dephosphorylation of the two proteins, 
respectively. Tubulin (tub) has been used as a loading control. Representative 
blots from three independent experiments have been shown. 
5.7 Probing Cdc14 - Fin1 interactions using Net1 as a tool 
Although Fin1’s binding to Cdc14 does not strongly impact its dephosphorylation, I 
next wondered if I could learn qualitative aspects of this enzyme-substrate interaction 
using Cdc14-Net1 interactions as a tool.  
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Net1 is a stoichiometric inhibitor of Cdc14, and is thought to not only tether Cdc14 in 
the nucleolus (Visintin, Hwang and Amon, 1999), but also restrict its phosphatase 
activity by a mode of competitive inhibition (Traverso et al., 2001b), until it is 
phosphorylated by various mitotic kinases. 
  
Net1 is thought to occlude the Cdc14 active site (Traverso et al., 2001b); it also exhibits 
crucial interactions with the non-catalytic domain A of the phosphatase, as a dominant 
active point mutation (P116L) within the CDC14TAB-6  allele reduces its ability to bind to 
and be inhibited by Net1 (Shou et al., 2001). 
 
Random mutagenesis of Cdc14 conducted by the Charbonneau group yielded 
additional point mutants, close to P116, that cluster within a single face of domain A 
(Fig. 5.14), away from the catalytic centre, and reduce its affinity for Net1 (Bremmer, 
2009). These mutants lie at the ‘back’ of the phosphatase, on the opposite face as that 
occupied by the active site. 
 
Thus, using Net1-Cdc14 interaction as a tool, I next wanted to examine the 
commonalities between the binding of Fin1 and Net1 to Cdc14. Is Net1 engaging in 
‘substrate-like’ interactions with Cdc14? 
 
All experiments discussed henceforth were repeated at least twice. 
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Figure 5.14 – Cdc14 point mutations that disrupt Net1 interaction. 
A homology model of Cdc14 is depicted with domain A in red, the linker alpha 
helix in green, and domain B in blue. In stick representations are the point 
mutants identified by the Charbonneau group that greatly reduce binding to and 
inhibition by Net1 (Bremmer, 2009). Positions of Tab6 and W108A mutants are 
indicated. 
 
5.7.1 Net1 and Fin1 can outcompete each other for binding to Cdc14 
As Net1 is a large, 128 kDa protein which is challenging to purify, I decided to work 
with a smaller truncation, Net11-600, that has been shown to be necessary and sufficient 
for Cdc14 binding and inhibition (Traverso et al., 2001b). 
 
Would Fin1 be able to compete with Net1 for binding to Cdc14? To answer this 
question, I immobilized GST-Cdc14 on glutathione beads, and bound Net11-600 to it. 
After washing, I incubated the pre-bound proteins with increasing amounts of either 
His6-Fin1, or the similarly sized His6-GFP, employed here as a control protein (Fig. 
5.15A). Only Fin1 was able to efficiently evict Net1 from GST-Cdc14.  
 
Further, could this competition work both ways – can Net1 also compete with Fin1 for 
Cdc14 binding? Increasing amounts of one protein were added in the presence of fixed 
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amounts of the other, in concentrations as indicated (Fig. 5.15B). This revealed that 
either protein could efficiently compete with the other for Cdc14 binding. 
 
The fact that complete binding of one protein to Cdc14 precludes the binding of the 
other indicates that they possess overlapping binding sites, or that binding of one 
induces a conformational change within the phosphatase such that the other cannot 
bind.  
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Figure 5.15 – Fin1 and Net1 can compete for binding to Cdc14. 
A. To GST-Cdc14 – Net11-600 complex bound to glutathione beads, 1-10 µM of 
Fin1 or GFP were added. After binding and washing, the beads were boiled in 
sample buffer, and the proteins visualized by SDS-PAGE and InstantBlue 
staining. B. As in A. GST-Cdc14 was immobilized on beads, and the indicated 
concentrations of Net1 and Fin1 were added together.  
 
 
It is possible that the two proteins are competing for the active site of Cdc14. To 
address this question, I made use of the observation that tungstate (WO42-), a phosphate 
mimic, can displace Net11-600 bound to Cdc14, presumably by competing with it for the 
active site (Traverso et al., 2001b). Increasing amounts of sodium tungstate were added 
to reactions containing fixed amounts of either Net1 or Fin1 (Fig 5.16). However, 
contrary to the published observations, Net1 displacement was not observed. Fin1, too, 
stayed put on Cdc14. Therefore, I cannot rule out this additional possibility of 
competition for the active site.  
 
 
Figure 5.16 – Tungstate ions do not compete with Net1 or Fin1 for binding 
to Cdc14. 
To glutathione beads-immobilized GST-Cdc14, 1 µM of Net1 or Fin1 was added 
in the presence of 0-10 mM sodium tungstate (Na2WO42-). Even at high 
concentrations, tungstate ions could not prevent the proteins from binding to 
Cdc14. 
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5.7.2 Net1 and Fin1 share distinct, but overlapping binding sites within 
Cdc14 
To further narrow down nature of interactions between these proteins, I asked if Net1, 
like Fin1, binds to the N-terminal domain A of Cdc14. This is a possibility as a number 
of Net1-disrupting mutations cluster within this domain of Cdc14 (Fig. 5.14). Pull-
downs with GST-tagged Cdc14WT, or its constituent domains revealed that only the 
wild type protein or Cdc14AB were able to interact with Net11-600 (Fig. 5.17A). This 
implies that firstly, the C-terminal domain of Cdc14 is dispensable for Net1 interaction, 
and secondly, unlike for substrate Fin1 binding, domain A is not sufficient for efficient 
interaction with Net1. There might be further interaction sites on domain B that are 
necessary. 
 
As mentioned earlier, the Cdc14Tab-6 mutation abrogates its binding to Net1. Is this the 
case for Fin1 as well? In addition to this point mutant, I chose Cdc14W108A (Fig. 5.14) a 
mutant identified by the Charbonneau lab, that shows poor binding to and inhibition 
of Cdc14 (Bremmer, 2009). 
 
Pull-downs with nickel-immobilized hexahistidine-tagged GFP (used as a control), 
Net11-600 or Fin1 revealed that whilst Net1 indeed does not bind to these mutant Cdc14 
proteins, Fin1-binding was unperturbed (Fig. 5.17B).  
 
Taken together, the above analyses reveal that Net1 and Fin1 indeed have 
commonalities in their mode of Cdc14 binding. However, they likely possess distinct, 
but overlapping binding sites. 
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Figure 5.17 – Features of Fin1 and Net1 binding to Cdc14.  
A. To nickel-immobilized Net1 or GFP, various Cdc14 constructs were added, 
and, following extensive washes, the bound proteins were visualized on stained 
SDS-PAGE gels. Only the full-length protein and domain AB interacted with 
Net1. B. As in A, GFP or Fin1 were first bound to nickel beads. The three Cdc14 
constructs, or GST alone were added to the bound proteins. As before, binding 
was visualized on an SDS-PAGE gel. Fin1 was able to bind to all three Cdc14 
alleles. 
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Chapter 6. Discussion and future perspectives 
6.1 Biochemical properties of Cdc14 
6.1.1 Cdc14 is a dimeric protein 
Through a number of complementary techniques, I have established that Cdc14 exists 
as a dimer in solution. Further, the non-conserved domain C was found to be 
dispensable for dimerization. These measurements are unlikely to have arisen due to 
the in vitro nature of the analysis performed for the following reasons: glycerol gradient 
sedimentation and gel filtration were performed in a close-to-physiological ionic 
strength buffer, at a Cdc14 concentration in the low micromolar range - a setup 
reminiscent of the in vivo situation in the nucleus during anaphase (calculated from 
parameters in (Ghaemmaghami et al., 2003; Milo et al., 2009). Thus, these in vitro 
conditions are unlikely to have driven spurious dimerization. 
 
Crosslinking and mass spectrometric analysis also revealed a number of symmetric 
crosslinks between two Cdc14 molecules, supporting the hypothesis of Cdc14 
dimerization in solution. 
 
Further, both Cdc14WT and Cdc14AB could also dimerize in the presence of 500 mM 
NaCl. This could be due to the existence of strong electrostatic forces holding the 
dimerizing proteins together that are not disrupted by competition provided by ions 
high in the Hofmeister series. Alternatively, the dimers could also be held together by 
hydrophobic interactions that are enhanced due to the hydrophobic effect. The two 
possibilities are not mutually exclusive. 
 
The fact that Cdc14 exists as a dimer is surprising considering that there is little 
functional requirement for dimerization. Extrapolating from the crystal structure of 
apo human Cdc14B, the catalytic Cys283 and general acid/base Asp253 are both 
primed for catalysis within the monomeric protein (Gray et al., 2003). Indeed, neither 
activation nor catalysis would need a dimeric Cdc14 protein. However, the observation 
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that the lethality of yeast cdc14-1ts (a D323G substitution) can be rescued by 
introduction of a second protein – a catalytic site mutant of Cdc14 (C283S) (Taylor et 
al., 1997) suggests that perhaps swapping of some structural modules occurs upon 
dimerization of these two proteins. This dimerization in turn could lead to generation 
of a dephosphorylation-competent protein, although it is hard to envisage the 
mechanics structurally. This also begs the question: why did hCdc14B crystallized as a 
monomer? Whilst the contrary case of enforced multimerization within a crystal lattice 
(such as that of Cks1 (Bourne et al., 2000)) is more readily observed, it is possible that 
crystal contacts disrupt the dimer interface. Alternatively, it is also possible that 
dimerization of Cdc14 proteins has not been conserved in the evolutionary ladder 
between yeast and humans, as the proteins do exhibit some differences in vitro. For 
instance, the human protein does not exhibit Net1 binding (data not shown). 
Accordingly, no Net1 homolog has been found in humans. 
6.1.2 Implications of Cdc14 dimerization 
What could be the importance of Cdc14 dimerization? It is well understood that Cdc14 
has a number of critical interactors throughout the cell cycle. Of them, Net1 is of chief 
importance, as it keeps its phosphatase activity in check via extensive physical 
interactions. It is possible that Cdc14 dimerization creates an interface that Net1 
recognizes. Accordingly, truncation analyses of both Cdc14 (this thesis) and Net1 
(Traverso et al., 2001b) have revealed that Net1 does not bind Cdc14 by a short, linear 
interaction motif, rather employing a web of extensive, structural interactions, of which 
dimerization could be a feature. 
 
Further, I consider it highly likely that dimerization could serve to enhance 
dephosphorylation dynamics of substrates. This could occur as dimerization, in effect, 
increases the local concentration of the phosphatase with regards to a substrate. Even if 
one molecule is engaged with the target of catalysis, it obligatorily brings in a second. 
This is known to be the case for Hsp90, wherein N-terminal dimerization enhances 
ATP hydrolysis (Richter, Muschler, Hainzl and Buchner, 2001). 
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The true significance of these properties of Cdc14 will only be revealed by comparison 
of monomeric and dimeric forms of the phosphatase. To identify the molecular basis of 
dimerization of Cdc14, it would be useful to first establish if hCdc14B is also dimeric. 
Should this not be the case, one could scan for differences between the primary 
sequences of human and yeast proteins and test if insertions in the latter are involved in 
dimerization. Preliminary analysis based on gel filtration profile of purified hCdc14B 
indicates that it is monomeric (data not shown). Alternatively, one could also take an 
error-prone mutagenesis approach, scanning for Cdc14 mutations that effect the 
dimerization equilibrium without having a significant impact in a p-NPP assay, for 
instance. 
 
Once a dimerization domain is identified, it would be interesting to directly compare 
activities of wild type Cdc14 and a monomerizing mutant. Additionally, titrating just 
the dimerization domain into an assay for catalysis of a substrate containing the wild 
type protein, and observing the effect on catalytic efficiency would be interesting. 
Titration of the inactive dimerization domain alone would, in effect, compete off wild 
type protein dimers, allowing one to observe impact of dimerization on catalytic 
parameters, or ascertain if it has subtler, allosteric effects on the enzyme. 
 
6.2 What is the function of different Cdc14 domains? 
Analysing the contribution of various Cdc14 domains towards substrate binding has 
further revealed that, like the full length protein, N-terminal domain A is competent in 
binding the substrates Fin1 and Sli15, but not the inhibitor Net1, which needs both 
domains A and B for efficient interactions. 
 
As hypothesized previously in chapter 3, it is possible that domain A is engaging in ‘B-
like’ interactions with substrates, as the two exhibit a similar overall structure. 
Alternatively, the nature of domain A-substrate interactions could be dissimilar to that 
of domain B-substrate interactions - it could also be recognizing features within 
substrate proteins independently of its similarity to domain B. Previous observations 
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that strongly binding substrates like Fin1 bind Cdc14 independently of their 
phosphorylation status, whilst the interaction of weak substrates is phosphorylation-
dependent (Bouchoux and Uhlmann, 20011) make it possible that domain A 
interaction, unlike that of domain B, is phosphorylation independent. Consistent with 
this possibility, domain A lacks all the residues required for catalysis. 
 
Mutations within domain A that disrupt its Fin1 interaction would be informative to 
understand its significance.  
 
6.2.1 Binding of Net1 and Fin1 to Cdc14 is mutually exclusive 
Pull-down experiments with Net1 have revealed a number of features of its interaction 
with Cdc14 and, that of Cdc14 and Fin1. First, as mentioned before, Net1 likely 
possesses an extensive web of interactions with Cdc14, encompassing both domains A 
and B. Truncating Cdc14 to a form that solely contains domain A perhaps increases the 
Kd of the interaction between Net1 and Fin1, leading to loss of binding between them at 
the concentrations used in the pull-down assay. Second, a number of Net1-disrupting 
interactions cluster in a single face of Cdc14, away from the latter’s active site. This 
suggests that Net1 could act as an allosteric inhibitor of Cdc14, perhaps leading to 
subtle changes in the active site, although it is been suggested to be a competitive 
inhibitor previously (Traverso et al., 2001b). The mode of inhibition can be ascertained 
by the following. For instance, should full length Net1 binding lead to a change in the 
Km of catalysis of a substrate (such as a peptide, p-NPP or DiFMUP), this would 
indicate a competitive mode of inhibition. Should the change be within both Km and 
Vmax, a non-competitive allosteric mode would be suggested. Does the protein directly 
occlude the active site of Cdc14? Competition experiments employing high 
concentrations of tungstate ions failed to show an effect on Net1 binding, as had been 
observed in other studies. Thus, I cannot rule out the possibility of Net1 occluding the 
active site of Cdc14, and that of a mixed mode of inhibition of the phosphatase by Net1. 
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The observation that Fin1 was able to displace Cdc14-bound Net1 indicates that the 
two share a considerable overlap within key Cdc14-binding features. This binding 
appears to be mutually exclusive as the inhibitor evicts bound substrate and vice versa. 
 
The fact that Fin1 was found to stimulate Cdc14 activity, rather than inhibiting it like 
Net1, also suggests a distinct mode of binding. Intriguingly, this effect has also been 
observed upon Cdc14 binding of Tof2, a protein that is present in the same complex as 
Net1, and shows some sequence identity to the N-terminus of Net1. Instead of 
inhibiting Cdc14 activity, Tof2 stimulates it in vitro according to one report (Geil, 
Schwab and Seufert, 2008). 
 
However, mutations in Cdc14 domain A, that appear to completely disrupt Cdc14-Net1 
interactions have little appreciable effect on Fin1 binding to the phosphatase. Thus, this 
binding interface within domain A is not conserved between the two proteins.  
 
6.2.2 Domain C is primarily a hub of regulatory input into Cdc14 
Cdc14 domain C is highly variable between different species. Coupled with the fact that 
it exhibits little in the way of reliably predicted structural features, its function is likely 
to be mostly regulatory rather than catalytic. Consistent with this hypothesis, domain C 
harbours regulatory NLS and NES signals within a number of known orthologs of 
Cdc14 (Mocciaro and Schiebel, 2010).  
 
Deletion of domain C caused a reduction in catalytic abilities of Cdc14 both in vitro 
and in vivo. In my interpretation, this could be due to altered protein folding. I suggest 
this due to the following reasons: first, domain C exhibits binding to none of the Cdc14 
interactors tested so far. Second, the order of protein dephosphorylation is not altered 
when Cdc14AB is the sole copy of the phosphatase within the cells. These observations 
indicate that qualitatively, domain C exerts little effect. The fact that substrate 
dephosphorylation occurs later within Cdc14AB cells indicates that they must await an 
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increased amount of released Cdc14AB for efficient substrate dephosphorylation, due to 
its reduced activity, reaffirming the quantitative model. 
 
Two studies have shown that there is a NLS at the very C-terminus of domain C (Mohl 
et al., 2009; Kobayashi, Hirano and Matsuura, 2015). One would expect that, in its 
absence, the NES would predominate and lead to mislocalization of Cdc14. However, I 
observed no adverse effects of domain C deletion on Cdc14 localization. In the same 
vein, if the phosphatase were mislocalized and were within the cytoplasm 
inappropriately during interphase, as is the case in net1∆ cells, one might expect an 
increase in the length of interphase, as Cdc14 would directly oppose substrate 
phosphorylation by the kinase. However, this was not the case, as exhibited by nearly 
identical FACS profiles and appearance of cell cycle markers within the wild type and 
mutant strains. These observations indicate that there is probably another sequence 
acting as an NLS within Cdc14AB. A prediction program predicted an NLS at the very 
C-terminus of Cdc14AB, next to the NES (Kosugi, Hasebe, Tomita and Yanagawa, 2009), 
perhaps providing an explanation for these observations. Mohl et. al. (2009) only 
analysed NLS function by overexpressing the last 100 amino acids of Cdc14 fused to 
GFP. This construct does not include the NLS predicted within Cdc14AB. Also, deletion 
of the last 100 residues only caused a minor effect in the localization of the wild type 
protein in this setup, with the majority of it going into the nucleolus.  
 
6.3 Phosphosite composition of a substrate has a profound 
impact on phosphorylation/dephosphorylation equilibrium 
6.3.1 Cdc14 is a serine-directed phosphatase 
A number of in vitro and in vivo experiments have shown that phosphosite 
composition of substrates is, by far, the largest determinant of dephosphorylation 
efficiency by Cdc14, at least in the context of Fin1. Replacement of Fin1’s 
phosphoserines to phosphothreonines led to a substantial defect in its 
dephosphorylation by Cdc14. However, at high concentrations, Cdc14 was able to 
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target this mutant variant. This suggests that whilst Cdc14 undoubtedly prefers to act 
on serine phosphorylations, phosphosite preferences are not all-or-none, but rather 
have some fluidity encoded in them. In a similar vein, even though conventional 
wisdom states that Cdk only targets Ser/Thr-Pro sites, there are reports of non-Ser/Thr-
Pro phosphorylations as well (Suzuki et al., 2015). 
 
In any case, a prediction of this phosphosite preference is that dephosphorylation 
events occurring early in anaphase (with little released Cdc14) would be enriched in 
serine dephosphorylations. However, phosphoproteomic analysis of substrates 
following Cdc14 overexpression revealed that some threonines are also 
dephosphorylated at this stage. Is there a ‘threonine-adaptor’ protein or a post-
translational modification of Cdc14 can direct its activity towards phosphothreonines 
in vivo? Or, is it possible, that there is division of labour between Cdc14 and a second, 
threonine-specific phosphatase that is active during mitotic exit?  
 
6.3.2 Which phosphatase dephosphorylates threonines in vivo? 
Thus far, a tacit assumption in budding yeast mitotic exit has been that Cdc14 is the 
only phosphatase that brings about dephosphorylation of all Cdk substrates. In the light 
of previously mentioned observations, it is worth considering whether other 
phosphatases also collaborate with Cdc14, as there is a high occurrence of pTPs 
amongst dephosphorylated substrates. The fact that multiple phosphatases are active 
during mitotic exit is well appreciated in some higher eukaryotes.  
 
Furthermore, Kuilman et. al. (2015) found that overall, disparate phosphosites within 
the same protein are co-ordinately dephosphorylated in vivo. Accordingly, the only TP 
site within Fin1, T68, is known to be dephosphorylated very early in anaphase 
(Kuilman et al., 2015), even though in an in vitro setting, Cdc14 targets it poorly 
(Bremmer et. al., 2012). It is possible that this second, threonine-specific phosphatase 
forms a complex with Cdc14 in vivo, targeting threonines and ensuring synchronized 
dephosphorylation of all phosphosites within a protein.  
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Within S. cerevisiae, PP2A-Cdc55 is a good candidate for a threonine-directed 
phosphatase. It exhibits specificity for threonine-containing peptides in vitro (Agostinis 
et al., 1990; 1992). My recent work with M. Godfrey in the lab indeed shows that a 
deletion of Cdc55 causes a marked increase in threonine phosphorylation during 
interphase. Mitotic exit, too, was found to be delayed in a cdc55∆swe1∆ strain 
compared to the swe1∆ control (Godfrey et al., in revision). In addition, another study 
found that phosphoproteins dephosphorylated early during an induced exit from 
mitosis in human cells are significantly enriched in threonine phosphosites. The 
phosphatase activity responsible for early threonine dephosphorylation was found to be 
sensitive to low concentrations of okadaic acid (McCloy et al., 2015), suggesting PP2A’s 
hand in the process. Moreover, a recent proteomic study of induced mitotic exit in 
human cells found that PP2A-B55 dependent targets are significantly enriched in 
threonines (Cundell et al., 2016). The structural basis of vertebrate PP2A-B55 threonine 
specificity has been speculated about in a recent review (Rogers, McCloy, Watkins and 
Burgess, 2015). Thus, it would be interesting to investigate if PP2A-Cdc55 is indeed a 
threonine-specific phosphatase in budding yeast mitotic exit.  
 
The activity of PP2A-Cdc55 is downregulated in a separase-dependent manner at the 
metaphase-to-anaphase transition due to a change in subcellular localization of Cdc55 
(Queralt, Lehane, Novak and Uhlmann, 2006; Rossio and Yoshida, 2011). At some 
point later in mitotic exit, it is thought to be reactivated. Whilst the activity dynamics of 
Cdc14 are well known, our knowledge of PP2A-Cdc55 lags behind in this regard. Thus, 
a method of detecting active Cdc55 within the cells would be immensely useful as one 
could then start to further interrogate its requirement as to substrate 
dephosphorylation. A Cdk1-cyclin B-inspired biosensor (Gavet and Pines, 2010) for 
PP2A-Cdc55, based on a known PP2A- phosphosite (such as those within Net1) would 
be one possible approach, as it would lead to in vivo activity measurements. This would 
circumvent the problem of disruption of subcellular localization in cell lysis and 
immunoprecipitation-type activity assays that are routinely performed for other 
proteins.  
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6.3.3 Phosphosite preferences of Cdk can also influence substrate 
dephosphorylation 
A recent study found that potential sites of phosphorylation within a peptide that 
contain SP motifs, followed by positive charges at the +3 position constitute some of 
the best Cdk substrates. Further, replacing the Ser with a Thr in this context caused a 
reduction in overall peptide phosphorylation. TP sites lacking any positive charges 
downstream, by far, constituted the worst Cdk sites (Suzuki et al., 2015). 
 
Accordingly, my experiments with the Fin16TPxA mutant variant revealed that this 
protein was never fully phosphorylated by the kinase either in vivo, or within the 
conditions tested, in vitro. This experiment also exhibited the combinatorial effects of 
tinkering with kinase and phosphatase specificity, as although this mutant is poorly 
targeted by both the kinase and the phosphatase, it is dephosphorylated very early into 
anaphase, showing that there are many ways of achieving ‘earliness’ of 
dephosphorylation. This also indicates that, to an extent, kinase and phosphatase 
substrate specificities have co-evolved, as Cdc14 also disfavours TP sites that lack basic 
residues downstream. However, there are important differences between the two that 
can have a significant impact on phosphorylation dynamics of a substrate.  
 
Taken together with related experiments, this also shows that whilst the kinase does not 
exhibit appreciable defects in targeting Fin16TP, further challenging it by mutating the 
+3 basic residues leads to severe impairment of catalysis. A larger scale analysis of 
whether TP sites in proteins tend to also contain a +3 K/R would be interesting. 
Additionally, expanding on previous discussion, it is known that the kinase 
phosphorylates thrice as many SP sites as TP sites within the proteome, even though 
the overall occurrence of both SPs and TPs is very similar. Whilst some of it is likely to 
come down to Cdk’s preferences, it is also possible that the extra methyl group of 
threonines makes them more hydrophobic and hence more likely to be buried in the 
interior of the protein, and hence inaccessible to the kinase. Thus, if possible, a survey 
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must also take into account whether a Cdk consensus peptide in question is indeed 
solvent accessible. 
 
Finally, budding yeast contains the Cdk accessory subunit Cks1, which docks on to 
phosphorylated residues and makes further Cdk phosphorylation events highly 
processive (McGrath et al., 2013). Thus, it is also possible that a Cks1-mediated switch 
from distributive to processive phosphorylation could enable full phosphorylation of 
non-preferred sites in vivo. 
6.3.4 Phosphosite-level knowledge of dephosphorylation reaction is 
needed 
So far, dephosphorylation has primarily been described in the context of entire proteins, 
which often contain multiple phosphosites. The points discussed above have revealed 
that significant catalytic differences are likely to exist between phosphosites even within 
a protein. Thus, we need to move away from ‘population’-level approaches, to a more 
granular approach, taking into account the behaviour of each phosphosite. This would 
also help explain which phosphosites/structures within a protein regulate its behaviour.  
 
Further, we know little about catalysis by phosphatases. Is it a processive reaction, such 
that dephosphorylation of one phosphosite makes dephosphorylation of others more 
likely? Or is it distributive, such that the phosphatase ‘sees’ each phosphosite 
separately? Whilst interpretations from mobility shifts upon protein dephosphorylation 
should be cautious, anaphase sees each substrate get dephosphorylated in a sharp time 
window in vivo, as opposed to a gradual, slow process, pointing to the former 
possibility. Furthermore, the fact that Cdc14 exists as a dimer could also contribute to 
processivity of dephosphorylation. 
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6.4 Phosphosite-independent factors in substrate 
dephosphorylation 
6.4.1 The role of early degradation of Clb5 in substrate 
dephosphorylation 
The theory behind early degradation of Clb5 enabling substrate dephosphorylation has 
been extensively discussed in sections 1.10.1 and 5.1. Although it had long been 
postulated, Clb5’s role in defining early substrate dephosphorylation had not been 
examined directly and represented a gap in our knowledge. In this study, I took 
advantage of the fact that catalytic efficiencies of both Clb5 and Clb2 have been 
determined towards Fin1, and it was found to be a preferred Clb5 target. Thus, it was 
possible to tease out the contribution of Clb5 degradation to Fin1 dephosphorylation in 
anaphase by stabilizing the former protein. Stabilization of its preferred cyclin-Cdk 
flavour caused a defect in Fin1’s in vivo dephosphorylation, an effect contingent upon 
the RxL motif found within the substrate. Taken together with the fact that the catalytic 
efficiency of Clb5-Cdk towards Fin1 is about 3.8 times that of Clb2-Cdk, the sum of 
these kinase activities perhaps overwhelms Cdc14 during early anaphase. 
 
It is indeed likely that evolution has chosen early Clb5 degradation as yet another way 
of bringing about early substrate dephosphorylation – rather than tinkering with the 
phosphatase input, choosing to dampen efficient kinase input towards the same end. 
We still do not know how general this principle is, and how other early, Clb5-specific 
substrates respond to its stabilization. In this regard, dephosphorylation of Yen1 - 
another early Cdc14 substrate possessing one of the highest Clb5-specificity scores 
(Loog and Morgan, 2005) – would be interesting to observe.  
 
However, concepts governing dephosphorylation timing appear to be very protein 
specific: even though Orc6, Sic1 and Cdh1 are highly Clb5-specific, they are 
dephosphorylated in late anaphase, perhaps due to the inability of the phosphatase to 
efficiently target them. Late dephosphorylation of Orc6, in particular, is important to 
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ensure that origin licensing only occurs later in mitosis, when the kinase activity has 
declined sufficiently so as to prevent inappropriate relicensing. 
6.4.2 Role of Cdc14 docking site interactions in Fin1 dephosphorylation 
Docking site interactions are a ubiquitous feature of cell cycle regulators and indeed, 
cellular regulation, with more such interactions being discovered each year. They 
enhance functional versatility within protein-protein interactions by bypassing the 
need for evolution of dedicated structural domains.  
 
Their contribution in facilitating kinase-substrate interactions has been appreciated for 
decades; but we are only beginning to scratch the surface as to their role in 
phosphatase-mediated regulation. In this regard, two studies have recently discovered a 
short linear motif that mediates interactions of substrates with the B56 regulatory 
subunit of PP2A, and guides PP2A-B56 towards them (Hertz et al., 2016; Wang et al., 
2016). This motif joins the rapidly growing repertoire already known for other 
phosphatases such as PP2B/calcineurin (Goldman et al., 2014). 
 
In this thesis, we hypothesized that Cdc14, too, could function by interacting with at 
least a subset of its substrates using docking motifs. Fin1 was chosen as a candidate to 
investigate this premise for the following reasons: its dephosphorylation occurs very 
early into anaphase, the phosphatase displays high catalytic efficiency towards it, and it 
has the ability to proficiently interact with the phosphatase compared to other 
substrates. 
 
In line with these observations, I found that Cdc14-Fin1 interaction was preserved even 
when the phosphatase is no longer catalytically proficient towards the protein due to 
phosphosite mutations within Fin1. Further, quantitative measurements of this 
interaction reveal that the phosphatase’s affinity towards Fin1 is considerably higher 
than that of Ask1. 
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However, analysing truncation mutants of Fin1 revealed that, whilst certain features 
within the C-terminus of the protein are important for efficient interaction, abrogating 
the interaction has comparatively little impact on catalysis in vitro and on 
dephosphorylation timing in vivo. Further, all Cdc14 non-interactors were found to be 
monomeric. It is possible that this causes a reduction in binding to Cdc14 due to lack of 
self-association of Fin1, without directly playing a part in Cdc14 recognition. Should 
this be the case, binding motif(s) present elsewhere would still be able to play a part, 
albeit slightly less efficiently. I consider this possibility likely because deletion of the C-
terminal coiled-coils of Fin1 reduce its ability to bind microtubules in vitro, even 
though the N-terminal domain is thought to encode microtubule-binding activity 
(Woodbury and Morgan, 2007). A similar principle is applicable to Fin1’s binding to 
the 14-3-3 protein Bmh2 (Mayordomo and Sanz, 2002). 
 
Similarly, peptide array analysis also indicated that the phosphatase interacts with a 
number of features within Fin1, in addition to a subset of its phosphosites. Again, 
sequentially mutating them in vivo did not change Fin1’s dephosphorylation timing. It 
is possible that mutating five residues at a time did not sufficiently abrogate a potential 
docking site. Further, it is also conceivable that Fin1 contains multiple, degenerate 
docking motifs, and mutating one would not have a significant impact. Such multiple, 
composite binding motifs are thought to govern the interactions between PP1 and its 
regulators/substrates (Wakula et al., 2003). 
 
Another possibility is that Fin1’s interaction with Cdc14 is not a major determinant of 
its efficient catalysis, but plays another role within the cells. It could be a targeting 
interaction, serving to recruit Cdc14 to the spindle and spindle pole bodies at anaphase 
where the latter can dephosphorylate other substrates. Such a targeting mechanism 
would be a variation on a well-appreciated theme, wherein a protein serves as a 
recruitment platform for others, that are then able to act on its surrounding proteins in 
a timely manner: a case well documented for PCNA. PCNA drafts in number of 
proteins (such as the flap endonuclease Fen1) to the replication fork via their PCNA 
interaction protein (PIP) boxes (Mailand, Gibbs-Seymour and Bekker-Jensen, 2013). 
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On a more general note, my computational analysis of in vivo Cdc14 substrates shows 
that whilst phosphosite motifs that predict efficient dephosphorylation by Cdc14 (SP-x-
K/R) are overrepresented amongst substrates, this enrichment is found in all classes of 
dephosphorylated proteins: form early to late.  Thus, phosphosites alone would provide 
poor discrimination of distinct substrate classes, and perhaps cannot order substrate 
dephosphorylation by themselves. Thus, I still consider it likely that docking site 
interactions could play a part in defining the timing of Cdc14-mediated substrate 
dephosphorylation.  
 
In this regard, crystal structures of the tight complex that Cdc14 forms with Net1 would 
be particularly informative, as the inhibitor does appear to share similarities with 
substrates. Thus, it is possible that binding site(s) within Net1 is of such high affinity 
that it converts it into an inhibitor. 
 
6.5 From yeast to higher organisms 
6.5.1 Substrate dephosphorylation in higher eukaryotes 
Is there a temporal order of substrate dephosphorylation within higher eukaryotes too? 
Whilst few studies have examined this question in depth, a gradual, reproducible 
decrease in substrate dephosphorylation - examined biochemically - following mitotic 
exit induction has been noted by many. In agreement, a dose-dependent effect of cyclin 
B1 on human mitosis has also been observed, with constantly high cyclin B1 levels 
causing a metaphase arrest whilst constant low levels allowing progression to telophase, 
where the cells then arrest (Wolf et al., 2006). Furthermore, mitotic exit events too 
follow a reproducible order. Elongation of mitotic spindle, chromosome 
decondensation, nuclear envelope reformation and cytokinesis obey a seemingly 
predetermined, logical sequence and occur long after cyclins have been degraded. 
While regulation of mitotic ordering by sequential APC substrate degradation has 
received attention (Glotzer, Murray and Kirschner, 1991; Pfleger and Kirschner, 1992), 
the above mentioned observations strongly suggest that the quantitative model of 
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substrate dephosphorylation is likely also applicable in higher organisms. Recent 
evidence from human cells by Cundell and colleagues (2016) also bolsters this 
argument. 
6.5.2 Role of phosphatases and future avenues 
Relentless pace of progress in a number of model organisms has brought to light the 
importance of phosphatases in cell cycle regulation. A close partnership between 
kinases and phosphatases is indeed a defining feature of eukaryotic life. However, we 
have but scratched the surface of the input of phosphatases to cell cycle regulation and 
as such, their precise identities, activity dynamics, features and important targets still 
remain to be uncovered.  
 
Recent studies have brought home the fact that, like their budding yeast counterpart, an 
exquisite level of control restrains phosphatase activity both spatially and temporally in 
the form of the conserved Greatwall - ENSA - PP2A pathway. Thus, our next frontier 
must constitute providing the crucial link between phosphatase activation, substrate 
dephosphorylation and cytological events. Overall, we must also integrate these 
observations into a systems-level view of cell cycle regulation. 
 
Do PP2A phosphatases exhibit substrate preferences too?  The evolutionarily conserved 
PP2A-B56 binding motifs and receptor sites (Hertz et al., 2016), and the threonine and 
+3 lysine/arginine preference of PP2A-B55 (McCloy et al., 2015; Cundell et. al., 2016) 
do argue in favour of this hypothesis. Further delineating phosphatase docking sites 
and other phosphosite preferences will provide a deeper mechanistic understanding of 
their activity. These could also provide new vistas for targeting cancer cells, which must 
be equally, if not more, reliant on phosphatase action. 
 
Finally, our description of the cell cycle has to shift from the realm of descriptive, 
qualitative events to a more quantitative understanding of the concepts involved, such 
as catalytic specificities and affinities of phosphatases towards their substrates, precise 
in vivo concentrations within different subcellular compartments of these proteins, 
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rates of changes in localization, etc., because it is the principles of chemistry and 
physics that ultimately control every aspect of cellular physiology.  
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Chapter 7. Appendix 
7.1 Determination of stoichiometry and shape of Cdc14 
7.1.1 Svedberg equation 
Used in chapter 3, the following equation gives the Svedberg equation: 
 𝑆 = 𝑀(1 − 𝑣2𝜌)/𝑁𝑜𝑓 = 𝑀(1 − 𝑣2𝜌)/(𝑁𝑜6𝜋𝜂𝑅𝑠)  
Here, M is the mass of the protein molecule in Dalton; No is Avogadro's number; v2 is 
the partial specific volume of the protein (Erickson, 2009). 
7.1.2 Smax formula 
The Smax value for Cdc14 was calculated using the following formula: 
 𝑆!"# = 0.00361𝑀2/3 
 
Here, M is the mass of the protein molecule in Dalton. 
 
7.2 List of early phosphopeptides 
Table 7.1 gives the list of phosphopeptides that disappears with ‘early’ timing (using 
data from (Kuilman et al., 2015)). The site of phosphorylation is followed by a lower-
case ‘p’ 
 
Systematic name Phosphopeptide 
YAR002W GDSTPVQPDLSVTpQK 
YBL007C NFTKSpSR 
YFL007W SpGRPSSSQGEIK 
YHR182W TSSTPTTpERPK 
Appendix 
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YJR083C VTTpLKPK 
YKR069W LEDFETSSSpNKK 
YLR190W NAGSFQNLLNSpTK 
YMR303C;YOL086C GLVKSpIK 
YOR051C KSDEPSRESTpVR 
YPL116W SNASpEKELHENKPR 
YAR002W SNVVVAETSpEKK 
YGL222C KHSpPSSpSSTTTLGK 
YAL035W STPAATPAATPTpSSASPNKK 
YBL103C VRSpSSSFR 
YBR007C LFKSpR 
YCR093W RQTpLQSNA 
YDL164C NKPTEGTPSpK 
YDR130C HSIQVTpR 
YDR155C KVESLGSpSGATK 
YDR358W VSLSSPKSpQENDTVVDILGDAHSK 
YDR458C MQIQEEKSpK 
YDR466W ASSEPSSpPPISR 
YER059W HESpSNESSLDK 
YER093C NITSSSpSTITNESSK 
YER161C KASpGATLR 
YGL075C YVYAHDTpSQNSR 
YHR056C SDSpDVPSMDQIR 
YHR090C SVTPVSpSIEK 
YHR149C SHGSpIHNNQLSR 
YJL050W NADTNVGDTpDHTQDKK 
YJL065C ETASAPLCSpK 
YKL042W VKPENNMSETFATPTpNNR 
YKL062W QATVSpNTR 
YLR219W TRSpELQDNLK 
YML057W TERPQSSTTpIDSK 
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YML093W TAQSNGNDDEDASpQLK 
YNR006W ANSSpTTNIDHLK 
YOL081W NSDNVNSLNSSpK 
YOR222W GISSpMLMEAPK 
YPR022C ENDNDLSPNSSSSpAER 
 
Table 7.1 – List of ‘early’ substrates used for the sequence logo in Fig. 
4.1. 
The table gives the systematic name of the protein along with the 
phosphopeptide sequence, with the phosphorylation site denoted with a lower-
case p. 
 
7.3 Michaelis-Menten equation 
Kinetics of enzyme substrate catalysis discussed in the introduction are often best 
described by the Michaelis-Menten equation: 𝑣 =  𝑉𝑚𝑎𝑥 [𝑆]𝐾𝑚 + [𝑆] 
 
Here, v refers to the velocity of substrate catalysis or product accumulation, Vmax is the 
maximum velocity achieved by the system and Km is the Michaelis constant, substrate 
concentration at which v is 50% of Vmax. 
 
Integrated form of the equation used in section 5.6.2 is: 
[𝑆 𝑃] 𝑡 =  [𝑆 𝑃] 0 (1 − 𝑒−𝑘𝑐𝑎𝑡𝐾𝑚 𝐸0 𝑡) 
where, [SP] is the phosphosubstrate concentration at time t, [SP]0 is the 
phosphosubstrate concentration at time 0 (0.64 µM), e is Euler’s number = 2.71828, E0 
is the enzyme concentration = 6.4 nM, and kcat/Km is the catalytic efficiency. 
Reference List 
 
166 
 
Reference List 
 
Adams, P.D., Sellers, W.R., Sharma, S.K., Wu, A.D., Nalin, C.M. and Kaelin, W.G., Jr, 
1996. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-
like cyclin-dependent kinase inhibitors. Molecular and Cellular Biology, 16(12), 
pp.6623–6633. 
Agostinis, P., Derua, R., Sarno, S., Goris, J. and Merlevede, W., 1992. Specificity of the 
polycation‐stimulated (type‐2A) and ATP, Mg‐dependent (type‐1) protein 
phosphatases toward substrates phosphorylated by P34cdc2 kinase. The FEBS Journal, 
205(1), pp.241–248. 
Agostinis, P., Goris, J., Pinna, L.A., Marchiori, F., Perich, J.W., Meyer, H.E. and 
Merlevede, W., 1990. Synthetic peptides as model substrates for the study of the 
specificity of the polycation‐stimulated protein phosphatases. The FEBS Journal, 189(2), 
pp.235–241. 
Akiyoshi, B. and Biggins, S., 2010. Cdc14-Dependent Dephosphorylation of a 
Kinetochore Protein Prior to Anaphase in Saccharomyces cerevisiae. Genetics, 186(4), 
pp.1487–1491. 
Akiyoshi, B., Nelson, C.R., Ranish, J.A. and Biggins, S., 2009. Quantitative proteomic 
analysis of purified yeast kinetochores identifies a PP1 regulatory subunit. Genes & 
Development, 23(24), pp.2887–2899. 
Archambault, V., Chang, E.J., Drapkin, B.J., Cross, F.R., Chait, B.T. and Rout, M.P., 
2004. Targeted Proteomic Study of the Cyclin-Cdk Module. Molecular Cell, 14(6), 
pp.699–711. 
Asakawa, K., Yoshida, S., Otake, F. and Toh-e, A., 2001. A Novel Functional Domain of 
Cdc15 Kinase Is Required for Its Interaction With Tem1 GTPase in Saccharomyces 
cerevisiae. Genetics, 157(4), pp.1437–1450. 
Azzam, R., 2004. Phosphorylation by Cyclin B-Cdk Underlies Release of Mitotic Exit 
Activator Cdc14 from the Nucleolus. Science, 305(5683), pp.516–519. 
Bardin, A.J., Boselli, M.G. and Amon, A., 2003. Mitotic Exit Regulation through 
Distinct Domains within the Protein Kinase Cdc15. Molecular and Cellular Biology, 
23(14), pp.5018–5030. 
Bardin, A.J., Visintin, R. and Amon, A., 2000. A Mechanism for Coupling Exit from 
Mitosis to Partitioning of the Nucleus. Cell, 102(1), pp.21–31. 
Bardwell, A.J., Flatauer, L.J., Matsukuma, K., Thorner, J. and Bardwell, L., 2001. A 
Conserved Docking Site in MEKs Mediates High-affinity Binding to MAP Kinases and 
Cooperates with a Scaffold Protein to Enhance Signal Transmission. Journal of 
Reference List 
 
167 
 
Biological Chemistry, 276(13), pp.10374–10386. 
Baro, B., Rodriguez-Rodriguez, J.-A., Calabria, I., Hernáez, M.L., Gil, C. and Queralt, 
E., 2013. Dual Regulation of the Mitotic Exit Network (MEN) by PP2A-Cdc55 
Phosphatase. PLoS Genetics, 9(12), p.e1003966. 
Barral, Y., Jentsch, S. and Mann, C., 1995. G1 cyclin turnover and nutrient uptake are 
controlled by a common pathway in yeast. Genes & Development, 9(4), pp.399–409. 
Bembenek, J., Kang, J., Kurischko, C., Li, B., Raab, J.R., Belanger, K.D., Luca, F.C. and 
Yu, H., 2014. Crm1-Mediated Nuclear Export of Cdc14 is Required for the Completion 
of Cytokinesis in Budding Yeast. Cell Cycle, 4(7), pp.961–971. 
Berdougo, E., Nachury, M.V., Jackson, P.K. and Jallepalli, P.V., 2014. The nucleolar 
phosphatase Cdc14Bis dispensable for chromosome segregation and mitotic exit in 
human cells. Cell Cycle, 7(9), pp.1184–1190. 
Bernal, M., Zhurinsky, J., Iglesias-Romero, A.B., Sanchez-Romero, M.A., Flor-Parra, I., 
Tomas-Gallardo, L., Perez-Pulido, A.J., Jimenez, J. and Daga, R.R., 2014. Proteome-
wide search for PP2A substrates in fission yeast. PROTEOMICS, 14(11), pp.1367–1380. 
Bhaduri, S. and Pryciak, P.M., 2011. Cyclin-Specific Docking MotifsPromote 
Phosphorylation of Yeast Signaling Proteins by G1/S Cdk Complexes. Current Biology, 
21(19), pp.1615–1623. 
Bhaduri, S., Valk, E., Winters, M.J., Gruessner, B., Loog, M. and Pryciak, P.M., 2015. A 
Docking Interface in the Cyclin Cln2 Promotes Multi-site Phosphorylation of 
Substrates and Timely Cell-Cycle Entry. Current Biology, 25(3), pp.316–325. 
Bloom, J. and Cross, F.R., 2007a. Multiple levels of cyclin specificity in cell-cycle 
control. Nature Reviews Molecular Cell Biology, 8(2), pp.149–160. 
Bloom, J. and Cross, F.R., 2007b. Novel Role for Cdc14 Sequestration: Cdc14 
Dephosphorylates Factors That Promote DNA Replication. Molecular and Cellular 
Biology, 27(3), pp.842–853. 
Bloom, J., Cristea, I.M., Procko, A.L., Lubkov, V., Chait, B.T., Snyder, M. and Cross, 
F.R., 2011. Global Analysis of Cdc14 Phosphatase Reveals Diverse Roles in Mitotic 
Processes. Journal of Biological Chemistry, 286(7), pp.5434–5445. 
Bokros, M., Gravenmier, C., Jin, F., Richmond, D. and Wang, Y., 2016. Fin1-PP1 Helps 
Clear Spindle Assembly Checkpoint Protein Bub1 from Kinetochores in Anaphase. Cell 
Reports, 0(0). 
Bouchoux, C. and Uhlmann, F., 2011. A Quantitative Model for Ordered Cdk Substrate 
Dephosphorylation during Mitotic Exit. Cell, 147(4), pp.803–814. 
Bourne, Y., Watson, M.H., Arvai, A.S., Bernstein, S.L., Reed, S.I. and Tainer, J.A., 2000. 
Reference List 
 
168 
 
Crystal structure and mutational analysis of the Saccharomyces cerevisiae cell cycle 
regulatory protein Cks1: implications for domain swapping, anion binding and protein 
interactions. Structure, 8(8), pp.841–850. 
Boustany, L.M. and Cyert, M.S., 2002. Calcineurin-dependent regulation of Crz1p 
nuclear export requires Msn5p and a conserved calcineurin docking site. Genes & 
Development, 16(5), pp.608–619. 
Bremmer, S.C., 2009. Characterization of the Cdc14 phosphatase activity and 
regulation in budding yeast. PhD Thesis, Purdue University. 
Bremmer, S.C., Hall, H., Martinez, J.S., Eissler, C.L., Hinrichsen, T.H., Rossie, S., 
Parker, L.L., Hall, M.C. and Charbonneau, H., 2012. Cdc14 Phosphatases Preferentially 
Dephosphorylate a Subset of Cyclin-dependent kinase (Cdk) Sites Containing 
Phosphoserine. Journal of Biological Chemistry, 287(3), pp.1662–1669. 
Burgess, A., Vigneron, S., Brioudes, E., Labbé, J.-C., Lorca, T. and Castro, A., 2010. Loss 
of human Greatwall results in G2 arrest and multiple mitotic defects due to 
deregulation of the cyclin B-Cdc2/PP2A balance. Proceedings of the National Academy 
of Sciences, 107(28), pp.12564–12569. 
Camps, M., Anthony, N., Corine, G., Bruno, A., Marco, M., Christian, C., Ursula, B. 
and Steve, A., 1998. Catalytic Activation of the Phosphatase MKP-3 by ERK2 Mitogen-
Activated Protein Kinase. Science, 280(5367), pp.1262–1265. 
Celton-Morizur, S., Bordes, N., Fraisier, V., Tran, P.T. and Paoletti, A., 2004. C-
Terminal Anchoring of mid1p to Membranes Stabilizes Cytokinetic Ring Position in 
Early Mitosis in Fission Yeast. Molecular and Cellular Biology, 24(24), pp.10621–10635. 
Chen, F., Archambault, V., Kar, A., Lio, P., D'Avino, P.P., Sinka, R., Lilley, K., Laue, 
E.D., Deak, P., Capalbo, L. and Glover, D.M., 2007. Multiple Protein Phosphatases Are 
Required for Mitosis in Drosophila. Current Biology, 17(4), pp.293–303. 
Chen, Z.A., Jawhari, A., Fischer, L., Buchen, C., Tahir, S., Kamenski, T., Rasmussen, M., 
Lariviere, L., Bukowski-Wills, J.-C., Nilges, M., Cramer, P. and Rappsilber, J., 2010. 
Architecture of the RNA polymerase II–TFIIF complex revealed by cross-linking and 
mass spectrometry. The EMBO Journal, 29(4), pp.717–726. 
Chou, M.F. and Schwartz, D., 2002. Biological Sequence Motif Discovery Using motif-x. 
onlinelibrary.wiley.com. Hoboken, NJ, USA: Current Protocols in Bioinformatics. 
Cori, G.T. and Cori, C.F., 1945. The enzymatic conversion of Phosphorylase a to b. The 
Journal of Biological Chemistry, 158, pp.321–322. 
Coudreuse, D. and Nurse, P., 2010. Driving the cell cycle with a minimal CDK control 
network. Nature, 468(7327), pp.1074–1079. 
Crooks, G.E., Hon, G., Chandonia, J.M. and Brenner, S.E., 2004. WebLogo: A Sequence 
Reference List 
 
169 
 
Logo Generator. Genome Research, 14(6), pp.1188–1190. 
Cueille, N., Salimova, E., Esteban, V., Blanco, M., Moreno, S., Bueno, A. and Simanis, 
V., 2001. Flp1, a fission yeast orthologue of the S. cerevisiae  
CDC14 gene, is not required for cyclin degradation or rum1p stabilisation and 
at the end of mitosis. Journal of Cell Science, 114(14), pp.2649–2664. 
Culotti, J. and Hartwell, L.H., 1971. Genetic control of the cell division cycle in yeast. 
Experimental Cell Research, 67(2), pp.389–401. 
Cundell, M.J., Bastos, R.N., Zhang, T., Holder, J., Gruneberg, U., Novak, B. and Barr, 
F.A., 2013. The BEG (PP2A-B55/ENSA/Greatwall) Pathway Ensures Cytokinesis 
follows Chromosome Separation. Molecular Cell, pp.1–13. 
Cundell, M.J., Hutter, L.H., Bastos, R.N., Poser, E., Holder, J., Mohammed, S., Novak, 
B. and Barr, F.A., 2016. A PP2A-B55 recognition signal controls substrate 
dephosphorylation kinetics during mitotic exit. The Journal of Cell Biology, 214(5), 
pp.539–554. 
D'Amours, D., Stegmeier, F. and Amon, A., 2004. Cdc14 and Condensin Control the 
Dissolution of Cohesin-Independent Chromosome Linkages at Repeated DNA. Cell, 
117(4), pp.455–469. 
Davey, N.E., Cyert, M.S. and Moses, A.M., 2015. Short linear motifs – ex nihilo 
evolution of protein regulation. Cell Communication and Signaling, 13(43). 
Dephoure, N., Zhou, C., Villen, J., Beausoleil, S.A., Bakalarski, C.E., Elledge, S.J. and 
Gygi, S.P., 2008. A quantitative atlas of mitotic phosphorylation. Proceedings of the 
National Academy of Sciences, 105(31), pp.10762–10767. 
Draetta, G., Luca, F., Westendorf, J., Brizuela, L., Ruderman, J. and Beach, D., 1989. 
cdc2 protein kinase is complexed with both cyclin A and B: Evidence for proteolytic 
inactivation of MPF. Cell, 56(5), pp.829–838. 
Drapkin, B.J., Lu, Y., Procko, A.L., Timney, B.L. and Cross, F.R., 2009. Analysis of the 
mitotic exit control system using locked levels of stable mitotic cyclin. Molecular 
Systems Biology, 5. 
Dryden, S.C., Nahhas, F.A., Nowak, J.E., Goustin, A.S. and Tainsky, M.A., 2003. Role 
for Human SIRT2 NAD-Dependent Deacetylase Activity in Control of Mitotic Exit in 
the Cell Cycle. Molecular and Cellular Biology, 23(9), pp.3173–3185. 
Egloff, M.P., Johnson, D.F., Moorhead, G., Cohen, P.T.W., Cohen, P. and Bardford, D., 
1997. Structural basis for the recognition of regulatory subunits by the catalytic subunit 
of protein phosphatase 1. The EMBO Journal, 16(8), pp.1876–1887. 
Reference List 
 
170 
 
Eissler, C.L., Mazón, G., Powers, B.L., Savinov, S.N., Symington, L.S. and Hall, M.C., 
2014. The Cdk/Cdc14 Module Controls Activation of the Yen1 Holliday Junction 
Resolvase to Promote Genome Stability. Molecular Cell, 54(1), pp.80–93. 
Elia, A.E.H., Cantley, L.C. and Yaffe, M.B., 2003. Proteomic Screen Finds pSer/pThr-
Binding Domain Localizing Plk1 to Mitotic Substrates. Science, 299(5610), pp.1228–
1231. 
Epstein, C.B. and Cross, F.R., 1992. CLB5: a novel B cyclin from budding yeast with a 
role in S phase. Genes & Development, 6(9), pp.1695–1706. 
Erickson, H.P., 2009. Size and Shape of Protein Molecules at the Nanometer Level 
Determined by Sedimentation, Gel Filtration, and Electron Microscopy. Biological 
Procedures Online, 11(1), pp.32–51. 
Errico, A., Deshmukh, K., Tanaka, Y., Pozniakovsky, A. and Hunt, T., 2010. 
Identification of substrates for cyclin dependent kinases. Advances in Enzyme 
Regulation, 50(1), pp.375–399. 
Fabrini, R., De Luca, A., Stella, L., Mei, G., Orioni, B., Ciccone, S., Federici, G., Bello, 
Lo, M. and Ricci, G., 2009. Monomer−Dimer Equilibrium in Glutathione Transferases: 
A Critical Re-Examination. Biochemistry, 48(43), pp.10473–10482. 
Ferguson, A.M., White, L.S., Donovan, P.J. and Piwnica-Worms, H., 2005. Normal Cell 
Cycle and Checkpoint Responses in Mice and Cells Lacking Cdc25B and Cdc25C 
Protein Phosphatases. Molecular and Cellular Biology, 25(7), pp.2853–2860. 
Ferrigno, P., Langan, T.A. and Cohen, P., 1993. Protein phosphatase 2A1 is the major 
enzyme in vertebrate cell extracts that dephosphorylates several physiological substrates 
for cyclin-dependent protein kinases. Molecular Biology of the Cell, 4(7), pp.669–677. 
Fischer, E.H. and Krebs, E.G., 1955. Conversion of phosphorylase b to phosphorylase a 
in muscle extracts. Journal of Biological Chemistry, pp.121–132. 
Fisher, D.L. and Nurse, P., 1996. A single fission yeast mitotic cyclin B p34cdc2 kinase 
promotes both S-phase and mitosis in the absence of G1 cyclins. The EMBO Journal, 
15(4), pp.850–860. 
Fragkos, M., Ganier, O., Coulombe, P. and Méchali, M., 2015. DNA replication origin 
activation in space and time. Nature Reviews Molecular Cell Biology, 16(6), pp.360–374. 
Fu, C., Ward, J.J., Loiodice, I., Velve-Casquillas, G., Nedelec, F.J. and Tran, P.T., 2009. 
Phospho-Regulated Interaction between Kinesin-6 Klp9p and Microtubule Bundler 
Ase1p Promotes Spindle Elongation. Developmental Cell, 17(2), pp.257–267. 
Gautier, J., Norbury, C., Lohka, M., Nurse, P. and Maller, J., 1988. Purified maturation-
promoting factor contains the product of a Xenopus homolog of the fission yeast cell 
cycle control gene cdc2. Cell, 54(3), pp.433–439. 
Reference List 
 
171 
 
Gavet, O. and Pines, J., 2010. Progressive Activation of CyclinB1-Cdk1 Coordinates 
Entry to Mitosis. Developmental Cell, 18(4), pp.533–543. 
Geil, C., Schwab, M. and Seufert, W., 2008. A Nucleolus-Localized Activator of Cdc14 
Phosphatase Supports rDNA Segregation in Yeast Mitosis. Current Biology, 18(13), 
pp.1001–1005. 
Geng, Y., Yu, Q., Sicinska, E., Das, M., Schneider, J.E., Bhattacharya, S., Rideout, W.M., 
III, Bronson, R.T., Gardner, H. and Sicinski, P., 2003. Cyclin E Ablation in the Mouse. 
Cell, 114(4), pp.431–443. 
Ghaemmaghami, S., Huh, W.-K., Bower, K., Howson, R.W., Belle, A., Dephoure, N., 
O'Shea, E.K. and Weissman, J.S., 2003. Global analysis of protein expression in yeast. 
Nature, 425(6959), pp.737–741. 
Gharbi-Ayachi, A., Labbe, J.C., Burgess, A., Vigneron, S., Strub, J.M., Brioudes, E., 
Van-Dorsselaer, A., Castro, A. and Lorca, T., 2010. The Substrate of Greatwall Kinase, 
Arpp19, Controls Mitosis by Inhibiting Protein Phosphatase 2A. Science, 330(6011), 
pp.1673–1677. 
Glotzer, M., Murray, A.W. and Kirschner, M.W., 1991. Cyclin is degraded by the 
ubiquitin pathway. Nature, 349(6305), pp.132–138. 
Godfrey, M., Touati, S.A., Kataria, M., Jones, A., Snijders, A.P. and Uhlmann, F., 
PP2ACdc55 phosphatase imposes phosphothreonine-specific ordering of cell cycle 
phosphorylation. In revision. 
Goldman, A., Roy, J., Bodenmiller, B., Wanka, S., Landry, C.R., Aebersold, R. and 
Cyert, M.S., 2014. The Calcineurin Signaling Network Evolves via Conserved Kinase-
Phosphatase Modules that Transcend Substrate Identity. Molecular Cell, 55(3), pp.422–
435. 
Grallert, A., Boke, E., Hagting, A., Ben Hodgson, Connolly, Y., Griffiths, J.R., Smith, 
D.L., Pines, J. and Hagan, I.M., 2014. A PP1-PP2A phosphatase relay controls mitotic 
progression. Nature, pp.1–19. 
Gray, C.H., Good, V.M., Tonks, N.K. and Barford, D., 2003. The structure of the cell 
cycle protein Cdc14 reveals a proline-directed protein phosphatase. The EMBO Journal, 
22(14), pp.3524–3535. 
Gruneberg, U., Glotzer, M., Gartner, A. and Nigg, E.A., 2002. The CeCDC-14 
phosphatase is required for cytokinesis in the Caenorhabditis elegansembryo. The 
Journal of Cell Biology, 158(5), pp.901–914. 
Hall, M.C., Jeong, D.E., Henderson, J.T., Choi, E., Bremmer, S.C., Iliuk, A.B. and 
Charbonneau, H., 2008. Cdc28 and Cdc14 Control Stability of the Anaphase-
promoting Complex Inhibitor Acm1. Journal of Biological Chemistry, 283(16), 
pp.10396–10407. 
Reference List 
 
172 
 
Hartwell, L.H., Culotti, J., Pringle, J.R. and Reid, B.J., 1974. Genetic Control of the Cell 
Division Cycle in Yeast: A model to account for the order of cell cycle events is deduced 
from the phenotypes of yeast mutants. Science, 183(4120), pp.46–51. 
Heim, A., Konietzny, A. and Mayer, T.U., 2015. Protein phosphatase 1 is essential for 
Greatwall inactivation at mitotic exit. Nature Publishing Group, 16(11), pp.1501–1510. 
Hertz, E.P.T., Kruse, T., Davey, N.E., Montoya, G., Olsen, J.V. and Nilsson, J., 2016. A 
Conserved Motif Provides Binding Specificity to the PP2A-B56 Phosphatase. [online] 
Molecular Cell.  
Hégarat, N., Vesely, C., Vinod, P.K., Ocasio, C., Peter, N., Gannon, J., Oliver, A.W., 
Novak, B. and Hochegger, H., 2014. PP2A/B55 and Fcp1 Regulate Greatwall and Ensa 
Dephosphorylation during Mitotic Exit. PLoS Genetics, 10(1), p.e1004004. 
Higuchi, T. and Uhlmann, F., 2005. Stabilization of microtubule dynamics at anaphase 
onset promotes chromosome segregation. Nature Cell Biology, 433(7022), pp.171–176. 
Hobiger, K. and Friedrich, T., 2015. Voltage sensitive phosphatases: emerging kinship 
to protein tyrosine phosphatases from structure-function research. Frontiers in 
Pharmacology, 6. 
Hochegger, H., Dejsuphong, D., Sonoda, E., Saberi, A., Rajendra, E., Kirk, J., Hunt, T. 
and Takeda, S., 2007. An essential role for Cdk1 in S phase control is revealed via 
chemical genetics in vertebrate cells. The Journal of Cell Biology, 178(2), pp.257–268. 
Hochegger, H., Takeda, S. and Hunt, T., 2008. Cyclin-dependent kinases and cell-cycle 
transitions: does one fit all? Nature Reviews Molecular Cell Biology, 9(11), pp.910–916. 
Hogan, E. and Koshland, D., 1992. Addition of extra origins of replication to a 
minichromosome suppresses its mitotic loss in cdc6 and cdc14 mutants of 
Saccharomyces cerevisiae. Proceedings of the National Academy of Sciences, 89(7), 
pp.3098–3102. 
Holt, L.J., Hutti, J.E., Cantley, L.C. and Morgan, D.O., 2007. Evolution of Ime2 
Phosphorylation Sites on Cdk1 Substrates Provides a Mechanism to Limit the Effects of 
the Phosphatase Cdc14 in Meiosis. Molecular Cell, 25(5), pp.689–702. 
Holt, L.J., Krutchinsky, A.N. and Morgan, D.O., 2008. Positive feedback sharpens the 
anaphase switch. Nature, 454(7202), pp.353–357. 
Holt, L.J., Tuch, B.B., Villen, J., Johnson, A.D., Gygi, S.P. and Morgan, D.O., 2009. 
Global Analysis of Cdk1 Substrate Phosphorylation Sites Provides Insights into 
Evolution. Science, 325(5948), pp.1682–1686. 
Hu, F. and Aparicio, O.M., 2005. Swe1 regulation and transcriptional control restrict 
the activity of mitotic cyclins toward replication proteins in Saccharomyces cerevisiae. 
Proceedings of the National Academy of Sciences, 102(25), pp.8910–8915. 
Reference List 
 
173 
 
Hu, F., Wang, Y., Liu, D., Li, Y., Qin, J. and Elledge, S.J., 2001. Regulation of the 
Bub2/Bfa1 GAP Complex by Cdc5 and Cell Cycle Checkpoints. Cell, 107(5), pp.655–
665. 
Jackson, L.P., Reed, S.I. and Haase, S.B., 2006. Distinct Mechanisms Control the 
Stability of the Related S-Phase Cyclins Clb5 and Clb6. Molecular and Cellular Biology, 
26(6), pp.2456–2466. 
Jaspersen, S.L. and Morgan, D.O., 2000. Cdc14 activates Cdc15 to promote mitotic exit 
in budding yeast. Current Biology, 10(10), pp.615–618. 
Jaspersen, S.L., Charles, J.F. and Morgan, D.O., 1999. Inhibitory phosphorylation of the 
APC regulator Hct1 is controlled by the kinase Cdc28 and the phosphatase Cdc14. 
Current Biology, 9(5), pp.227–236. 
Jensen, S., Geymonat, M., Johnson, A.L., Segal, M. and Johnston, L.H., 2002. Spatial 
regulation of the guanine nucleotide exchange factor Lte1 in Saccharomyces cerevisiae. 
Journal of Cell Science, 115(24), pp.4977–4991. 
Jin, F., Liu, H., Liang, F., Rizkallah, R., Hurt, M.M. and Wang, Y., 2008. Temporal 
control of the dephosphorylation of Cdk substrates by mitotic exit pathways in budding 
yeast. Proceedings of the National Academy of Sciences, 105(42), pp.16177–16182. 
Jin, F., Richmond, D. and Wang, Y., 2014. The multilayer regulation of the metaphase-
to-anaphase transition. Cell Cycle, 8(5), pp.700–704. 
Johnson, L.N., Brown, N.R., Noble, M.E.M. and Endicott, J.A., 1999. The structural 
basis for specificity of substrate and recruitment peptides 
for cyclin-dependent kinases. Nature Cell Biology, 1(7), pp.438–443. 
Kalaszczynska, I., Geng, Y., Iino, T., Mizuno, S.-I., Choi, Y., Kondratiuk, I., Silver, D.P., 
Wolgemuth, D.J., Akashi, K. and Sicinski, P., 2009. Cyclin A Is Redundant in 
Fibroblasts but Essential in Hematopoietic and Embryonic Stem Cells. Cell, 138(2), 
pp.352–365. 
Kao, L., Wang, Y.T., Chen, Y.C., Tseng, S.F., Jhang, J.C., Chen, Y.J. and Teng, S.C., 
2014. Global Analysis of Cdc14 Dephosphorylation Sites Reveals Essential Regulatory 
Role in Mitosis and Cytokinesis. Molecular & Cellular Proteomics, 13(2), pp.594–605. 
Kennelly, P.J. and Krebs, E.G., 1991. Consensus sequences as substrate specificity 
determinants for protein kinases and protein phosphatases. The Journal of Biological 
Chemistry, 266(24), pp.15555–15558. 
Kimura, M., Suzuki, H. and Ishihama, A., 2002. Formation of a Carboxy-Terminal 
Domain Phosphatase (Fcp1)/TFIIF/RNA Polymerase II (pol II) Complex in 
Schizosaccharomyces pombe Involves Direct Interaction between Fcp1 and the Rpb4 
Subunit of pol II. Molecular and Cellular Biology, 22(5), pp.1577–1588. 
Reference List 
 
174 
 
Kobayashi, J., Hirano, H. and Matsuura, Y., 2015. Crystal structure of the karyopherin 
Kap121p bound to the extreme C-terminus of the protein phosphatase Cdc14p. 
Biochemical and Biophysical Research Communications, 463(3), pp.309–314. 
Kosugi, S., Hasebe, M., Tomita, M. and Yanagawa, H., 2009. Systematic identification 
of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of 
composite motifs. Proceedings of the National Academy of Sciences, 106(25), pp.10171–
10176. 
Kozar, K., Ciemerych, M.A., Rebel, V.I., Shigematsu, H., Zagozdzon, A., Sicinska, E., 
Geng, Y., Yu, Q., Bhattacharya, S., Bronson, R.T., Akashi, K. and Sicinski, P., 2004. 
Mouse Development and Cell Proliferation in the Absence of D-Cyclins. Cell, 118(4), 
pp.477–491. 
Kõivomägi, M., Örd, M., Iofik, A., Valk, E., Venta, R., Faustova, I., Kivi, R., Balog, 
E.R.M., Rubin, S.M. and Loog, M., 2013. Multisite phosphorylation networks as signal 
processors for Cdk1. Nature Structural & Molecular Biology, 20(12), pp.1415–1424. 
Kõivomägi, M., Valk, E., Venta, R., Iofik, A., Lepiku, M., Morgan, D.O. and Loog, M., 
2011. Dynamics of Cdk1 Substrate Specificity during the Cell Cycle. Molecular Cell, 
42(5), pp.610–623. 
Krasinska, L., de Bettignies, G., Fisher, D., Abrieu, A., Fesquet, D. and Morin, N., 2007. 
Regulation of multiple cell cycle events by Cdc14 homologues in vertebrates. 
Experimental Cell Research, 313(6), pp.1225–1239. 
Krebs, E.G. and Fischer, E.H., 1956. The phosphorylase b to a converting enzyme of 
rabbit skeletal muscle. Biochimica et Biophysica Acta, 20, pp.150–157. 
Krek, W., Ewen, M.E., Shirodhkar, S., Arany, Z., Kaelin, W.G., Jr and Livingston, D.M., 
1994. Negative regulation of the growth-promoting transcription factor E2F-1 by a 
stably bound cyclin A-dependent protein kinase. Cell, 78(1), pp.161–172. 
Kroll, E.S., Hyland, K.M., Hieter, P. and Li, J.J., 1996. Establishing genetic interactions 
by a synthetic dosage lethality phenotype. Genetics, 143(1), pp.95–102. 
Kuilman, T., Maiolica, A., Godfrey, M., Scheidel, N., Aebersold, R. and Uhlmann, F., 
2015. Identification of Cdk targets that control cytokinesis. The EMBO Journal, 34(1), 
pp.81–96. 
Lee, S.E., Jensen, S., Frenz, L.M., Johnson, A.L., Fesquet, D. and Johnston, L.H., 2001. 
The Bub2-dependent mitotic pathway in yeast acts every cell cycle and regulates 
cytokinesis. Journal of Cell Science, 114(12), pp.2345–2354. 
Li, L., Ernsting, B.R., Wishart, M.J., Lohse, D.L. and Dixon, J.E., 1997. A Family of 
Putative Tumor Suppressors Is Structurally and Functionally Conserved in Humans 
and Yeast. Journal of Biological Chemistry, 272(47), pp.29403–29406. 
Reference List 
 
175 
 
Lin, H., Ha, K., Lu, G., Fang, X., Cheng, R., Zuo, Q. and Zhang, P., 2015. Cdc14A and 
Cdc14B Redundantly Regulate DNA Double-Strand Break Repair. Molecular and 
Cellular Biology, pp.MCB.00233–15. 
Loog, M. and Morgan, D.O., 2005. Cyclin specificity in the phosphorylation of cyclin-
dependent kinase substrates. Nature, 434(7029), pp.104–108. 
López-Avilés, S., Kapuy, O., Novak, B. and Uhlmann, F., 2009. Irreversibility of mitotic 
exit is the consequence of systems-level feedback. Nature, 459(7246), pp.592–595. 
Lu, D., Hsiao, J.Y., Davey, N.E., Van Voorhis, V.A., Foster, S.A., Tang, C. and Morgan, 
D.O., 2014. Multiple mechanisms determine the order of APC/C substrate degradation 
in mitosis. The Journal of Cell Biology, 207(1), pp.23–39. 
Ma, S., Vigneron, S., Robert, P., Strub, J.M., Cianferani, S., Castro, A. and Lorca, T., 
2016. Greatwall dephosphorylation and inactivation upon mitotic exit is triggered by 
PP1. Journal of Cell Science. 
Mah, A.S., Jang, J. and Deshaies, R.J., 2001. Protein kinase Cdc15 activates the Dbf2-
Mob1 kinase complex. Proceedings of the National Academy of Sciences, 98(13), 
pp.7325–7330. 
Mailand, N., Gibbs-Seymour, I. and Bekker-Jensen, S., 2013. Regulation of PCNA–
protein interactions for genome stability. Nature Reviews Molecular Cell Biology, 14(5), 
pp.269–282. 
Mailand, N., Lukas, C., Kaiser, B.K., Jackson, P.K., Bartek, J. and Lukas, J., 2002. 
Deregulated human Cdc14A phosphatase disrupts centrosome separation and 
chromosome segregation. Nature Cell Biology, 4(4), pp.318–322. 
Manchado, E., Guillamot, M., de Cárcer, G., Eguren, M., Trickey, M., García-Higuera, 
I., Moreno, S., Yamano, H., Cañamero, M. and Malumbres, M., 2010. Targeting Mitotic 
Exit Leads to Tumor Regression In Vivo: Modulation by Cdk1, Mastl, and the 
PP2A/B55α,δ Phosphatase. Cancer Cell, 18(6), pp.641–654. 
Marianayagam, N.J., Sunde, M. and Matthews, J.M., 2004. The power of two: protein 
dimerization in biology. Trends in Biochemical Sciences, 29(11), pp.618–625. 
Masui, Y. and Markert, C.L., 1971. Cytoplasmic control of nuclear behavior during 
meiotic maturation of frog oocytes. Journal of Experimental Zoology, 177(2), pp.129–
145. 
Mayer-Jaekel, R.E., Ohkura, H., Gomes, R., Sunkel, C.E., Baumgartner, S., Hemmings, 
B.A. and Glover, D.M., 1993. The 55 kd regulatory subunit of Drosophila protein 
phosphatase 2A is required for anaphase. Cell, 72(4), pp.621–633. 
Mayordomo, I. and Sanz, P., 2002. The Saccharomyces cerevisiae 14-3-3 protein Bmh2 
is required for regulation of the phosphorylation status of Fin1, a novel intermediate 
Reference List 
 
176 
 
filament protein. Biochemical Journal, 365(1), pp.51–56. 
McCloy, R.A., Parker, B.L., Rogers, S., Chaudhuri, R., Gayevskiy, V., Hoffman, N.J., Ali, 
N., Watkins, D.N., Daly, R.J., James, D.E., Lorca, T., Castro, A. and Burgess, A., 2015. 
Global Phosphoproteomic Mapping of Early Mitotic Exit in Human Cells Identifies 
Novel Substrate Dephosphorylation Motifs. Molecular & Cellular Proteomics, 14(8), 
pp.2194–2212. 
McGrath, D.A., Balog, E.R.M., Kõivomägi, M., Lucena, R., Mai, M.V., Hirschi, A., 
Kellogg, D.R., Loog, M. and Rubin, S.M., 2013. Cks confers specificity to 
phosphorylation-dependent CDK signaling pathways. Nature Structural & Molecular 
Biology, 20(12), pp.1407–1414. 
McGuffin, L.J., Bryson, K. and Jones, D.T., 2000. The PSIPRED protein structure 
prediction server. Bioinformatics, 16(4), pp.404–405. 
Miller, D.P., Hall, H., Chaparian, R., Mara, M., Mueller, A., Hall, M.C. and Shannon, 
K.B., 2015. Dephosphorylation of Iqg1 by Cdc14 regulates cytokinesis in budding yeast. 
Molecular Biology of the Cell, 26(16), pp.2913–2926. 
Milo, R., Jorgensen, P., Moran, U., Weber, G. and Springer, M., 2009. BioNumbers--the 
database of key numbers in molecular and cell biology. Nucleic Acids Research, 
38(Database), pp.D750–D753. 
Minshull, J., Blow, J.J. and Hunt, T., 1989. Translation of cyclin mRNA is necessary for 
extracts of activated Xenopus eggs to enter mitosis. Cell, 56(6), pp.947–956. 
Mirchenko, L. and Uhlmann, F., 2010. Sli15INCENP Dephosphorylation Prevents 
Mitotic Checkpoint Reengagement Due to Loss of Tension at Anaphase Onset. Current 
Biology, 20(15), pp.1396–1401. 
Mocciaro, A. and Schiebel, E., 2010. Cdc14: a highly conserved family of phosphatases 
with non-conserved functions? Journal of Cell Science, 123(17), pp.2867–2876. 
Mocciaro, A., Berdougo, E., Zeng, K., Black, E., Vagnarelli, P., Earnshaw, W., Gillespie, 
D., Jallepalli, P. and Schiebel, E., 2010. Vertebrate cells genetically deficient for Cdc14A 
or Cdc14B retain DNA damage checkpoint proficiency but are impaired in DNA 
repair. The Journal of Cell Biology, 189(4), pp.631–639. 
Mochida, S. and Hunt, T., 2007. Calcineurin is required to release Xenopus egg extracts 
from meiotic M phase. Nature, 449(7160), pp.336–340. 
Mochida, S., Ikeo, S., Gannon, J. and Hunt, T., 2009. Regulated activity of PP2A–B55δ 
is crucial for controlling entry into and exit from mitosis in Xenopus egg extracts. The 
EMBO Journal, 28(18), pp.2777–2785. 
Mochida, S., Maslen, S.L., Skehel, M. and Hunt, T., 2010. Greatwall Phosphorylates an 
Inhibitor of Protein Phosphatase 2A That Is Essential for Mitosis. Science, 330(6011), 
Reference List 
 
177 
 
pp.1670–1673. 
Mohl, D.A., Huddleston, M.J., Collingwood, T.S., Annan, R.S. and Deshaies, R.J., 2009. 
Dbf2–Mob1 drives relocalization of protein phosphatase Cdc14 to the cytoplasm 
during exit from mitosis. The Journal of Cell Biology, 184(4), pp.527–539. 
Monica, Della, R., Visconti, R., Cervone, N., Serpico, A.F., Grieco, D. and Hunter, T., 
2015. Fcp1 phosphatase controls Greatwall kinase to promote PP2A-B55 activation and 
mitotic progression. eLife, 4, p.e10399. 
Morgan, D.O., 2007. The Cell Cycle: Principles of Control. New Science Press. 
Murray, A.W. and Kirschner, M.W., 1989. Cyclin synthesis drives the early embryonic 
cell cycle. Nature, 339(6222), pp.275–280. 
Musacchio, A., 2015. The Molecular Biology of Spindle Assembly Checkpoint Signaling 
Dynamics. Current Biology, 25(20), pp.R1002–R1018. 
Nigg, E.A., 1991. The substrates of the cdc2 kinase. Seminars in Cell Biology, 2(4), 
pp.261–270. 
Oikonomou, C. and Cross, F.R., 2011. Rising Cyclin-CDK Levels Order Cell Cycle 
Events. PLOS ONE, 6(6), p.e20788. 
Ovejero, S., Ayala, P., Bueno, A. and Sacristan, M.P., 2012. Human Cdc14A regulates 
Wee1 stability by counteracting CDK-mediated phosphorylation. Molecular Biology of 
the Cell, 23(23), pp.4515–4525. 
Pabbisetty, K.B., Yue, X., Li, C., Himanen, J.P., Zhou, R., Nikolov, D.B. and Hu, L., 
2007. Kinetic analysis of the binding of monomeric and dimeric ephrins to Eph 
receptors: Correlation to function in a growth cone collapse assay. Protein Science, 
16(3), pp.355–361. 
Pagliuca, F.W., Collins, M.O., Lichawska, A., Zegerman, P., Choudhary, J.S. and Pines, 
J., 2011. Quantitative Proteomics Reveals the Basis for the Biochemical Specificity of 
the Cell-Cycle Machinery. Molecular Cell, 43(3), pp.406–417. 
Palani, S., Meitinger, F., Boehm, M.E., Lehmann, W.D. and Pereira, G., 2012. Cdc14-
dependent dephosphorylation of Inn1 contributes to Inn1–Cyk3 complex formation. 
Journal of Cell Science, 125(13), pp.3091–3096. 
Pereira, G., 2003. Separase Regulates INCENP-Aurora B Anaphase Spindle Function 
Through Cdc14. Science, 302(5653), pp.2120–2124. 
Pereira, G., Manson, C., Grindlay, J. and Schiebel, E., 2002. Regulation of the Bfa1p–
Bub2p complex at spindle pole bodies by the cell cycle phosphatase Cdc14p. The 
Journal of Cell Biology, 157(3), pp.367–379. 
Reference List 
 
178 
 
Pédelacq, J.-D., Cabantous, S., Tran, T., Terwilliger, T.C. and Waldo, G.S., 2005. 
Engineering and characterization of a superfolder green fluorescent protein. Nature 
Biotechnology, 24(1), pp.79–88. 
Pfleger, C.M. and Kirschner, M.W., 1992. The KEN box: an APC recognition signal 
distinct from the D box targeted by Cdh1. Genes & Development, 14, pp.655–665. 
Potapova, T.A., Daum, J.R., Pittman, B.D., Hudson, J.R., Jones, T.N., Satinover, D.L., 
Stukenberg, P.T. and Gorbsky, G.J., 2006. The reversibility of mitotic exit in vertebrate 
cells. Nature, 440(7086), pp.954–958. 
Queralt, E. and Uhlmann, F., 2008. Separase cooperates with Zds1 and Zds2 to activate 
Cdc14 phosphatase in early anaphase. The Journal of Cell Biology, 182(5), pp.873–883. 
Queralt, E., Lehane, C., Novak, B. and Uhlmann, F., 2006. Downregulation of 
PP2ACdc55 Phosphatase by Separase Initiates Mitotic Exit in Budding Yeast. Cell, 
125(4), pp.719–732. 
Richardson, H.E., Wittenberg, C., Cross, F. and Reed, S.I., 1989. An essential G1 
function for cyclin-like proteins in yeast. Cell, 59(6), pp.1127–1133. 
Richter, K., Muschler, P., Hainzl, O. and Buchner, J., 2001. Coordinated ATP 
Hydrolysis by the Hsp90 Dimer. Journal of Biological Chemistry, 276(36), pp.33689–
33696. 
Rogers, S., McCloy, R., Watkins, D.N. and Burgess, A., 2015. Mechanisms regulating 
phosphatase specificity and the removal of individual phosphorylation sites during 
mitotic exit. Inside the Cell, pp.n/a–n/a. 
Rossio, V. and Yoshida, S., 2011. Spatial regulation of Cdc55–PP2A by Zds1/Zds2 
controls mitotic entry and mitotic exit in budding yeast. The Journal of Cell Biology, 
193(3), p.445. 
Saito, R.M., Perreault, A., Peach, B., Satterlee, J.S. and van den Heuvel, S., 2004. The 
CDC-14 phosphatase controls developmental cell-cycle arrest in C. elegans. Nature, 
6(8), pp.777–783. 
Santamaría, D., Barrière, C., Cerqueira, A., Hunt, S., Tardy, C., Newton, K., Cáceres, 
J.F., Dubus, P., Malumbres, M. and Barbacid, M., 2007. Cdk1 is sufficient to drive the 
mammalian cell cycle. Nature, 448(7155), pp.811–815. 
Schmitz, M.H.A., Held, M., Janssens, V., Hutchins, J.R.A., Hudecz, O., Ivanova, E., 
Goris, J., Trinkle-Mulcahy, L., Lamond, A.I., Poser, I., Hyman, A.A., Mechtler, K., 
Peters, J.-M. and Gerlich, D.W., 2010. Live-cell imaging RNAi screen identifies PP2A-
B55[alpha] and importin-[beta]1 as key mitotic exit regulators in human cells. Nature 
Cell Biology, 12(9), pp.886–893. 
Schwab, M., Lutum, A.S. and Seufert, W., 1997. Yeast Hct1 Is a Regulator of Clb2 
Reference List 
 
179 
 
Cyclin Proteolysis. Cell, 90(4), pp.683–693. 
Schwede, T., Kopp, J., Guex, N. and Peitsch, M.C., 2003. SWISS-MODEL: an 
automated protein homology-modeling server. Nucleic Acids Research, 31(13), 
pp.3381–3385. 
Schwob, E. and Nasmyth, K., 1993. CLB5 and CLB6, a new pair of B cyclins involved in 
DNA replication in Saccharomyces cerevisiae. Genes & Development, 7(7a), pp.1160–
1175. 
Shirayama, M., Tóth, A., Gálová, M. and Nasmyth, K., 1999. Access : APCCdc20 
promotes exit from mitosis by destroying the anaphase inhibitor Pds1 and cyclin Clb5 : 
Nature. Nature, 402(6758), pp.203–207. 
Shou, W., Azzam, R., Chen, S.L., Huddleston, M.J., Baskerville, C., Charbonneau, H., 
Annan, R.S., Carr, S.A. and Deshaies, R.J., 2002. Cdc5 influences phosphorylation of 
Net1 and disassembly of the RENT complex. BMC Molecular Biology, 3(1), p.1. 
Shou, W., Sakamoto, K.M., Keener, J., Morimoto, K.W., Traverso, E.E., Azzam, R., 
Hoppe, G.J., Feldman, R.M.R., DeModena, J., Moazed, D., Charbonneau, H., Nomura, 
M. and Deshaies, R.J., 2001. Net1 Stimulates RNA Polymerase I Transcription and 
Regulates Nucleolar Structure Independently of Controlling Mitotic Exit. Molecular 
Cell, 8(1), pp.45–55. 
Skoufias, D.A., Indorato, R.-L., Lacroix, F., Panopoulos, A. and Margolis, R.L., 2007. 
Mitosis persists in the absence of Cdk1 activity when proteolysis or protein 
phosphatase activity is suppressed. The Journal of Cell Biology, 179(4), pp.671–685. 
Songyang, Z., Blechner, S., Hoagland, N., Hoekstra, M.F., Piwnica-Worms, H. and 
Cantley, L.C., 1994. Use of an oriented peptide library to determine the optimal 
substrates of protein kinases. Current Biology, 4(11), pp.973–982. 
Stegmeier, F. and Amon, A., 2004. Closing Mitosis: The Functions of the Cdc14 
Phosphatase and Its Regulation. Annual Review of Genetics, 38(1), pp.203–232. 
Stegmeier, F., Visintin, R. and Amon, A., 2002. Separase, Polo Kinase, the Kinetochore 
Protein Slk19, and Spo12 Function in a Network that Controls Cdc14 Localization 
during Early Anaphase. Cell, 108(2), pp.207–220. 
Stern, B. and Nurse, P., 1996. A quantitative model for the cdc2 control of S phase and 
mitosis in fission yeast. Trends in Genetics, 12(9), pp.345–350. 
Strausfeld, U., Labbe, J.C., Fesquet, D., Cavadore, J.C., Picard, A., Sadhu, K., Russell, P. 
and Dorée, M., 1991. Dephosphorylation and activation of a p34cdc2/cyclin B complex 
in vitro by human CDC25 protein. Nature, 351(6323), pp.242–245. 
Sullivan, M. and Uhlmann, F., 2003. A non-proteolytic function of separase links the 
onset of anaphase to mitotic exit. Nature Cell Biology, 5(3), pp.249–254. 
Reference List 
 
180 
 
Sullivan, M., Higuchi, T., Katis, V.L. and Uhlmann, F., 2004. Cdc14 Phosphatase 
Induces rDNA Condensation and Resolves Cohesin-Independent Cohesion during 
Budding Yeast Anaphase. Cell, 117(4), pp.471–482. 
Sullivan, M., Holt, L. and Morgan, D.O., 2008. Cyclin-Specific Control of Ribosomal 
DNA Segregation. Molecular and Cellular Biology, 28(17), pp.5328–5336. 
Suzuki, K., Sako, K., Akiyama, K., Isoda, M., Senoo, C., Nakajo, N. and Sagata, N., 2015. 
Identification of non-Ser/Thr-Pro consensus motifs for Cdk1 and their roles in mitotic 
regulation of C2H2 zinc finger proteins and Ect2. Scientific Reports, 5, p.7929. 
Tanguay, P.-L., Rodier, G. and Meloche, S., 2010. C-terminal domain phosphorylation 
of ERK3 controlled by Cdk1 and Cdc14 regulates its stability in mitosis. Biochemical 
Journal, 428(1), pp.103–111. 
Taylor, G.S., Liu, Y., Baskerville, C. and Charbonneau, H., 1997. The Activity of 
Cdc14p, an Oligomeric Dual Specificity Protein Phosphatase from Saccharomyces 
cerevisiae, Is Required for Cell Cycle Progression. Journal of Biological Chemistry, 
272(38), pp.24054–24063. 
Tonks, N.K., 2006. Protein tyrosine phosphatases: from genes, to function, to disease. 
Nature Reviews Molecular Cell Biology, 7(11), pp.833–846. 
Traverso, E.E., Baskerville, C., Liu, Y., Shou, W., James, P., Deshaies, R.J. and 
Charbonneau, H., 2001a. Characterization of the Net1 Cell Cycle-dependent Regulator 
of the Cdc14 Phosphatase from Budding Yeast. Journal of Biological Chemistry, 276(24), 
pp.21924–21931. 
Traverso, E.E., Baskerville, C., Liu, Y., Shou, W., James, P., Deshaies, R.J. and 
Charbonneau, H., 2001b. Characterization of the Net1 Cell Cycle-dependent Regulator 
of the Cdc14 Phosphatase from Budding Yeast. Journal of Biological Chemistry, 276(24), 
pp.21924–21931. 
Traverso, E.E., Baskerville, C., Liu, Y., Shou, W., James, P., Deshaies, R.J. and 
Charbonneau, H., 2001c. Characterization of the Net1 Cell Cycle-dependent Regulator 
of the Cdc14 Phosphatase from Budding Yeast. Journal of Biological Chemistry, 276(24), 
pp.21924–21931. 
Tyers, M., 1996. The cyclin-dependent kinase inhibitor p40SIC1 imposes the 
requirement for Cln G1 cyclin function at Start. Proceedings of the National Academy of 
Sciences, 93(15), pp.7772–7776. 
Tyson, J.J. and Novak, B., 2011. Cell Cycle: Who Turns the Crank? Current Biology, 
21(5), pp.R185–R187. 
Ubersax, J.A., Woodbury, E.L., Quang, P.N., Paraz, M., Blethrow, J.D., Shah, K., Shokat, 
K.M. and Morgan, D.O., 2003. Targets of the cyclin-dependent kinase Cdk1. Nature, 
425(6960), pp.859–864. 
Reference List 
 
181 
 
Uhlmann, F., 2016. SMC complexes: from DNA to chromosomes. Nature Reviews 
Molecular Cell Biology, 17(7), pp.399–412. 
Uhlmann, F., Lottspeich, F. and Nasmyth, K., 1999. Sister-chromatid separation at 
anaphase onset is promoted by cleavage of the cohesin subunit Scc1. Nature, 400(6739), 
pp.37–42. 
van Hemert, M.J., Deelder, A.M., Molenaar, C., Steve, A. and van Heusden, G.P.H., 
2003. Self-association of the Spindle Pole Body-related Intermediate Filament Protein 
Fin1p and Its Phosphorylation-dependent Interaction with 14-3-3 Proteins in Yeast. 
Journal of Biological Chemistry, 278(17), pp.15049–15055. 
Van Roey, K., Uyar, B., Weatheritt, R.J., Dinkel, H., Seiler, M., Budd, A., Gibson, T.J. 
and Davey, N.E., 2014. Short Linear Motifs: Ubiquitous and Functionally Diverse 
Protein Interaction Modules Directing Cell Regulation. Chemical Reviews, 114(13), 
pp.6733–6778. 
Vazquez-Novelle, M.D., Mailand, N., Ovejero, S., Bueno, A. and Sacristan, M.P., 2010. 
Human Cdc14A Phosphatase Modulates the G2/M Transition through Cdc25A and 
Cdc25B. Journal of Biological Chemistry, 285(52), pp.40544–40553. 
Vigneron, S., Brioudes, E., Burgess, A., Labbé, J.-C., Lorca, T. and Castro, A., 2009. 
Greatwall maintains mitosis through regulation of PP2A. The EMBO Journal, 28(18), 
pp.2786–2793. 
Virchow, R.L.K., 1858. Cellular pathology. John Churchill. 
Visintin, C., Tomson, B.N., Rahal, R., Paulson, J., Cohen, M., Taunton, J., Amon, A. 
and Visintin, R., 2008. APC/C-Cdh1-mediated degradation of the Polo kinase Cdc5 
promotes the return of Cdc14 into the nucleolus. Genes & Development, 22(1), pp.79–
90. 
Visintin, R., Craig, K., Hwang, E.S., Prinz, S., Tyers, M. and Amon, A., 1998. The 
Phosphatase Cdc14 Triggers Mitotic Exit by Reversal of Cdk-Dependent 
Phosphorylation. Molecular Cell, 2(6), pp.709–718. 
Visintin, R., Hwang, E.S. and Amon, A., 1999. Cfi1 prevents premature exit from 
mitosis by anchoring Cdc14 phosphatase in the nucleolus : Article : Nature. Nature, 
398(6730), pp.818–823. 
Visintin, R., Stegmeier, F. and Amon, A., 2003. The Role of the Polo Kinase Cdc5 in 
Controlling Cdc14 Localization. Molecular Biology of the Cell, 14(11), pp.4486–4498. 
Wakula, P., Beullens, M., Ceulemans, H., Stalmans, W. and Bollen, M., 2003. 
Degeneracy and Function of the Ubiquitous RVXF Motif That Mediates Binding to 
Protein Phosphatase-1. Journal of Biological Chemistry, 278(21), pp.18817–18823. 
Walter, D., Hoffmann, S., Komseli, E.-S., Rappsilber, J., Gorgoulis, V. and Sørensen, 
Reference List 
 
182 
 
C.S., 2016. SCFCyclin F-dependent degradation of CDC6 suppresses DNA re-
replication. Nature Communications, 7, p.10530. 
Wan, J., Xu, H. and Grunstein, M., 1992. CDC14 of Saccharomyces cerevisiae. Cloning, 
sequence analysis, and transcription during the cell cycle. Journal of Biological 
Chemistry, 267(16), pp.11274–11280. 
Wang, J., Wang, Z., Yu, T., Yang, H., Virshup, D.M., Kops, G.J.P.L., Lee, S.H., Zhou, 
W., Li, X., Xu, W. and Rao, Z., 2016. Crystal structure of a PP2A B56-BubR1 complex 
and its implications for PP2A substrate recruitment and localization. Protein & Cell, 
7(7), pp.516–526. 
Wang, W.Q., Bembenek, J., Gee, K.R., Yu, H., Charbonneau, H. and Zhang, Z.Y., 2004. 
Kinetic and Mechanistic Studies of a Cell Cycle Protein Phosphatase Cdc14. Journal of 
Biological Chemistry, 279(29), pp.30459–30468. 
Wäsch, R. and Cross, F.R., 2002. APC-dependent proteolysis of the mitotic cyclin Clb2 
is essential for mitotic exit. Nature, 418(6897), pp.556–562. 
Wienken, C.J., Baaske, P., Rothbauer, U., Braun, D. and Duhr, S., 2010. Protein-binding 
assays in biological liquids using microscale thermophoresis. Nature Communications, 
1(7), p.100. 
Williams, B.C., Filter, J.J., Blake-Hodek, K.A., Wadzinski, B.E., Fuda, N.J., Shalloway, 
D., Goldberg, M.L. and Pines, J., 2014. Greatwall-phosphorylated Endosulfine is both 
an inhibitor and a substrate of PP2A-B55 heterotrimers. eLife, 3, p.e01695. 
Wilmes, G.M., Archambault, V., Austin, R.J., Jacobson, M.D., Bell, S.P. and Cross, F.R., 
2004. Interaction of the S-phase cyclin Clb5 with an ‘RXL’ docking sequence in the 
initiator protein Orc6 provides an origin-localized replication control switch. Genes & 
Development, 18(9), pp.981–991. 
Wlodarchak, N. and Xing, Y., 2016. PP2A as a master regulator of the cell cycle. Critical 
Reviews in Biochemistry and Molecular Biology, 51(3), pp.162–184. 
Wolf, F., Wandke, C., Isenberg, N. and Geley, S., 2006. Dose-dependent effects of stable 
cyclin B1 on progression through mitosis in human cells. The EMBO Journal, 25(12), 
pp.2802–2813. 
Wolfe, B.A. and Gould, K.L., 2004. Fission yeast Clp1p phosphatase affects G2/M 
transition and mitotic exit through Cdc25p inactivation. The EMBO Journal, 23(4), 
pp.919–929. 
Wolfe, B.A., McDonald, W.H., Yates, J.R., III and Gould, K.L., 2006. Phospho-
Regulation of the Cdc14/Clp1 Phosphatase Delays Late Mitotic Events in S. pombe. 
Developmental Cell, 11(3), pp.423–430. 
Woodbury, E.L. and Morgan, D.O., 2006. Cdk and APC activities limit the spindle-
Reference List 
 
183 
 
stabilizing function of Fin1 to anaphase. Nature Cell Biology, 9(1), pp.106–112. 
Woodbury, E.L. and Morgan, D.O., 2007. The Role of Self-association in Fin1 Function 
on the Mitotic Spindle. Journal of Biological Chemistry, 282(44), pp.32138–32143. 
Wu, J., Cho, H.P., Rhee, D.B., Johnson, D.K., Dunlap, J., Liu, Y. and Wang, Y., 2008. 
Cdc14B depletion leads to centriole amplification, and its overexpression prevents 
unscheduled centriole duplication. The Journal of Cell Biology, 181(2), pp.475–483. 
Wu, J.Q., Guo, J.Y., Tang, W., Yang, C.-S., Freel, C.D., Chen, C., Nairn, A.C. and 
Kornbluth, S., 2009. PP1-mediated dephosphorylation of phosphoproteins at mitotic 
exit is controlled by inhibitor-1 and PP1 phosphorylation. Nature, 11(5), pp.644–651. 
Yeong, F.M., Lim, H.H., Padmashree, C.G. and Surana, U., 2000. Exit from Mitosis in 
Budding Yeast. Molecular Cell, 5(3), pp.501–511. 
Yoshida, S. and Toh-e, A., 2002. Budding yeast Cdc5 phosphorylates Net1 and assists 
Cdc14 release from the nucleolus. Biochemical and Biophysical Research 
Communications, 294(3), pp.687–691. 
Zhai, Y., Yung, P.Y.K., Huo, L. and Liang, C., 2010. Cdc14p resets the competency of 
replication licensing by dephosphorylating multiple initiation proteins during mitotic 
exit in budding yeast. Journal of Cell Science, 123(22), pp.3933–3943. 
 
